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1. Summary 
 
PRC1 targeting to heterochromatin and its dependency with the Suv39h/Hp1β pathway in 
mouse zygotes. 
 Constitutive heterochromatin in mouse is mainly detected around the centromeres of 
chromosomes. It consists of highly abundant, repetitive AT-rich DNA. These repeats are called 
major satellite repeats. They are marked by the epigenetic, repressive Suv39h pathway in 
various cell types. In mouse zygotes, maternal pericentric heterochromatin (PCH) displays the 
marks of the Suv39h pathway: tri-methylation of lysine 9 on histone tail H3 (H3K9me3), 
H4K20me3 and Hp1β (Santos et al., 2005) (Figure 1.1). Paternal PCH on the other hand does 
not exhibit the Suv39h marks. It is enriched for proteins of another major epigenetic repressive 
complex: the Polycomb repressive complex 1 (PRC1) (Puschendorf et al., 2008) (Figure 1.2). 
This complex, consisting of Polycomb group proteins (PcG), has been shown to be important for 
gene repression (Lewis, 1978). In mouse zygotes, however, PRC1 also represses paternal 
transcription of major satellite repeats. It has been shown to mark paternal PCH immediately 
after fertilization (Puschendorf et al., 2008).  
 The first major question addressed in this thesis is how PRC1 is targeted to PCH. We 
show that PRC1 targeting to paternal PCH is dependent on two protein modules of Cbx2, a core 
member of PRC1 in early mouse zygotes. The first module is the N-terminal chromodomain 
(CD), which preferentially binds H3K27me3 (Kaustov et al., 2011), a histone mark that appears 
on paternal PCH in the late zygotic stages. The second module is an AT-hook motif, which is 
located just C-terminal of the CD. AT-hook motifs have been shown to bind the minor groove of 
AT-rich DNA sequences, therefore, the AT-rich major satellite repeats are putative target 
sequences for this motif. Indeed, treatment of zygotes with dystamicin, a compound that binds 
AT-rich DNA sequences, diminishes PRC1 enrichment at paternal PCH in early zygotes. 
Furthermore, insertion of a point mutation into either the CD or the AT-hook results in reduced 
heterochromatin enrichment. Nevertheless, only the introduction of point mutations into both 
modules results in complete loss of enrichment. Additionally, the Cbx2 targeting to PCH is Ezh2 
and RNA independent. By performing fluorescence recovery after bleaching (FRAP) 
experiments, we show that overexpressed Cbx2 at heterochromatin is dynamic with an average 
half recovery time of 7 seconds. Upon introduction of point mutations into either the CD or AT-
hook modules, the dynamics strongly increase, suggesting weaker binding. Finally, we show 
S
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that among all five Cbx paralogs in mouse, only Cbx2 contains an AT-hook motif, which is highly 
conserved from fish to humans. Thus, this targeting mechanism of PRC1 is strictly Cbx2 
dependent. 
 The second major question addressed in this thesis concerned the hierarchy of the two 
major epigenetic, repressive pathways at PCH in mouse zygotes. Zygotes that are deficient for 
the Suv39h2 histone methyltransferase (HMT), as well as embryonic stem cells (ESCs) lacking 
both Suv39h1 and Suv39h2 HMTs and therefore any downstream mark, exhibit PRC1 
enrichment at paternal and maternal PCH and at chromocenters in ESCs, respectively. These 
observations suggest a hierarchy between the two epigenetic, repressive pathways. We show 
that Hp1β, a downstream member of the Suv39h pathway, but not the Suv4-20 HMTs, actively 
prevents PRC1 members from binding to maternal PCH. In Hp1β maternally deficient zygotes 
(Hp1βm-z+) as in Suv39h2m-z+ zygotes, PRC1 members strongly localize to maternal PCH, 
despite the presence of the H3K9me3 and H4K20me3 maternal histone marks. Furthermore, 
we show that enhancing the affinity of the Cbx2 CD for H3K9me3 by a single amino acid (aa) 
exchange enables its co-localization with members of the Suv39h pathway on maternal PCH 
and in wild type (wt) ESC, respectively. We show that this aa residue confers the H3K27me3 
specificity of Cbx2. Interestingly, this aa residue is conserved in Cbx2 among eumetazoa.  
 Taken together, we propose a simple targeting mechanism for PRC1 to 
heterochromatin, based on a CD and an AT-hook motif. A similar targeting mechanism for 
PRC1 can be envisioned for the AT-rich DNA of euchromatin. Furthermore, we map the 
interdependency of the Suv39h pathway with PRC1 to the CDs of Hp1β and Cbx2.   
 
Size Difference of Maternal and Paternal Pronuclei 
 Although the maternal and the paternal genomes are equally large, the paternal 
pronucleus (PN) is bigger than the maternal PN. This suggests that DNA in the maternal PN is 
more compacted. Interestingly, this size difference is not only observed in PN5 zygotes but 
throughout zygotic development, which suggests that it is maintained by proteins present in the 
zygote.  
 Here we show that the size difference between maternal PN and paternal PN is due to 
Hp1β. The maternal PN is smaller than the paternal PN because of Hp1β, putatively bound to 
maternal H3K9me3. In Hp1βm-z+ zygotes, this size difference is lost. Microinjection of 
T
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recombinant Hp1β into Hp1βm-z+ zygotes reestablishes the size decrease of maternal PN, 
suggesting that it is a zygotic phenotype. Furthermore, the maternal and paternal PN sizes of wt 
zygotes can be decreased by the presence and the enzymatic activity of abundant exogenously 
provided proteins of the Suv39h pathway. 
 
Impact of Epigenetic Repressors on Zygotic 5mC to 5hmC conversion  
 Within a few hours after fertilization, the paternal genome rapidly loses its global 5mC 
DNA methylation (Mayer et al., 2000a; Oswald et al., 2000; Santos et al., 2002). The maternal 
genome remains DNA methylated in the zygote. A maternal factor called PGC7/Stella was 
identified to protect the maternal DNA methylation state (Nakamura et al., 2007). Recently, it 
was shown that paternal 5mC is converted to 5hmC by the Tet3 proteins (Gu et al., 2011). 
 Zygotes, which were maternally deficient for either PcG proteins or members of three 
H3K9 HMT pathways, were analyzed for their maternal and paternal 5mC and 5hmC content. 
The most evident effect on the 5mC to 5hmC conversion in zygotes was observed in maternally 
deficient G9a and Hp1β zygotes. In both lines, enhanced conversion of maternal 5mC was 
observed. This suggests that G9a and even more so Hp1β protect maternal 5mC from 
conversion to 5hmC.  
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Figure 1.1: Cartoon showing the canonical, heterochromatin associated Suv39h pathway, which is highly conserved 
among metazoan. The Suv39h HMTs tri-methylate H3K9me3. This chromatin mark is bound by the CD of the Hp1 
orthologs. They, in turn, recruit the Suv4-20h HMTs, which tri-methylate H4K20.    

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Figure 1.2: Cartoon of the two main complexes formed by PcG: PRC1 and PRC2. Shown are the core members of 
PRC1 and PRC2 present in the mouse zygote. In this simplified model, Ezh2 of PRC2 tri-methylates H3K27me3. 
This mark is bound by the PRC1 member Cbx2, which then recruits the other complex members via its PcBox.    

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2. Introduction 
 
Emil Heitz: distinction of euchromatin and heterochromatin  
 In the late 1920s Emil Heitz (1892-1965 (Passarge, 1979; Zacharias, 1995)), a 
cytological geneticist, to use his terminology, fixed moss material in 2/3 of alcohol and 1/3 of 
acetic acid. He stained it in carmine acetic acid and prepared single cell layers. By putting 
gentle pressure to the cover slip he obtained the best metaphase spreads free of cytoplasm 
(Heitz, 1926, 1928a, b, 1933a). Applying this method, the longitudinal differentiation of mitotic 
chromosomes became apparent. He further stained cells throughout the cell cycle. Regions that  
continuously showed dense staining were named heterochromatin, while regions that showed 
no staining, thus decondensed during interphase, were called euchromatin (Heitz, 1928a). 
Later, Heitz started a series of cytological investigations searching for heterochromatin in 
somatic cell nuclei of Diptera (Figure 2.1). He showed that heterochromatin was a general 
phenomenon occurring in both animals and plants (Heitz, 1933b).  
 
Spencer W. Brown: definition of the ‘heterochromatin state’  
 A few decades after Heitz, another geneticist, Spencer Brown, makes the following 
statement in a report on heterochromatin (Brown, 1966): “probably all chromosome regions 
are potentially capable of becoming heterochromatic, but in most organisms only certain 
segments will usually so respond during development. We must, therefore, regard euchromatin 
and heterochromatin as states rather than substances.”  
 Scientists to this day continue to study the heterochromatic state, how dynamic it is, how 
it is established, structured and maintained throughout cell cycles. Many proteins have been 
shown to be important for these processes. I will highlight the function of Hp1 within the Suv39h 
pathway in epigenetic silencing and oppose it to the function of PcG proteins in this respect.    
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2.1 Chromatin States 
  
 The genomic DNA of eukaryotic nuclei is packaged by histones into chromatin. Two H3-
H4 histone dimers interact to form a stable tetramer, which is in turn flanked by two H2A-H2B 
dimers. Together they form the so-called histone octamer. 146 base pairs (bp) of DNA is 
wrapped 1.7 times in superhelical turns around such a histone octamer (Davey et al., 2002; 
Luger et al., 1997). This structure is referred to as a nucleosome. The nucleosomal histones 
interact with each other through a histone fold domain (Davey et al., 2002). The nucleosomal 
arrangement results in a fiber 11 nm in diameter, which represents the lowest level of chromatin 
organization in the nucleus (Luger et al., 1997). The binding of linker histones H1 protects the 
internucleosomal linker DNA (Woodcock et al., 2006), and organizes the nucleosomal 
arrangement into a more condensed 30 nm fiber, which is referred to as the second structural 
level of chromatin organization (Robinson et al., 2006). Two models for the 30 nm fiber have 

Figure 2.1: Chromatin structure of three Drosophila species. Darkly stained chromosomal regions during 
metaphase indicate heterochromatin. In interphase nuclei the heteropycnotic material is associated with 
chromocenters (adapted from Heitz, 1934, Figure 9 and 1935, Figure7).  
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been proposed. The solenoid model suggests that chromatin is arranged in a superhelical path 
in which a nucleosome interacts with its fifth and sixth neighbor nucleosome (Widom and Klug, 
1985). In the zigzag model, chromatin is arranged in a zig-zag manner such that one 
nucleosome in the fiber binds to the second neighbor nucleosome (Dorigo et al., 2004; Schalch 
et al., 2005; Williams et al., 1986). The folding of a chromatin fiber into a next higher level is less 
understood. For example, some microscopic studies have identified larger fiber-like structures in 
mammalian nuclei ranging from 60-80nm in interphase and up to 750 nm in metaphase cells 
(Kireeva et al., 2004). In addition to that, recent technological advances in chromosome 
conformation capture (3C) based methods enable to map the three-dimensional chromosome 
organization at a resolution of several kb (Sanyal et al., 2011). 
 The folding of a chromatin fiber into a higher level is putatively influenced by epigenetic 
modifiers and their chromatin signature. A prominent, functionally important feature of a 
chromatin signature is the post-translational modifications of histones. Such modifications occur 
on all four core histones. The ones best studied localize to the unstructured N-terminal tail of 
histone H3 and H4, which are extruded from the core of the nucleosome. Depending on which 
modification marks the chromatin, it appears either more or less condensed.  
 Another functionally important chromatin feature is DNA methylation. A methyl group is 
added to the position 5 of the cytosine ring (5mC). In mammals, genome wide profiles of DNA 
methylation show that cytosine methylation occurs in the context of CpG dinucleotides. Most 
cytosines of intergenic regions, coding regions and repeats in the CpG context are methylated 
(reviewed in (Guibert, 2009)).    
 Furthermore, the grade of condensation of chromatin has been implicated with the 
accessibility of the transcription machinery, and thus transcription in general. This refers also to 
Heitz’ original observation: “Euchromatin is genicly active, heterochromatin genicly passive” 
(Heitz, 1929). This, although, as we know by now, is not entirely valid.  
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2.1.1. Euchromatin 
  
 Euchromatin is less compacted than heterochromatin and generally highly 
transcriptionally active. It has been suggested that higher-order chromatin structures inhibit 
polymerases and DNA repair factors (Campos and Reinberg, 2009). Accordingly, nucleosomal 
arrays impede transcription in vitro (Morse, 1989). Nevertheless, euchromatin is not 
nucleosome free (Schones et al., 2008). On the contrary, it remains nucleosome dense in vivo. 
Access to the DNA for the transcription-, replication– and repair-machinery is ensured by the 
displacement of nucleosomes via chromatin remodeling factors (Workman, 2006). Post-
translational modifications of the histone tails influence the recruitment of chromatin-modifying 
effectors as well as the local chromatin structure (Campos and Reinberg, 2009). Histone 
modifications that have been implicated with transcribed euchromatin include acetylation, 
H3K4me3 at transcription start site (Barski et al., 2007) and H3K36me3 within gene bodies 
(Bannister et al., 2005). Additionally, histone variants H3.3 (Tagami et al., 2004) and H2A.Z 
(Suto et al., 2000) are enriched at euchromatin.  
 In addition to specific histone modifications within euchromatin, cytosine residues of 
euchromatin are methylated in the CpG context. Around 40 % of the mammalian promoters are 
CpG poor. The CpG dinucleotides within these promoters are usually DNA methylated 
irrespective of the transcriptional activity of the associated gene, suggesting that low DNA 
methylation does not prevent transcription (Meissner et al., 2008). The other 60 % of promoters 
are enriched for CpG dinucleotides. Most of them remain unmethylated even when the 
associated gene is not expressed, suggesting that they are protected from DNA methylation, 
independent of transcription (Meissner et al., 2008). Recent studies, though, show that also a 
fraction of high CpG content promoters are hypermethylated in various somatic cell types, which 
coincides with transcriptional repression (Illingworth et al., 2008; Shen et al., 2007; Weber et al., 
2007). 
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2.1.2. Heterochromatin 
  
 Two major distinct heterochromatic types have been defined: constitutive and facultative 
heterochromatin. 
 
 
2.1.2.2. Constitutive Heterochromatin 
  
 The chromatin of lower eukaryotes is almost entirely in a euchromatic conformation. 
Only regions that ensure genome integrity, such as telomeres and centromeres, are in a 
heterochromatic conformation and are referred to as constitutive heterochromatin (Grewal and 
Jia, 2007; Grunstein, 1998). In higher eukaryotes the same chromosomal regions are kept in a 
heterochromatic conformation. Additionally, a large portion of the genome consists of repetitive 
and non-coding sequences, resulting in an increase in genome size (Kent et al., 2002). Most of 
these repetitive sequences are in a constitutive heterochromatin conformation, in order to 
ensure genome stability (Lehnertz et al., 2003). The most prominent, constitutively silenced 
chromosomal domains are localized around the centromeres, thus they are called 
pericentromeric. They are largely devoid of genes and enriched for repetitive elements. In 
mouse, these are the so-called major satellite repeats (Lehnertz et al., 2003). They contribute to 
centromere function and chromosome segregation (Malik and Henikoff, 2009; Peng and 
Karpen, 2008; Peters et al., 2001). Despite the condensed state of pericentromeric 
heterochromatin, transcription at these genomic regions is possible and in some cases also 
required for the establishment of constitutive heterochromatin (Grewal and Elgin, 2007), as 
discussed in 2.2. The transcript levels, though, remain low.  
 Many proteins involved in the formation and maintenance of heterochromatin were first 
identified in genetic screens for position effect variegation (PEV) in Drosophila. Around 150 loci, 
so-called suppressor of variegation (Su(var)) genes, are thought to be involved in 
heterochromatin formation in Drosophila (Eissenberg and Reuter, 2009; Schotta et al., 2003). 
They will be discussed in more detail in 2.2.2.1. Other components of heterochromatin are the 
histone variants H1.0 and H2A/Z, chromatin binders like the Hmga1/2 proteins, nucleosome 
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remodelers like Atrx and proteins involved in DNA methylation like the DNA methyltransferases 
(DNMT) and methyl-CpG binding domain (MBD) 1, -2, -4 proteins, as well as DNA methylation 
itself (Fodor et al., 2010).  
   
 
2.1.2.1. Facultative Heterochromatin 
  
 Using cytological staining methods, facultative heterochromatin is either 
indistinguishable from constitutive heterochromatin, like the inactive X chromosome, or is 
restricted to a region that cannot be distinguished from euchromatin. Therefore, it has been 
proposed that facultative heterochromatin adopts a wide range of chromatin condensation 
states (Trojer and Reinberg, 2007). Similar to constitutive heterochromatin, facultative 
heterochromatin is transcriptionally inactive. Nevertheless, facultative, silent chromatin regions 
are able to de-condense and become transcriptionally active within a temporal (e.g. 
developmental stages), spatial (e.g. nuclear localization) or parent of origin (e.g. monoallelic 
gene expression) specific manner (Trojer and Reinberg, 2007).  
 A classic example of facultative chromatin is the inactive X-chromosome present in 
mammalian, female cells. Before gastrulation, one of the X-chromosomes, randomly chosen, is 
stably silenced. This state is maintained throughout the life of the organism (Trojer and 
Reinberg, 2007). Similar mechanisms have been reported to achieve the repression of 
autosomal imprinted genomic loci. These silencing mechanisms will be discussed in more detail 
in 2.2.2.2. Other well studied regions of facultative heterochromatin are the clustered Hox 
genes, which exhibit a pattern of transcriptionally active and inactive genes. Once this pattern is 
established, it is maintained throughout developmental stages (Lewis, 1978).  
 The pathways involved in the setting up of facultative heterochromatin will be discussed 
in more detail in 2.2.2.1 and 2.2.2.2. Generally, a non-coding RNA (ncRNA) or a specific DNA 
sequence is implicated in the recruitment of the proteins, like the PcG proteins, that maintain the 
silenced state. The maintenance of facultative heterochromatin is also associated with DNA 
methylation and repressive histone marks. 
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2.2. Heterochromatin Formation and Maintenance in Model Organisms 
 
2.2.1. Fungi 
 
2.2.1.1. S. cerevisiae 
  
 The 16 chromosomes of budding yeast, S. cerevisiae, are too small for the visualization 
of heterochromatin by the cytological stainings used by Heitz. Nevertheless, they display 
chromosomal regions, which appear to be more condensed (Loo and Rine, 1994; Weiss and 
Simpson, 1998), replicate late in S-phase (Bianchi and Shore, 2007) and localize in foci at the 
nuclear periphery (Gotta et al., 1996; Palladino et al., 1993). These dense regions are found at 
the telomeres of chromosomes and at the silent mating loci.  
 
Telomeres 
 Yeast telomeres consist of around 300 bp, containing a short single stranded 3’ 
overhang and double stranded, irregular repeats (reviewed in (Buhler and Gasser, 2009)). They 
are free of nucleosomes. It has been shown that these DNA repeats associate with the N-
terminus of the non-histone protein RAP1 (Conrad et al., 1990). The subtelomeric, 
heterochromatic regions on the other hand are only moderately repetitive, and they are 
nucleosomal (Vega-Palas et al., 1998). Interestingly, chromatin in these regions is 
hypoacetylated at lysine residues of histones H2B, H3 and H4. Furthermore, the highly 
conserved H3K4 methylation and H4K16 acetylation marks, which are associated with 
transcribed DNA regions, are absent from subtelomeric histones (reviewed in (Buhler and 
Gasser, 2009)). The hypoacetylation of histones suggests localization specific activity of histone 
deacetylases. Indeed, SIR2, a conserved NAD-dependent histone deacetylase, specifically 
deacetylates subtelomeric H4K16, in addition to other acetylated residues on the histone tails of 
H3 and H4 (Blander and Guarente, 2004). The hypoacetylation enables binding of the silent 
information regulatory (SIR) complex, consisting of SIR2/3/4, which ensures transcriptional 
repression of subtelomeric regions (Cubizolles et al., 2006).  
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Mating Type Loci 
 There are three mating type loci in S. cerevisiae: HMLα (hidden MAT left), MAT and 
HMRa (hidden MAT right). Whereas HMLα and HMRa are the silenced loci, the MAT locus, 
displaying either α or a, is the active locus. The silenced loci carry the information for the two 
mating types α and a. Sterility screens identified SIR1, 2, 3 and 4 as being essential for the 
repression of the silent loci (Rusche et al., 2002). Interestingly, the origin recognition complex 
(ORC), consisting of six subunits (Orc1-6), which plays a crucial role in the initiation of DNA 
replication at the AT-rich autonomously replicating sequences (ARS), has been shown to be 
involved in silencing elements of HMR (Bell et al., 1993; Foss et al., 1993b; Micklem et al., 
1993).     
 
Summary 
 Taken together, subtelomeric heterochromatin formation in S. cerevisiae histone tails 
relies on the absence of active histone marks. The canonical pathway associated with 
heterochromatin formation in metazoa, the Su(var) pathway, is absent in S. cerevisiae.  
 
 
2.2.1.2. S. pombe  
  
 In fission yeast, like in budding yeast, telomeres and the mating type loci are 
epigenetically silenced. In addition, the outer repeats of the centromeres are also subject to 
epigenetic silencing (Grewal and Jia, 2007).  
  
The Su(var) pathway in S. pombe 
 The assembly of subtelomeric and pericentromeric heterochromatin as well as at the 
silent mating type loci, requires deacetylation of histone tails H3 and H4 (Shankaranarayana et 
al., 2003), similar to S. cerevisiae. Sir2 proteins act cooperatively with Clr3, a NAD-independent 
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histone deacetylase, throughout the silent regions. The most significant deacetylation sites are 
H3K14 acetylation for Clr3 and H3K9 acetylation for Sir2 (Wiren et al., 2005). This, 
subsequently, enables activity of the histone lysine methyltransferase Clr4, an ortholog of the 
mammalian Suv39h HMT, which tri-methylates histone H3K9. This histone mark is present at 
pericentromeric and subtelomeric DNA as well as at the silent mating-type loci (Nakayama et 
al., 2001). Methylation of H3K9 by Clr4 creates a binding site for proteins with CDs, like Swi6, 
Chp1 and 2, or Clr4 itself. From these CD containing proteins, Swi6 and Chp2 display high 
sequence similarity. They both belong to the HP1 protein family. These four CD containing 
proteins are detected at pericentromeric and subtelomeric heterochromatin and contribute to 
heterochromatin assembly (Partridge et al., 2000; Partridge et al., 2002; Thon and Verhein-
Hansen, 2000). Interestingly, H3K4 acetylation plays a role in the transition of H3K9 methylation 
occupancy from Chp1/Clr4 to Chp2/Swi6, creating a CD switch between a more transcriptionally 
active heterochromatic state (Clr4/Chp1) and an inactive state (Swi6/Chp2) (Xhemalce and 
Kouzarides, 2010). In respect to Swi6/Chp2, it was shown that Swi6 is expressed abundantly 
and plays a dose-dependent role in forming a repressive structure through its self-association 
property, whereas Chp2 is expressed at low levels only and does not show this simple dose-
dependent repressive activity, but it contributes to the recruitment of chromatin modulating 
factors. Furthermore, it was shown that the disruption of the balance between Swi6 and Chp2 is 
critical for heterochromatin assembly (Sadaie et al., 2008). Interestingly, the recognition of H3K9 
methylation in vitro relies on an interface between two Swi6 CDs (Canzio et al., 2011). This 
interaction causes Swi6 to tetramerize on a nucleosome. Strengthening this CD-CD interaction 
results in enhanced heterochromatin silencing and heterochromatin spreading in vivo (Canzio et 
al., 2011). Additionally, Swi6 also dimerizes. This dimerization occurs via its C-terminal 
chromoshadow domain (CSD) (Cowieson et al., 2000). CSD domains have been shown to be 
involved in protein-protein interactions (Smothers and Henikoff, 2000).  
  
Targeting the Su(var) pathway to heterochromatin 
 Non-coding transcripts of repeat elements, processed by the RNAi pathway, have been 
shown to target the heterochromatin machinery to these repeats (Hall et al., 2002; Volpe et al., 
2002). Interestingly, Swi6 associates with a set of nuclear proteins and with non-coding 
centromeric transcripts. It is required for efficient RNAi-dependent processing of these 
transcripts. Chp2, on the other hand, associates with the SHREC histone deacetylase complex 
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(SHREC2). It is needed for histone H3K14 deacetylation and mediates transcriptional 
repression by limiting RNA polymerase II access to heterochromatin (Motamedi et al., 2008). 
Interestingly, Chp1 contributes to de novo heterochromatin formation at all sites, but it 
contributes to its maintenance only at the centromeres (Sadaie et al., 2004), suggesting that 
pericentromeric heterochromatin is less stable than subtelomeric heterochromatin in S. pombe, 
relying on constant signals for de novo heterochromatin formation for proper heterochromatin 
assembly. Strikingly, Chp1 is a core member of an RNAi effector complex termed RNA-induced 
initiation of transcriptional gene silencing (RITS) that is required for heterochromatin formation. 
It resides together with Ago1, the fission yeast Argonaute homolog, and Tas3, a previously 
undescribed protein (Verdel et al., 2004). Later, it was shown that RNAi contributes to de novo 
heterochromatin formation at all heterochromatic sites, while, like shown for Chp1, it is also 
required for maintenance on pericentromeric heterochromatin. Additionally, genetic deletion of 
RNAi components results in loss of H3K9 methylation and Swi6 at pericentromeric 
heterochromatin (Volpe et al., 2002).  
 Similar to S. cerevisiae, DNA replication origins (ORI) in S. pombe coincide with AT-rich 
islands. Interestingly, they also occur at the mating type loci, centromeres and subtelomeric 
regions (Segurado et al., 2003).  One of the orc proteins, Orc4, contains an AT-hook motif (Lee 
et al., 2001), which might target ORC to the AT-rich ORI and possibly also to the AT-rich mating 
type loci, centromeres and subtelomeric regions, possibly linking replication origins and 
transcriptional silencing. Nevertheless, AT-richness is not the only determinant for ORC 
localization, since DNA stretches with similar AT-richness display different ORC occupancy 
(Bell, 2002).  
 
Summary 
 While heterochromatin in S. cerevisiae does not contain histone marks associated with 
repression, heterochromatin maintenance in S. pombe displays the canonical marks of the 
highly conserved Su(var) pathway. Furthermore, the RNAi pathway has been implicated in de 
novo establishment of heterochromatin. Possibly, also ORC plays a role in transcriptional 
silencing.  
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2.2.1.3. N. crassa 
  
 The filamentous fungus Neurospora crassa is not as widely studied as S. cerevisiae or 
S. pombe. However, in respect to heterochromatin formation, it exhibits a feature that is not 
present in either S. cerevisiae or S. pombe, but that contributes to gene silencing and 
heterochromatin formation in mammals: DNA methylation. Therefore, N. crassa can be used as 
a model organism to study DNA methylation mechanisms.  
  
DNA methylation 
 Heterochromatin in N. crassa is mostly detected around centromeres and near 
telomeres. The underlying DNA sequences are usually relics of invasive DNAs (e.g. 
transposons, retrotransposons, viruses) (Selker, 2009). A defense system, called repeat-
induced point mutation (RIP), protects the Neurospora genome from such invasive DNA and 
ensures genome stability (Foss et al., 1993a; Selker et al., 2003). RIP senses duplicated 
regions in the genome and rapidly mutates them by G:C to A:T conversion during its 
reproductive phase. The remaining cytosines at altered regions are typically methylated (Selker 
et al., 2003). This methylation is not restricted to symmetrical sequences, unlike in most 
vertebrates (Selker and Stevens, 1985). In addition to DNA methylation, such heterochromatic 
sites also show hypoacetylated histones, methylated H3K9 and HP1 enrichment (Bhaumik et 
al., 2007). Furthermore, colocalization of DNA methylation, H3K9me3 and HP1 was observed 
on 44 discrete heterochromatic domains (Lewis et al., 2009).  
 
Genetics of DNA methylation 
 The treatment of Neurospora with Trichostatin-A, an inhibitor of HDACs, causes 
selective loss of DNA methylation (Selker, 1998). This was the first observation that DNA 
methylation is linked to histone modifications in Neurospora. Genetic studies then identified two 
mutants defective in DNA methylation, dim-2 and dim-5, which abolish DNA methylation in 
vegetative tissue (Foss et al., 1993a; Tamaru and Selker, 2001). DIM-2 was then shown to be 
the only DNA methyltransferase in Neurospora. dim-5, on the other hand, encodes for a histone 
methyltransferase, which tri-methylates H3K9. While Neurospora strains deficient for dim-5 
show loss of DNA methylation, strains deficient for dim-2 do not show any alteration of H3K9 
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methylation, which shows that dim-5 is upstream of dim-2 (Tamaru and Selker, 2001). Unlike 
the homologous HMTs in mammals and Drosophila, dim-5 does not contain a CD. 
Nevertheless, there are proteins in Neurospora that contain CDs, among them an HP1 ortholog. 
Inactivation of hpo, the gene that codes for HP1, does not globally affect H3K9 methylation 
(Lewis et al., 2009), but it results in the loss of DNA methylation in vegetative tissues (Freitag et 
al., 2004a). Additionally, it was shown that the CSD of HP1 interacts with two PXCXL-like 
domains of DIM-2 (Honda and Selker, 2008), linking dim-5 with HP1 and dim-2.  
  
Summary 
 In Neurospora, not only the Su(var) pathway is implicated in the maintenance of 
heterochromatin, but also DNA methylation. Interestingly, genetic analysis showed that the two 
pathways are linked. How DIM-5 is targeted to heterochromatin remains unknown for the 
moment. Unlike in S. pombe, where the RNAi pathway is implicated in heterochromatin 
assembly, the RNAi pathway in N. crassa, although present, is not required for either the 
initiation or maintenance of heterochromatin (Freitag et al., 2004b). 
  
 
2.2.2. Animals 
 
2.2.2.1. D. melanogaster 
  
 In Drosophila, around 1/3 of the genome is considered to be in heterochromatic 
conformation. Of the four chromosomes of D. melanogaster, the entire Y chromosome, most of 
the small fourth chromosome, which is referred to as the ‘dot’ chromosome, as well as 40 % of 
the X chromosome and the pericentromeric 20 % of the large autosomes are heterochromatic.  
 
Position Effect Variegation  
 A few years after Heitz’ first cytological stainings, Muller, a Drosophila geneticist, used 
X-rays as a mutagen in Drosophila and observed the following phenotype: the fly eyes 
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displayed red and white spots. Thus, the eye color was variegating (Muller, 1930). The gene 
responsible for this variegating eye color was called the white gene, referring to the phenotype 
observed in the mutant state (wild type flies have red eyes). It was concluded that the white 
gene itself was not damaged in flies with a variegating phenotype, since the red pigment was 
still produced in some cells (Figure 2.2.B). Later analysis of polytene chromosomes in mutant fly 
lines revealed either an inversion or a rearrangement of the chromosome with one part of the 
inverted sequence close to the white gene and the other one close to pericentromeric 
heterochromatin. Therefore, this genetic incident was called position-effect variegation (PEV) 
(Figure 2.2.A and 2.2.C). The vicinity of the white gene to the pericentric heterochromatin 
resulted in its silencing in some cells, while in others expression remained, which suggested 
that heterochromatic organization is able to spread along the chromosome (Baker, 1968; Lewis, 
1950; Morgan, 1942). PEV has been shown to occur also in yeast and mammals, but has been 
used to study heterochromatin formation mostly in Drosophila.  
 In the 1950s, Schultz, another Drosophila geneticist, identified dominant modifier 
mutations of the whitem4 line (Schultz, 1950). In this line, originally generated by Muller, the 
variegated phenotype is sensitive to modifiers. Importantly, its chromosomal inversion does not 
interfere with the viability of the flies, since the euchromatic and heterochromatic breakpoints do 
not reside in essential DNA sequences (Appels and Hilliker, 1982) (A. Ebert and G. Reuter, 
unpublished). Since this time, several modifier screens using EMS, X-rays or P-elements have 
been performed using similar fly lines (Reuter and Wolff, 1981; Sinclair D.A.R, 1983; Wustmann 
et al., 1989) in order to identify proteins, which act as enhancers of white variegation, E(var), or 
suppressors of white variegation, Su(var). A large number of genes has been identified that are 
putatively involved in PEV. 15-20 of them have been molecularly described. Well studied are 
two so-called haplo-triplo dosage-dependent modifier genes Su(var)2-5 and Su(var)3-9. Haplo-
triplo means that the loss of one copy of gene leads to the loss of PEV, while the presence of 
three copies enhances PEV (Figure 2.3). This suggests that the protein amount of such genes 
is required in a stoichiometric amount.  
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Figure 2.2: PEV in the ln(1)wm4 fly line. A. Relocalization of the white gene in the wm4 line. B. Variegation for 
white. A white eye color indicates silencing. C. Hetero-chromatinisation of the white gene visible by a condensed 
and underreplicated chromosome structure (adapted from: Schotta, et al, 2003). 

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Su(var)2-5 
 The Drosophila Su(var)2-5 gene encodes HP1, one of the first heterochromatin 
associated proteins cloned (James and Elgin, 1986). Mutations in Su(var)2-5 are recessive 
lethal at the third larval instar (Eissenberg and Hartnett, 1993). Mutant larvae approaching that 
stage show loss of heterochromatin silencing (Lu et al., 2000). Interestingly, in Su(var)2-5 
mutant flies, the expression of two essential genes, which are located within a heterochromatic 
region, is reduced. This suggests that HP1 is also required for normal transcriptional activation 
of such heterochromatic genes (Lu et al., 2000). It was shown that the CD as well as the CSD of 
Drosophila HP1 is sufficient for localization to heterochromatin in vivo (Platero et al., 1995; 
Powers and Eissenberg, 1993). Point mutations in the CD (in particular Y24F and V26M) of HP1 
inactivate its ability to contribute to heterochromatin silencing (Platero et al., 1995). Similarly, 
deletion studies of the CSD also resulted in the inability of heterochromatin silencing 
(Eissenberg and Hartnett, 1993; Eissenberg et al., 1992). The first crystal structure of a CD was 
obtained from Drosophila HP1 (Jacobs and Khorasanizadeh, 2002). It showed that it consists of 

Figure 2.3: Dosage effect of PEV modifier genes in the ln(1)wm4 fly line. Deletion of one gene copy results in 
dominant suppression, whereas gain of one copy of the same gene causes a triplo-enhancer effect (like 
observed for Su(var)2-5 and Su(var)3-9) (adapted from: Schotta et al, 2003).  

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two antiparallel β-sheets at the N-terminus, which are linked by short α-helices with a third 
antiparallel β-sheet (Figure 2.4.A). The HP1 CD preferentially binds H3K9me3 with a 
dissociation constant (Kd) of 4 µM. The methylated histone tail is bound by a ‘cage’ formed by 
three aromatic residues (Tyr23, Trp45 and Tyr48) (Figure 2.4.A). But not only methylated K9 is 
important for the binding of the HP1 CD. Also preceding and following aa residues of the histone 
H3 tail (TARK9S) form hydrogen bonds with the hydrophobic cavitiy of the CD (Jacobs and 
Khorasanizadeh, 2002). Furthermore, HP1 is highly phosphorylated in vivo. This 
phosphorylation influences its heterochromatin binding and silencing activity (Zhao and 
Eissenberg, 1999; Zhao et al., 2001).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Protein structures of selected Drosophila and human CDs. A. CD of Drosophila HP1 bound to an 
H3K9me3 modified peptide (adapted from Jacobs et al, 2001). B. CD of human HP1β, crystal without the H3 
peptide (adapted from Kaustov et al, 2011). C. CD of human HP1α bound to an H3K9me3 modified peptide 
(adapted from Kaustov et al, 2011). D. CD of Drosophila PC bound to an H3K27me3 modified peptide (adapted 
from Fischle et al, 2003). E. CD of human CBX2 with an H3K27me3 modified peptide (adapted from Kaustov et al, 
2011). Color code: orange: CD of HP1 and homologs; violet: CD of PC and homologs; grey: H3 peptide; green: 
H3K9me3; cyan: H3K27me3; pink: aromatic cage residues.   

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Su(var)3-9 and Su(var)4-20 
 Similar to Su(var)2-5, a mutation in the Su(var)3-9 gene also results in the loss of 
heterochromatin silencing (Tschiersch et al., 1994). SU(VAR)3-9 contains a CD motif, like HP1, 
and a SET domain, which displays histone methyltransferase activity. Yeast two-hybrid screens, 
using SU(VAR)3-9 as bait, showed that its N-terminus interacts with the CSD of HP1 (Schotta et 
al., 2002). Interestingly, in Su(var)3-9 mutants, HP1 localization at pericentric heterochromatin is 
drastically reduced, whereas in HP1 null mutants, SU(VAR)3-9 is not restricted to 
heterochromatin anymore, but dispersed across the chromosomes, suggesting an 
interdependence of the two proteins. Nevertheless, Su(var)3-9 dominates the PEV modifier 
effects, indicating that it is epistatic (Schotta et al., 2002). Later, a H4K20 methyltransferase was 
described in mammals and shown to act as a PEV also in Drosophila within the Su(var) 
pathway (Schotta et al., 2004). This SU(VAR)4-20 histone methyltransferase has been 
described to act downstream of HP1 in Drosophila.  
  
The Dot Chromosome 
 The fourth chromosome of D. melanogaster is referred to as the ‘dot’-chromosome or 
Muller’s F-element (Muller, 1930), because it is the smallest chromosome of Drosophila with a 
length of only 4.2 Mb (Locke and McDermid, 1993). Interestingly and in contrast to other 
autosomes in Drosophila, its gene rich regions display features of euchromatin and 
heterochromatin (Riddle and Elgin, 2006). For example, the euchromatin of the dot 
chromosome replicates late, lacks recombination (although it contains a number of important 
genes) and shows high H3K9 methylation, altogether features of heterochromatin. 
Nevertheless, the euchromatin remains transcriptionally active and does not show any PEV 
induction (Riddle and Elgin, 2006). Thus, no spreading of heterochromatin is observed. The dot 
chromosome contains also more repetitive sequences than the other Drosophila autosomes 
(Wilson et al., 2008). Most of these repeats consist of fragments derived from transposable 
elements (Slawson et al., 2006). These repetitive elements are not arranged in blocks of 
heterochromatin, but appear interspersed with genes. This arrangement is similar to the one 
observed in mammalian chromosomes, where repetitive elements and genes appear in 
proximity to each other along the chromosome arms. Therefore, transcriptional regulation of 
genes on the dot chromosome in Drosophila is also achieved in repeat-rich genomic regions. 
Nevertheless, it is more characteristic to mammalian genomes. The repetitive elements, though, 
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are transcriptionally silenced in order to ensure genomic stability. Unlike in N. crassa, where 
DNA methylation is involved in the silencing of such elements, in Drosophila there is only sparse 
DNA methylation observed (Lyko et al., 2006). Nevertheless, HP1 and H3K9me2 strongly stain 
the dot chromosome. While polytene chromosomes in SU(VAR)3-9 mutants globally lack 
H3K9me2, this mark is not affected on the dot chromosome (Schotta et al., 2002), where it is 
set by another methyltransferase named EGG (also known as ESET) (Seum et al., 2007; Tzeng 
et al., 2007). In lines mutant for egg, HP1, H3K9me2 and painting of fourth (POF), a protein that 
specifically associates with the dot chromosome (Larsson et al., 2001), are strongly diminished 
(Tzeng et al., 2007). Similarly, in POF mutants, the dot chromosome lacks H3K9me2 and HP1 
to a large degree (Tzeng et al., 2007), and in HP1 mutants, there is no POF enrichment on the 
dot chromosome and H3K9me2 is redistributed (Johansson et al., 2007). All this genetic 
evidence suggests an interdependence of the three players, which remains to be unraveled.   
 
Targeting of the Su(var) pathway to heterochromatin 
 The proteins identified in PEV screens helped in understanding the heterochromatin 
setup on a molecular and biochemical level, which led to models of how to define 
heterochromatin and how DNA sequences are transcriptionally silenced. Nevertheless, it is not 
known yet, how this heterochromatin assembly machinery is targeted to specific DNA stretches 
and not to others. There are two general models that might explain this specific targeting: either 
through binding of a sequence specific protein present in the complex, or alternatively through 
the targeting via non-coding transcripts.  
 One example supporting the first possibility is the protein D1, an AT-hook containing 
protein. AT-hook motifs have been described to bind AT-rich DNA sequences. The type III 
satellite DNA in the centromeric heterochromatin region of the X-chromosome in Drosophila 
displays such AT-richness, and D1 was shown to bind them (Aulner et al., 2002). Furthermore, 
mutations in D1 cause suppression of variegation (Aulner et al., 2002). A more recent report 
challenges these results though, suggesting no PEV effect of D1 (Weiler and Chatterjee, 2009). 
Furthermore, no association of D1 with the Su(var) pathway has been described. In addition to 
D1, ORC might play a role in targeting HP1 to AT-rich DNA sequences as already observed in 
yeast. In Drosophila, ORC consists of five subunits (Orc1-5). It was shown that Orc2 colocalizes 
with HP1 at pericentromeric heterochromatin (Pak et al., 1997). Surprisingly, Orc2 mutants even 
exhibit a Su(var) phenotype, which strongly suggests a role of ORC in heterochromatin 
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organization (Huang et al., 1998; Loupart et al., 2000; Pak et al., 1997). Later it was shown that 
hypophosphorylated HP1 forms a complex together with ORC (Orc1, 3 and 6) and an HMG-like 
HP1/ORC-associated protein (HOAP). The N-terminus of HOAP contains similarity to an HMG 
box, which binds AT-rich satellite sequences in vitro (Badugu et al., 2003; Huang et al., 1998; 
Shareef et al., 2001), suggesting a targeting mechanism of HP1 to AT-rich satellites, like it was 
proposed for D1. However, this targeting mechanism cannot explain the heterochromatin 
formation of various, variable transposable elements as they appear on the dot chromosome, 
but only less specific targeting to abundant AT-rich repeats.  
 Alternatively, ncRNA transcripts of the transposable elements recruit proteins that set up 
heterochromatin. This could provide a more specific targeting of the heterochromatin formation 
complexes. For example, POF shows similarity to RNA-binding proteins, which might link 
transcription of repeats with the association of POF and, therefore, HP1 and EGG (Riddle et al., 
2009). Another targeting mechanism could involve the RNAi machinery, which has been shown 
to be important for heterochromatin formation in S.pombe (as discussed in 2.2.1.2.) and in 
plants (Verdel et al., 2009). Homologs of the RNAi pathway have also been identified in 
Drosophila (Riddle and Elgin, 2008). Interestingly, in somatic cells, it was shown that mutations 
in piwi, aubergine, or spindle-E, which encode RNAi components, show weak loss of silencing 
(Pal-Bhadra et al., 2004). Furthermore, these mutations result in the reduction of H3K9 
methylation and delocalization of HP1 (Pal-Bhadra et al., 2004). Especially, the PIWI-associated 
RNAs (piRNA), whose presence correlates with the emergence of germ cells in evolution have 
been shown to be involved in transposon control (Aravin et al., 2007). In yeast 2-hybrid studies, 
PIWI has been shown to directly interact with the CSD of HP1 (Brower-Toland et al., 2007). In a 
proposed model (Riddle and Elgin, 2006), long non-coding transcripts from transposons, such 
as flamenco, are generated (Brennecke et al., 2007; Sarot et al., 2004) and processed to short 
piRNAs by the proteins of the PIWI-clade, AGO3, AUB and PIWI (Brennecke et al., 2007; 
Gunawardane et al., 2007; Saito et al., 2006). The generated piRNAs might target the 
heterochromatin machinery to the complementary transposon DNA sequence via the CSD of 
HP1, resulting in transcriptional silencing. However, this model is limited to the germline due to 
the germ cell specific presence of piRNAs. For the soma, despite the weak suppression of 
variegation effect of RNAi components, it is still debated, whether they have a function in 
heterochromatin formation or whether, once heterochromatin formation is initiated in the germ 
line, this state is maintained in the presence of the members of the SU(VAR) proteins in somatic 
cells.   
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Polycomb Group Proteins: PcG 
 While the SU(VAR) pathway has been implicated in silencing of pericentromeric 
heterochromatin and repeats, another pathway, consisting of the PcG proteins, originally 
identified in Drosophila, has been shown to be critical for gene silencing. The anterior-posterior 
axis in Drosophila and other metazoans is set by the expression pattern of HOX genes. This 
leads to the segment specific expression pattern of the HOX genes, which is maintained 
throughout the development of the fly. Interestingly, this pattern is maintained even after the 
transcriptional activators or repressors (e.g. retinoic acid, or proteins of gap or pair-rule genes 
(Small et al., 1992)), are gone (Deschamps et al., 1999). Genetic analysis of the HOX gene 
cluster then identified trans-acting regulators responsible for this maintenance. One of the first 
PcG Proteins, which also gave them its name, was Polycomb (PC) (Lewis, 1978). Misregulation 
of PcG proteins leads to the upregulation of HOX genes, which results in a phenomenon called 
homeotic transformation, where one body segment is convertent into another one (Denell, 1978; 
Sato et al., 1983). Therefore, PcG were proposed to act as repressors of HOX genes in trans. 
Besides PcG proteins, another group of trans-acting regulators, named Trithorax Group 
Proteins (TrxG), which function antagonistically to PcG, maintaining active transcription of HOX 
genes, were identified. Furthermore, PcG phenotypes are partially rescued by trxG mutations, 
suggesting, indeed, that they are involved in the maintenance of the expression state, but not its 
establisment (Moehrle and Paro, 1994).  
 
PRC1 and 2 
 PcG proteins have been characterized to form two major protein complexes: PRC1 and 
2 (Beisel and Paro, 2011). Different variants of PRC2 complexes have been purified from 
Drosophila embryos. They all contain four core members (Levine et al., 2004). First, Enhancer 
of Zeste (E(Z)) (Jones and Gelbart, 1990; Shearn et al., 1978) is a SET containing histone 
methyltransferase that tri-methylates H3K27 (Cao et al., 2002; Czermin et al., 2002). It interacts 
via a C5 domain with the Suppressor of Zeste12 (SU(Z)12), which contains C2H2-type zinc 
finger and a carboxy terminal VEFS domain (Birve et al., 2001). Additional components include 
ESC and p55, which contain five and six WD40 repeats, respectively (Hennig et al., 2005; 
Struhl, 1981), and are necessary for protein-protein interactions with the other core members 
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(Tie et al., 1998). Finally, Nurf55 contains a WD40 propeller, which has been shown to interact 
with SU(Z)12 (Schmitges et al., 2011). Together with SU(Z)12, it is required for nucleosome 
assembly of PRC2 (Schuettengruber et al., 2007).    
 The PRC1 repressor complex contains stoichiometric amounts of the four core 
members: Polycomb (PC), Polyhomeotic (PH), Posterior Sex Combx (PSC), and Ring1 
(dRing/SCE) (Shao et al., 1999). PC possesses sequence similarity to HP1 (Paro and Hogness, 
1991). Both proteins contain an N-terminal CD (Cowell and Austin, 1997). While the CD of HP1 
strongly binds H3K9 methylation, the CD of PC preferentially binds methylated H3K27 (Min et 
al., 2003), in particular H3K27me3 with which it interacts with a Kd of 5 µM (Fischle et al., 2003). 
The PC CD is thought to distinguish its methylation target on the H3 tail via an extended 
recognition groove that binds five additional residues preceding the ARKS motif 
(LATKAARK27S) (Figure 2.4.D). In order to study the domains involved in targeting these 
regions to chromatin, a chimeric protein with the CD of PC and the CSD of HP1 fused to β-
galactosidase has been generated. This protein targets β-galactosidase to both HP1 and PC 
binding sites. It also mislocalizes endogenous HP1 to euchromatic PC sites and endogenous 
PC to heterochromatin, which suggests importance of the CD of PC and the CSD of HP1 in 
protein-protein interactions (Platero et al., 1996). Furthermore, and not in full agreement with the 
previous study, the exchange of the CD of HP1 with the CD of PC shows exclusion of the 
chimeric protein with H3K9me2, while exchange of the CD of PC with the CD of HP1 results in 
displacement of PC to H3K9me2 sites, suggesting that the CD targets the proteins to specific 
domains (Fischle et al., 2003).   
 PH (Dura et al., 1985) contains a zinc finger and a SAM domain, which have been 
shown to participate in interactions with other proteins (Min et al., 2003). This supports the 
results, where PcG proteins have been detected and might act in foci called PcG bodies (Saurin 
et al., 1998). Third, there is PSC, which contains a C3HC4 ring finger motif. This motif might be 
involved in protein-protein interactions and shows homology to the murine Bmi1 oncogene 
(Brunk et al., 1991). The final component of PRC, RING1 (Breen and Duncan, 1986) has only 
been detected via biochemical purification as part of this complex. It is thought to play a 
structural role (Francis et al., 2001; Lavigne et al., 2004). It contains a RING domain that 
mediates E3 ubiquitin ligase activity, resulting in mono-ubiquitination of histone H2A at K119 
(Wang et al., 2004a).  
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Targeting PcG proteins 
 As with targeting of the Su(var) pathway to constitutive heterochromatin, various PcG 
targeting mechanisms in Drosophila have been investigated. A number of DNA binding proteins 
have been found to associate with PcG proteins. For example, pleiohomeotic (PHO) and 
pleiohomeiotic-like (PHOL) encode DNA-binding proteins (Brown et al., 2003; Brown et al., 
1998). Additionally, DNA specific modules, referred to as Polycomb response elements (PRE), 
have been shown to be involved in the control of the transcriptional status of target genes. The 
number and order of PRE consensus motifs is not conserved between different PREs. They are 
mostly a few hundred base pairs (bp) long and contain motifs, which are recognized by DNA 
binding proteins like PHO and PHOL (Ringrose and Paro, 2007; Schwartz and Pirrotta, 2007). 
In a study of the ubx PRE, it was shown that PHO/PHOL recruit E(Z), which leads to H3K27 
methylation. This in turn is the binding site for PC of PRC1 (Wang et al., 2004b). Moreover, 
inactivation of E(Z) results in the loss of PRC1 from polytene chromosomes (Czermin et al., 
2002), and likewise PCH  binding is competed with H3K27me3 peptides (Ringrose et al., 2004). 
These observations lead to the model of sequential targeting of the two complexes. 
Nevertheless, recent results suggest that PcG recruitment is more complex. For example, PcG 
sites in polytene chromosomes are stained normally in pho/phol double mutants (Brown et al., 
2003). Additionally, PHO/PHOL binding sites are insufficient to tether PcG protein in vivo 
(Brown et al., 2003; Dejardin et al., 2005). Mapping of the chromosomal distribution of 
Drosophila candidate DNA-binding factors for PcG recruitment showed that PHO exhibits strong 
binding to silenced regions, whereas PHOL preferentially binds to PREs of active promoters, 
which questions the function of PHOL in recruiting PcG proteins to silenced PREs 
(Schuettengruber et al., 2009). Furthermore, in ChIP analysis it was shown that PRC1 and 
PRC2 peak at PREs, while H3K27me3 is distributed along the transcribed region and spans 
often several kilo bases (kb) (Kahn et al., 2006; Papp and Muller, 2006; Schwartz et al., 2006), 
suggesting that they act partly also independently. Finally, PRC1 and PRC2 members have not 
been found to physically interact. Additionally, it remains unknown for the moment, how PRC1 
and 2 bound to PRE, which are often far away from their target promoters, maintain silencing of 
transcription on a molecular level. It has been suggested that PRE bound complexes form loops 
to contact their target promoter (Bantignies et al., 2003; Cleard et al., 2006; Lanzuolo et al., 
2007; Vazquez et al., 2006).  
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Summary 
 In summary, the Su(var) pathway is conserved also in Drosophila. It is essential for 
constitutive heterochromatin silencing. The piRNA pathway has been implicated in 
heterochromatin formation in the germ line, but not necessarily in somatic cells, suggesting that 
formation in the germ line is sufficient and that there is possibly no de novo heterochromatin 
formation in somatic cells required anymore. In addition to the Su(var) pathway, the PcG 
pathway was identified in Drosophila. It has been shown to be essential for gene silencing. 
PREs have been shown to be crucial for the targeting of the two PcG complexes PRC1 and 
PRC2.    
 
 
2.2.2.2. M. musculus 
  
 All of the Mus musculus subspecies show the same karyotype of 20 pairs of 
chromosomes with 19 autosomal pairs and the X and Y sex chromosomes. This number was 
first determined by Painter (Painter, 1928). All 19 autosomes as well as the X chromosome are 
acrocentric, meaning that the centromere is adjacent to one telomere (Figure 2.5). This makes it 
more difficult to distinguish the chromosomes. Nevertheless, there are several staining 
procedures, which differentially stain the chromosomes. The use of the dye Giemsa, for 
example, results in darkly stained chromosomal bands, called G bands. The G bands underlying 
DNA condenses early in the cell cycle, replicates late and is relatively A:T rich. In contrast, there 
are R-bands, which show a Giemsa negative staining. The R-band associated DNA condenses 
late, replicates early and is G:C rich (Bickmore and Sumner, 1989). Housekeeping genes, for 
example, are located in R bands. The two band types are also associated with different repeats: 
G-bands contain the long interspersed elements (LINE-1) elements, while R-bands contain 
short interspersed elements (SINE) elements.  
 
Repeats and Single Genes 
 Renaturation analysis of mouse DNA revealed that 5% of the genome renatures almost 
one million times faster than the bulk DNA. This class represents the satellite DNA. These 
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highly repetitive DNA sequences are thought to consist of the centromeric sequences, 
comprising the euchromatin-proximal major satellite repeat (234 bp long) and the telomere 
proximal minor repeat (120 bp long) found on some chromosomes (Horz and Altenburger, 1981; 
Joseph et al., 1989; Wong and Rattner, 1988). In the mouse sequencing project, the major 
satellite repeats were detected in only 3.6% of the reads, which is lower than estimated 
previously in density gradient experiments, where major satellites comprise around 5.5%, or 
approximately 8 Mb per chromosome, which suggests that each centromere contains 35’000 
copies (Davisson, 1989; Waterston et al., 2002). The minor satellite repeats were poorly 
represented in the mouse genome project. Previous reports suggest that they are present in 
around 50-100’000 copies in the whole genome (Davisson, 1989; Waterston et al., 2002). 
These two satellite repeats appear to have a common ancestor (Silver, 1995). This first class of 
DNA that renatures very fast is followed by a second class of DNA, which consists of various 
types of repeats. Their copy number varies from few up to hundreds of thousands. It comprises 
four classes of transposable elements: the autonomous long interspersed nucleotide elements 
(LINE), the LINE-dependent, RNA-derived short interspersed nucleotide elements (SINE), 
retrovirus-like elements with long terminal repeats (LTRs) and DNA transposons (Smit, 1999; 
Waterston et al., 2002). LINE-1 elements are present at more than 80’000 chromosomal sites. 
This family of retrotransposons is very old and has also been detected in protists and plants. 
Full-length LINE-1 elements are 7 kb in length, however, most are reduced in size to 500 bp and 
are non-functional in respect to transposition (Martin, 1991). SINE elements comprise two 
subfamilies of repetitive elements, B1 and B2, which are 140 and 190 bp long respectively and 
do not code for a reverse transcriptase. Thus they are dependent on elements such as LINE-1 
for reverse transcription. They are thought to have evolved from small cellular RNA species, 
such as tRNAs. The B1 element is repeated 150’000 times, and the B2 90’000 times (Hasties, 
1998). The third repeat class contains the long terminal repeat (LTR) elements. Among them, 
the MaLR with 388’000 copies, which are still active in mouse, the intracisternal-A particles 
(IAP), the early-transposons (ETn), which are highly abundant and active and the mouse 
mammary tumour virus, which is also still active, but present in only a few copies (Hamilton and 
Frankel, 2001; Waterston et al., 2002). The fourth group of DNA transposons is small in mouse 
compared to the primate lineage. It consists of four lineage-specific families (Waterston et al., 
2002).  Finally, the bulk of DNA that renatures latest includes the unique sequences, consisting 
of genes, pseudogenes, simple sequence repeats, which are perfect or near-perfect tandem 
repeats, and other low copy number repeats (Breslauer et al., 1986; Davisson, 1989; Silver, 
1995). Furthermore, sequencing the mouse genome showed that it contains altogether around 
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2.5 giga bases (Gb). Interestingly, in respect to transcription, it has been shown for humans that 
a large proportion of its genome is transcribed (Birney et al., 2007). Therefore, it is possible that 
also a large amount of the mouse genome is transcribed, while only a fraction of the transcribed 
RNA is actually translated. Finally, it has been suggested that the mouse genome contains 
30’000 protein-coding genes (Waterston et al., 2002).  
  
Suv39h1 and Suv39h2 
 The SET domain, originally characterized in SU(VAR)3-9, E(Z) and TRX, from SUV39H1 
was the first domain shown to methylate H3K9 (Rea et al., 2000). Many other SET containing 
proteins have since been shown to specifically methylate lysine residues of histones and other 
proteins. In mouse, there are two forms of the Drosophila SU(VAR)3-9 methyltransferase. Both 
have H3K9me activity. Furthermore, as in Drosophila, they contain a CD that preferentially 
binds the mark that they set: H3K9me3, which might result in a positive feedback loop. While 
Suv39h1 has been shown to modulate chromatin dynamics in somatic cells, Suv39h2 displays a 
more specific expression pattern, with high expression during oogenesis, spermatogenesis and 
in early preimplantation embryos (Aagaard et al., 2000; O'Carroll et al., 2000; Puschendorf et 
al., 2008; Rea et al., 2000). Both proteins strongly localize to the major satellite repeats. They 
mark and silence pericentromeric heterochromatin (Lachner et al., 2001; Lehnertz et al., 2003; 
Peters et al., 2001). A mouse deficient for both Suv39h HMTs shows loss of H3K9 methylation 
at pericentromeric heterochromatin, impaired viability and chromosomal instability that is 
associated with an increased tumor risk (Peters et al., 2001). Additionally, it shows a loss of 
enrichment for downstream members of the Suv39h pathway at pericentromeric 
heterochromatin (Lachner et al., 2001; Schotta et al., 2004). More recently, Suv39h1 has also 
been shown to repress pluripotency genes in trophoblast stem (TS) cells, which are primed by 
PRC1 and the RNA polymerase in ES cells (Alder et al., 2010). Nevertheless, Suv39h and PcG 
remain mutual exclusive, as in other silenced chromatin regions (Alder et al., 2010).  
 
The three Hp1 paralogs: Hp1α, Hp1β and Hp1γ 
 Like the SU(VAR)3-9 gene, SU(VAR)5-2 was multiplied during evolution. Vertebrates, 
from fish to humans, contain three Hp1 isoforms: Hp1α, Hp1β and Hp1γ (also known as: Cbx5, 
Cbx1 and Cbx3 respectively). All three contain the highly conserved N-terminal CD that strongly 
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binds H3K9me3 (Lachner et al., 2001), a less conserved hinge domain and the conserved C-
terminal CSD that carries out various functions. The measured Kd of Hp1α, Hp1β and Hp1γ 
towards H3K9me3 are 30 µM, 5 µM and 15 µM, respectively (Kaustov et al., 2011) (Figure 2.4.B 
and 2.4.C). The CSD of Hp1β was the first to be crystalized (Brasher et al., 2000). The structure 
strongly resembles that of a CD with three β-sheets, but with two C-terminal α-helices instead of 
one. Unlike CDs it was crystallized as a homodimer. The aa residues involved in dimerization 
were mapped to the dimer interface (e.g. Hp1βI161). Furthermore, an intact, dimeric CSD is 
required for interaction with Caf1 and Tif1β proteins (Brasher et al., 2000). The linker domain 
among the three isoforms is less conserved. It is flexible and exposed to the surface (Singh and 
Georgatos, 2002). Furthermore, it has been shown to bind RNA (Muchardt et al., 2002). Knock-
out (KO) mice for each of the Hp1 isoforms have been generated. An Hp1α KO mouse does not 
show any severe phenotypes compared to wild-type littermates, suggesting redundant function 
with its homologs (Aucott et al., 2008; Brown et al., 2010). Hp1β deficient mice are perinatal 
lethal due to respiratory failure. Furthermore, defective development of the cerebral neocortex 
and neuromuscular junctions was observed (Aucott et al., 2008). Hp1γ function is required for 
male germ cell survival and spermatogenesis (Brown et al., 2010). More specifically, 
centromere clustering and synapsis are affected in Hp1γ deficient spermatocytes. This Hp1γ 
function has been shown to be within the G9a pathway (Takada et al., 2011). It is interesting to 
note that Suv39h-dn animals live, whereas Hp1β deficient mice die perinatally. This is similar to 
the situation observed in Drosophila, where HP1 mutants die at the third larval instar stage, 
whereas SU(VAR)3-9 mutants remain viable, as discussed above. This suggests that the 
essential function of Hp1β is not within the Su(var) pathway (Billur et al., 2010). While Hp1γ has 
been described to localize to euchromatin, Hp1α and β both localize to euchromatin as well as 
to heterochromatin (Bartova et al., 2007; Horsley et al., 1996; Minc et al., 1999; Nielsen et al., 
1999). The heterochromatin localization of Hp1β is cell cycle dependent. Phosphorylation of 
H3S10 reduces the affinity of the Hp1β CD for H3K9me3 greatly. This might explain the 
displacement of chromatin bound Hp1β into the cytoplasm in metaphase chromosomes (Fischle 
et al., 2005; Hirota et al., 2005). Another histone mark that has been reported to modulate Hp1α 
function is phosphorylation of H3Y41 by Jak2. It prevents Hp1α, but not Hp1β, from binding to 
chromatin (Dawson et al., 2009). Furthermore, as in Drosophila, the Hp1 isoforms themselves 
are phosphorylated. Some sites are phosphorylated in a cell cycle specific manner (Minc et al., 
1999), while others are implicated with other functions, like general chromatin binding 
(Hiragami-Hamada et al., 2011). For example, Hp1γS83 phosphorylation impairs its silencing 
activity and is a marker of transcriptional elongation (Lomberk et al., 2006), while Hp1βS51 
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phosphorylation has been implicated in Hp1β mobilization during the initiation of the DNA 
damage response (Ayoub et al., 2008). Another post-translational modification, SUMOylation, 
has been shown to promote targeting of Hp1α to pericentromeric heterochromatin (Maison et 
al., 2011). Such SUMO-modified Hp1 proteins were shown to bind ncRNA of major satellite 
transcripts (Maison et al., 2011). Interestingly, the SUMOylation sites are within the hinge 
domain, which has been shown to bind RNA previously (Maison et al., 2002; Muchardt et al., 
2002). Notably, SUMOylation of Hp1α was shown to be critical for Hp1α targeting to pericentric 
domains (Maison et al., 2011).  Besides the association with RNA, the Hp1 isoforms have also 
been shown to interact with many proteins. For example, it was shown that gene silencing by 
the sex determination transcription factor SRY is mediated by a Krab-O protein that recruits the 
Kap1 co-repressor, which binds the CSD of Hp1 via its PxVxL motif (Peng et al., 2009). Another 
example is the p150 subunit of the chromatin assembly factor 1 (Caf-1), which has been shown 
to promote delivery of Hp1α to heterochromatic sites during replication (Quivy et al., 2004). 
 
Suv4-20h1 and Suv4-20h2 
 The most downstream member of the Su(var) pathway described so far, are the two 
Suv4-20h histone methyltransferases. The Suv4-20h proteins both contain a SET domain that 
tri-methylates H4K20 (Schotta et al., 2004). The proteins as well as the histone mark they set, 
localize to pericentromeric heterochromatin (Schotta et al., 2004). Suv4-20-dn embryos are born 
smaller than wt littermates and die perinatally a few hours after birth, probably due to an 
alveolar defect in the lungs. They have lost nearly all H4K20me2 and H4K20me3. Furthermore, 
the genome-wide transition to an H4K20me1 state in these mutants results in increased 
sensitivity to damaging stress (Schotta et al., 2008). The interaction of the Suv4-20h enzymes 
with Hp1 isoforms suggests a sequential mechanism to establish H3K9 and H4K20 tri-
methylation at pericentromeric heterochromatin (Schotta et al., 2004). This interaction domain 
was mapped to the CSD of Hp1 and aa 347-435 of Suv4-20h2 (Souza et al., 2009).  
 
Targeting Su(var) 
 Targeting of the Su(var) pathway to the AT-rich major satellite repeats of the 
pericentromeric heterochromatin is not well understood currently. As in Drosophila, DNA binding 
proteins or ncRNAs, in this case transcripts of the major satellite repeats, are candidate 
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mechanisms investigated (Probst and Almouzni, 2011). This will be discussed in more detail in 
2.3.3.3. Furthermore, ORC (Orc1-5) has also been shown to interact with Hp1 and associate 
with heterochromatin in mammals, similar to Drosophila (Auth et al., 2006; Deng et al., 2007; 
Prasanth et al., 2004; Prasanth et al., 2010). Interestingly, Orc2 and Orc3 deficiency results in 
loss of Hp1α enrichment at heterochromatin and abnormal chromosome condensation. Orc1 
and Orc5 deficiency, on the other hand, results in redistribution of Hp1α around the nucleolar 
periphery (Prasanth et al., 2010). Recently, an ORC associated, WD40 containing protein called 
Orca has been shown to play a crucial role in heterochromatin organization (Bartke et al., 2010; 
Shen et al., 2010; Vermeulen et al., 2010). Orc and Orca are both enriched at H3K9me3 of 
satellite repeats. Surprisingly, it was also shown that this complex binds H3K9me3, H3K27me3 
and H4K20me3 (Vermeulen et al., 2010). Furthermore, the recruitment of ORC is DNA 
methylation dependent (Bartke et al., 2010).  
 In addition to ORC, several studies have identified ncRNAs as being involved in 
targeting Su(var) in mouse. Interestingly, like in Drosophila, piRNA clusters have been detected 
in the germline of male mice. They were shown to be important for spermatogenesis, and they 
have been implicated in transposon control (Aravin et al., 2006; Aravin et al., 2007; Watanabe et 
al., 2006). Deficiency of Mili or Miwi2, murine homologs of Piwi, results in de-repression and 
loss of methylation of transposons in the male germline (Carmell et al., 2007). Furthermore, in 
mouse oocytes, 20-24nt transcripts derived from retroelements were detected (Watanabe et al., 
2006). It has also been shown that deletion of Dicer results in an increase of major and minor 
satellite transcripts, with no detectable change in DNA or H3K9 methylation (Kanellopoulou et 
al., 2005; Murchison et al., 2005). More recent studies have identified some DNA methylation 
changes following Dicer deletion, but these changes were mediated via the miRNA pathway and 
not via siRNA (Benetti et al., 2008; Sinkkonen et al., 2008). Therefore, as in Drosophila, small 
RNAs are implicated with controlling repetitive elements in the germline. For the moment, 
though, there is only little evidence for a role in somatic cells. Furthermore, a recent study 
associates Hp1β and Hp1γ as well as Suv39h1 and Eset with long intergenic non-coding (linc) 
RNA (Guttman et al., 2011), which might specifically recruit them to their targets.   
  
Dynamics of Su(var) 
 The dynamics of Suv(39) pathway have been studied extensively. Fluorescent recovery 
after photobleaching (FRAP) experiments for Suv39h1 in fibroblast cells revealed a substantial 
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population of immobile Suv39h1 at pericentromeric heterochromatin. The average half recovery 
time for Suv39h1 at heterochromatin was 19 seconds. This stable binding is mediated by the 
SET domain. Furthermore, DNA demethylation, achieved by treatment with the DNA 
methyltransferase inhibitor 5-aza-C, increased the dynamics of Suv39h1, but not that of Hp1β 
(Krouwels et al., 2005), suggesting that DNA methylation stabilizes the localization of Suv39h1 
at heterochromatin. The Hp1 isoforms on the other hand are highly dynamic at heterochromatin 
with a half recovery time of 2.5 seconds. This dynamic interaction depends on Suv39h. In 
addition, the CD and the CSD of Hp1 are both needed in vivo for binding chromatin (Cheutin et 
al., 2003). Dynamics of Hp1α in human cells were also measured in relation to dynamics of 
ORC subunits. Whereas Orc2, Orc3 and Hp1α displayed high dynamics with half recovery times 
of 4-5 seconds, Orc1 is more stably bound to heterochromatin (Prasanth et al., 2010). The 
same study showed that Orc1 and Orc3 physically interact with Hp1α (Prasanth et al., 2010). 
Further analysis identified a low-mobility fraction of the Hp1 isoforms (t1/2= 10 sec) 
(Schmiedeberg et al., 2004). In 4-cell embryos, the Hp1β dynamics are rather stable, with a half 
recovery time of 9 seconds, which is similar to the low-mobility fraction measured in cells, 
suggesting, altogether, more stably bound proteins at heterochromatin in embryos than in cells 
(Yamazaki et al., 2007). Another study showed high mobility of Hp1 with slightly different 
dynamics during the cell cycle. Suv4-20h2, though, remained strongly bound to pericentromeric 
heterochromatin throughout the cell cycle. Only 8.4% of Suv4-20h2 recovered after 30 seconds 
(Souza et al., 2009), suggesting that it is stably bound to heterochromatin. 
 
DNA methylation in mouse  
 Pericentromeric heterochromatin and other repetitive sequences in mouse is DNA 
methylated. It has been shown that this plays a critical role in silencing transcription of 
retrotransposons during embryonic development and spermatogenesis (Bourc'his and Bestor, 
2004; Walsh et al., 1998). In mammals, DNA methylation occurs mostly on cytosines in a CpG 
context, unlike in Neurospora. Chemically, this means that carbon 5 of a cytosine receives a 
methyl group. This is catalyzed by so-called DNA methyltransferases. Early experiments 
showed that DNA methylation silences the expression of viral genomes and that embryonic cells 
have the capability to de novo methylate DNA (Jahner et al., 1982; Stewart et al., 1982). 
Dnmt3a and Dnmt3b were identified to be the de novo methyltransferases, as ES cells lacking 
both proteins were unable to de novo methylate proviral genomes and repetitive elements 
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(Okano et al., 1999). Loss of Dnmt3a causes postnatal lethality, male sterility and failure to 
establish methylation imprints in male and female germ cells (Li, 2007). Furthermore, cells 
lacking Dnmt3a or an associated regulatory factor, Dnmt3l, fail to establish distinct methylation 
patterns at imprinted genes (Hata et al., 2002; Kaneda et al., 2004). Dnmt3b deficiency on the 
other hand leads to demethlyation of minor satellite DNA and embryonic lethality around E14.5 
(Li, 2007). Deficiency for both de novo methyltransferases results in early embryonic lethality 
(Okano et al., 1999). Furthermore, Dnmt3a methylates SINE-B1 elements, while Dnmt3a and 
Dnmt3b cooperate to methylate IAP and LINE-1 elements (Kato et al., 2007). Dnmt1, the 
founding member of DNA methyltransferase family, is needed for the maintenance of DNA 
methylation. It recognizes hemimethylated sites and methylates the cytosine of the newly 
synthesized DNA strand. Loss of Dnmt1 results in severe genome-wide hypomethylation and 
lethality during gastrulation (Li et al., 1992; Li, 2007). Furthermore, it results in abnormal 
expression of imprinted genes, ectopic X-chromosome inactivation and activation of silent 
transposons (Li, 2007). Interestingly, it was shown that Suv39h1 interacts in vitro and in vivo 
with Dnmt3a, via its PHD-like motif. Additionally, H1β binds Dnmt1 and Dnmt3a. This directly 
links DNA methylation with histone methylation (Fuks et al., 2003). It has subsequently been 
shown that silencing of the Survivin gene coincides with recruitment of G9a, another H3K9 
methyltransferase, and Hp1 in wt cells, but not in Dnmt1 deficient cells, suggesting that the Hp1 
Dnmt1 interaction mediates silencing of euchromatic genes (Smallwood et al., 2007).  
 During mammalian development there are two waves of global DNA methylation 
reprogramming. Both waves include the active removal of 5mC. One occurs immediately after 
fertilization, where the paternal pronucleus (PN) actively loses 5mC (Mayer et al., 2000a; 
Oswald et al., 2000; Santos et al., 2002). The second wave occurs when the primordial germ 
cells (PCG) migrate to the genital ridge around E11.5 (Lees-Murdock and Walsh, 2008; Sasaki 
and Matsui, 2008). Since the description of these two waves of loss of 5mC in mouse a search 
for an enzyme responsible for this DNA ‘demethylation,’ as it has been described in plants 
(Gehring et al., 2006), has occured. Many mechanisms and enzymes have been reported to be 
involved in this process in mammals (Wu and Zhang, 2010). Most recently, the Ten-eleven 
translocation (Tet) proteins have been implicated with DNA demethylation (discussed in (Veron 
and Peters, 2011)). The model proposed for these proteins activity is that the Tet proteins 
hydroxy-methylate 5-methylcytosine (5mC) to 5 hydroxmethylcytosine (5hmC). This 5hmC 
modification is thought to be an intermediate state that can be either removed or changed back 
into 5mC. The near future will bring more insight into this model.  
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PcG in mouse 
 Like in Drosophila, PcG proteins form two distinct complexes in mice. PRC2 comprises 
the SET domain containing histone methyltransferases Ezh1 and Ezh2 (E(Z) homologs), 
embryonic ectoderm development Eed (ESC homologs), Suz12 (SU(Z)12 homolog) and RbAp 
48/46 (homologs of NURF55) (Faust et al., 1995; Niswander et al., 1988; O'Carroll et al., 2001; 
Pasini et al., 2004). Mice deficient for any PRC2 core member are inviable. They die during 
early post-implantation development with severe developmental and proliferative defects (Faust 
et al., 1995; O'Carroll et al., 2001; Pasini et al., 2004). Loss of Ezh2 reduces di- and tri-
methylation globally. Ezh1 displays only weak H3K27me2/3 activity (Margueron et al., 2008). It 
is thought to be responsible for mono-methylation of H3K27 mainly (Shen et al., 2008). Eed 
must be involved in all three H3K27 methylation states, since its deletion results in loss of all 
H3K27 methylation states. Recently, a crystal structure revealed that Ezh2 binds to the WD 
domain of Eed (Han et al., 2007).  
 PRC1 contains the following core members, depending on the cell type: Cbx2, Cbx4, 
Cbx6, Cbx7 and Cbx8 (PC homologs; it must be noted again that Cbx1, Cbx3 and Cbx5 are 
other gene names for Hp1α, Hp1β and Hp1γ, which belong to another family of CDs), Ring1a 
and Ring1b (dRING homologs), Phc-1-3 (PH homologs) and Bmi1, Pcgf1-7 and Mel18 (PSC 
homologs) (Sawarkar and Paro, 2010). Deletion of several PRC1 members leads to homeotic 
transformations (Akasaka et al., 1996; Core et al., 1997; del Mar Lorente et al., 2000; van der 
Lugt et al., 1994).  
 PRC2 mediated H3K27me3 provides a binding site for the N-terminal CD of some of the 
Cbx homologs. Interestingly, different Kds for H3K27me3 and H3K9me3 have been determined 
for the five paralogs. One study measured strong H3K27me3 binding for the CDs of Cbx2 and 
Cbx7, similarly strong H3K9me3 binding for the CDs of Cbx2, Cbx4 and Cbx7 and no binding of 
the CDs of Cbx6 and Cbx8 (Bernstein et al., 2006). Another study measured equally strong 
H3K27me3 binding for CBX2, CBX4 and CBX7, but binding to H3K9me3 only by CBX4 and 
CBX7 and again no binding of the CDs of CBX6 and CBX8 (this study analyzed the human 
CDs, which are all fully conserved compared to the mouse CD)(Kaustov et al., 2011) (Figure 
2.4.E). Thus, the strong H3K27me3 binding of the PC CD is not conserved in mouse. 
Additionally, H3 peptide permutation arrays revealed greater sequence tolerance of the Cbx 
CDs. Comparison of the human CBX CD crystal structures with the HP1 CD crystal structures 
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revealed that two conserved aa residues form a hydrophobic clasp in the CBX orthologs, while 
the aa residues at the same position in HP1β form polar fingers surrounding the peptide in the 
HP1 orthologs (Kaustov et al., 2011).  Nevertheless, this does not explain why some Cbx CDs 
bind more strong to H3K27me3 than to H3K9me3. C-terminal, all five Cbx homologs contain a 
conserved PcBox, a motif necessary for the interaction with Ring1a and Ring1b (Garcia et al., 
1999; Whitcomb et al., 2007). Besides these two motifs, the conservation of the five homologs is 
low.  
 Cbx2, which is predominantly expressed in oocytes and pre-implantation embryos, 
contains an AT-hook motif located just to the C-terminal end to the CD (Senthilkumar and 
Mishra, 2009; Whitcomb et al., 2007). Moreover, it has been implicated in maintenance of the 
inactive X chromosome (Plath et al., 2004) and phosphorylation of a conserved residue in the 
CD results in specificity changes for methylated histone H3 in specific cell types (Hatano et al., 
2010). Interestingly, loss of Cbx2 in mice has been reported to lead to a male-to-female sex 
reversal (Katoh-Fukui et al., 1998).  
 Cbx4 on the other hand binds the transcriptional co-repressor C-terminal binding protein 
(CtBP) (Sewalt et al., 1999). It is the only Cbx homolog to contain an E3 SUMO ligase, including 
CtBP as a target (Kagey et al., 2003; Roscic et al., 2006). Furthermore, it has been described 
as a repressor of C-Myc (Satijn et al., 1997).  
 While Cbx6 has not been studied thoroughly, Cbx7 and Cbx8 have been shown to be 
involved in maintaining the repression of the Ink4-Arf locus, which regulates cellular proliferation 
and senescence (Dietrich et al., 2007; Gil et al., 2004). Binding of Cbx8 to Ink4-Arf depends on 
Bmi1, while binding of Cbx7 is Bmi1 independent (Dietrich et al., 2007; Gil et al., 2004). Cbx7 
KD increases the Arf and Ink4a expression which causes impairment of cell growth (Gil et al., 
2005). Interestingly, a study has also shown that Cbx7 together with Suv39h2 suppress the 
p16Arf-p15 locus in gastric cancer cell lines. Mutation of the Cbx7 CD and the PcBox abolishes 
Cbx7 binding and H3K9me3 formation at this locus. In addition, siRNA KD of Suv39h2 blocked 
the repressive effect of Cbx7 on p16 transcription (Li et al., 2010). Surprisingly, in these cancer 
cell lines, polycomb and Su(var), which have been described to be distinct, co-localize to this 
gene.  
 Mel-18 and Bmi1 (two of the PSC homologs in mammals) mutants display similar but 
nevertheless unique homoeotic phenotypes (Akasaka et al., 1996; van der Lugt et al., 1994). 
Only 30% of Bmi1-regulated genes were found to be co-regulated by Mel-18 and vice-versa 
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(Wiederschain et al., 2007). Strangely, Bmi1 was shown to be oncogenic (Haupt et al., 1991), 
while Mel-18 is associated with tumor-suppressor function (Sparmann and van Lohuizen, 2006). 
Both proteins form stable PRC1 complexes, but only Bmi1 has been shown to positively 
regulate H2AK119 ubiquitination by Ring1b (Cao et al., 2005).  
 The two mammalian Ring proteins, Ring1a and Ring1b, also exhibit different functions. 
Ring1a heterozygous mutant mice exhibit classical homeotic transformations (del Mar Lorente 
et al., 2000), while Ring1b heterozygous mutant mice do not show such a phenotype (Voncken 
et al., 2003). Nevertheless, Ring1b null embryos do not live beyond E10.5 (Voncken et al., 
2003). Such Ring1bm+z- embryos show global reduction of H2A ubiquitination, with only some 
staining remaining on the X-chromosome, while Ring1a/Ring1b double KO cells show a 
complete loss of H2A ubiquitination (de Napoles et al., 2004), suggesting certain redundancy of 
the two mammalian Ring proteins.  
 Finally, the mammalian polyhomeotic homologs have not been studied thoroughly yet, 
but Phc3, for example, has been suggested to act as a suppressor of colony formation of tumor 
cells (Iwata et al., 2010).  
 
PcG targeting in mice 
 How PcG are recruited to their targets is still poorly understood. Unlike in Drosophila, the 
existence of PREs in mammals has been questioned. Only recently, the first vertebrate PRE 
was identified. This PRE recruits PRC1 and PRC2 to repress MafB gene expression. 
Interestingly, PRC1 is recruited to this PRE with higher affinity than PRC2. Furthermore, a 
palindromic double Pho-binding site was present in the mouse sequence (Sing et al., 2009). Its 
function in respect to PcG targeting remains to be unraveled. Another study describes a 44 kb 
region corresponding to the Zfpm2 locus. It initiates de novo recruitment of PRC2. A CpG island 
within this locus is both necessary and sufficient for PRC2 recruitment. Furthermore, two 1 kb E. 
coli DNA fragments with a GC content comparable to a mammalian CpG island were capable of 
recruiting PRC2 when integrated into the mouse ESCs. This suggests that GC-rich elements 
recruit PRC2 in mouse ESCs (Mendenhall et al., 2010). Nevertheless, large-scale ChIP data 
sets for chromatin modifications and PRC1 and 2 members showed that PcG target regions do 
not contain a simple arrangement of consensus motifs (Barski et al., 2007; Boyer et al., 2006; 
Bracken et al., 2006; Guenther et al., 2007; Ku et al., 2008; Lee et al., 2006). Overlap with 
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pluripotency transcription factors Oct4, Sox2 and Nanog suggests importance of DNA 
transcription factors in recruiting PcG (Lee et al., 2006). Furthermore, one can envision, that 
PRC1 or 2 themselves bind target DNA, for example via the AT-hook motif of Cbx2, in a similar 
mechanism as it was described for the AT-hook motif containing protein D1 in Drosophila 
(Aulner et al., 2002).  
 Another possible targeting mechanism could involve ncRNAs. A prominent example of 
targeting the repression machinery by a ncRNA is the X-inactivation specific transcript (Xist) 
(Borsani et al., 1991; Brockdorff et al., 1991; Brown et al., 1991). Xist transcript accumulates on 
the inactivated X (Xi). It is required for the initiation of silencing (Marahrens et al., 1997; Penny 
et al., 1996), but not for the maintenance of gene repression on Xi in differentiated cells (Brown 
and Willard, 1994; Csankovszki et al., 1999; Wutz and Jaenisch, 2000). The transition from 
initiation to maintenance involves DNA methylation and PcG mediated chromatin modifications, 
the latter of which is Xist binding dependent (Wutz, 2011).  
 Other examples of ncRNA dependent PcG targeting include short ncRNAs (50-200 nt), 
derived from upstream elements of the transcription start site of PcG repressed loci (Kanhere et 
al., 2010) and long nc (lnc) RNAs. One well studied lncRNA called ANRIL is encoded by the 
Ink4b/Arf locus. It has been shown to bind Cbx7. Together with the recognition of H3K27 
methylation, binding to ANRIL RNA contributes to Cbx7 function, and disruption of either 
interaction impacts the ability of Cbx7 to repress the Ink4b/Arf/Ink4a locus (Yap et al., 2010). In 
addition to Cbx7, also Cbx4, Cbx6 and Cbx8 have been reported to bind to RNA (Bernstein et 
al., 2006).  
 Another example is a 2.2 kb large intergenic non-coding RNA (lincRNA) expressed by 
the HoxC locus, called HOTAIR. Depletion of HOTAIR diminishes targeting of PRC2 and H3K27 
methylation to HoxD and results in its de-repression (Rinn et al., 2007). More recently, RNA-
Suz12 and RNA-Ezh2 complexes were crosslinked and immunoprecipitated. Altogether, 24 
lincRNAs (around 10% of the ES cell lincRNAs) were strongly enriched for these Polycomb 
components (Guttman et al., 2011). Another study shows association of approximately 20 % of 
the around 3’000 identified lincRNA with PcG (Khalil et al., 2009).  
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Summary 
 Although more complex in mice, the major features of epigenetic silencing at constitutive 
heterochromatin, facultative heterochromatin or at single loci are conserved within metazoan. 
The targeting of either the Su(var) pathway or PcG proteins is not well understood yet, but 
ncRNAs as well as DNA binding factors have been implicated in it. Unlike in Drosophila, DNA 
methylation is a third major component of transcriptional silencing in mice. Furthermore, several 
studies have linked the Su(var) pathway with DNA methylation, whereas the Su(var) pathway 
and PcG remain exclusive with only few single exceptions further discussed in 2.4.   
 
 
2.3. (Hetero-) Chromatin dynamics in the mouse zygote 
 
2.3.1. Spermatogenesis 
  
 Spermatogenesis can be divided into three major phases: mitotic proliferation of 
spermatogonial stem cells, reduction of chromosomal number by meiosis and the morphological 
transformation of the haploid germ cell into a spermatozoon (de Kretser et al., 1998).  
 Various epigenetic processes take place during male germ cell development. Paternally 
imprinted genes are DNA methylated (Davis et al., 1999; Li et al., 2004). All members of the 
DNMT family have been implicated in this process (Li et al., 1993; Li et al., 1992; Sasaki et al., 
2000). Furthermore, transposable elements are silenced by DNA methylation before and during 
early steps of spermatogenesis. This prevents genomic instability (Bourc'his and Bestor, 2004; 
Suetake et al., 2004). Besides DNA methylation, histone methylation is implicated in 
spermatogenesis. Suv39h-dn mice undergo apoptosis at the pachytene stage of meiotic 
prophase as a consequence of incomplete homolog pairing and synapsis (Peters et al., 2001). 
Additionally, G9a mutant mice are sterile (Tachibana et al., 2007). Furthermore, centromere 
clustering and synapsis was affected in G9a as well as in Hp1γ deficient spermatocytes 
(Takada et al., 2011). This implicates importance of H3K9 methylation during spermatogenesis. 
 In the post-meiotic stages of spermatogenesis, the haploid round spermatids undergo 
cytoplasmic metamorphosis and chromatin remodeling. This includes transcriptional silencing 
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and condensation of the chromatin into a volume of about 5% of that of a somatic cell nucleus, 
which is assisted by double strand breaks and histone-to-protamine exchange (Doenecke et al., 
1997; Govin et al., 2004; Marushige and Marushige, 1975). Protamines are small basic 
arginine- and cysteine-rich proteins, which are spermatid-specific (Wouters-Tyrou et al., 1998). 
Nevertheless, the histone-to-protamine exchange is not complete. Around 1% of nucleosomes 
are retained in mouse and 15% in humans (Tanphaichitr et al., 1978; Wykes and Krawetz, 
2003). The importance of these retained histones is not understood. Recent studies show that 
the retained histones carry post-translational modifications and are associated with specific 
promoters (Brykczynska et al., 2010; Hammoud et al., 2009). This suggests a model, in which 
histone marks are transmitted via the paternal germline to the embryo, assuring correct gene 
expression (Brykczynska et al., 2010).  
 
 
2.3.2. Oogenesis 
  
 During female gametogenesis, the diameter of an oocyte increases up to 8 times, while 
its volume increases more than 100-fold. Concomitantly, the maternal genome is highly 
transcribed and transcripts accumulate (De Leon et al., 1983). In mouse oocytes, more than 
5’000 different transcripts are detected (Evsikov et al., 2006; Kocabas et al., 2006). Many 
transcripts are directly translated, some of which have been cataloged in proteomic profiling 
(Latham et al., 1991; Vitale et al., 2007). These proteins ensure early embryonic development. 
They nurture the embryo until the major zygotic genome activation (ZGA) occurs in the late 2-
cell stage, upon which the embryo relies on its own transcripts and proteins (Tadros and 
Lipshitz, 2009). 
 Oogenesis initiates during fetal development around embryonic day E13.5 after the 
primordial germ cells (PGC) have entered the genital ridge. The PGCs divide mitotically, which 
leads to the generation of oogonia. In turn, they enter meiosis and begin forming primordial 
follicles (Acevedo and Smith, 2005). Around 10’000 oocytes remain to assure functional 
gametes for the reproductive phase of the female. The fully grown oocytes, called germinal 
vesicle (GV) oocytes, are divided into two populations based on their chromatin organization 
(De La Fuente et al., 2004a). The non-surrounded nucleolus (NSN) oocyte is characterized by a 
diffuse chromatin configuration. NSN-oocytes are still immature and cannot be fertilized. They 
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then develop to the surrounded-nucleolus (SN) oocyte configuration. This transition is 
accompanied with the cessation of transcription and the rearrangement of the peri- and 
centromeric DNA into a ring like structure, surrounding the ribosomal DNA (rDNA). A similar 
PCH arrangement is observed in the zygote (Figure 2.5) and the early 2-cell embryo. This ring-
like structure in the oocyte shows reduced histone acetylation (De La Fuente et al., 2004b) and 
enrichment for the histone variant macroH2A (Chang et al., 2005). It is bound by the chromatin 
remodeler Atrx, which is needed for proper chromosome segregation during meiosis (De La 
Fuente et al., 2004b), and is enriched for the histone marks established by the Su(var) pathway 
and Hp1β. Finally, the SN-GV oocyte completes the first meiotic division and then arrests in 
metaphase of the second meiotic division (MII oocytes), ready to be fertilized by the sperm. 
Once fertilized, the second meiotic division is completed and the maternal pronucleus is formed.  
 
 
2.3.3. The Zygote 
  
 At the onset of mouse development, a spermatozoon fertilizes a mature oocyte. 
Fertilization triggers a cascade of crucial events in embryonic development. Sperm entry 
initiates Ca2+ spiking, which leads to the activation of a signaling pathway that triggers the 
resumption of the cell cycle (Jones, 1998). The second meiotic division is completed, and the 
maternal genome is now haploid. At the same time, paternal chromatin undergoes major 
remodeling events and finally forms a pronucleus (PN), similar to the maternal PN. Initially, both 
PN are small in size and far apart from each other. During zygotic development, the chromatin 
of both PN decondenses (in wt zygotes the paternal PN is the larger), and they move towards 
each other and the center of the zygote. Based on the PN morphology, zygotic substages have 
been defined (Adenot et al., 1997; Santos et al., 2002). PN0 refers to the zygote right after 
fertilization. It is characterized by maternal chromosome segregation and paternal sperm 
decondensation. PN1 pronuclei are small and reside at the periphery of the embryo. PN2/3 
pronuclei display an increased size and have started to migrate toward the center of the 
embryo. PN4 pronuclei are close to each other and PN5 refers to large central pronuclei. At the 
end of zygotic development, the pronuclear membranes break down and the two parental 
genomes fuse during the first mitotic division. However, maternal and paternal genomes will be 
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indistinguishable by global chromatin marks only by the 4-8 cell stage (Mayer et al., 2000b; 
Puschendorf et al., 2008).  
 As in oogenesis, PCH is arranged in a ring-like structure surrounding the nucleoli (Probst 
et al., 2007; Zuccotti et al., 1995) (Figure 2.5). Only oocytes with this PCH organization develop 
beyond the two-cell stage when fertilized in vitro, thus this structure correlates with the 
developmental competence of the embryo (De La Fuente et al., 2004a; Zuccotti et al., 2002). As 
the maternal PN forms, individual minor satellite signals can be resolved by DNA fluorescence 
in situ hybridization (FISH) experiments, suggesting absence of association of the centromeres 
(Figure 2.6). In PN2, the major satellites align and form a discontinuous ring, surrounding the 
nucleolar precursor bodies (NPB) with insertion of some minor satellites between the major 
satellite repeats (Probst et al., 2007) (Figure 2.6). Paternally in PN1, the minor satellite repeats 
remain tightly associated with pericentromeric repeats in the center of the nucleus, with no 
association with the recently formed NPB observed. In paternal PN during PN2, the major 
satellite repeats form a continuous ring with the minor satellites on either side, surrounding the 
NPB (Probst et al., 2007) (Figure 2.6). 
 
 
Figure 2.5: Top: cartoon of chromosomal regions of an acrocentric chromosome, a somatic cell and a 
zygote in mouse. Bottom: DNA (visualized by DAPI) arrangement of an acrocentric metaphase 
chromosome, an ES cell and a PN5 zygote. 
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2.3.3.1. Asymmetry of Histones in the Zygote 
  
 Within 30 minutes after sperm entry, the protamines are shed from the paternal DNA 
(van der Heijden et al., 2005). As the sperm head decondenses, presence of the histone H3.3 
chaperone Hira is observed (van der Heijden et al., 2005) and the replication independent H3 
variant H3.3 is incorporated into the male PN right after fertilization (Torres-Padilla et al., 2006). 
Maternally, the DNA remains wrapped around the canonical histone variants H3.1/2, as 
inherited by the oocyte (van der Heijden et al., 2005). These canonical histone variants H3.1/2, 
which differ from H3.3 by five and four aa residues, respectively, are incorporated by a 
replication dependent pathway (Ahmad and Henikoff, 2002). Recently, it was also shown that 
these two variants are also incorporated in the context of DNA repair (Polo et al., 2006). This 
incorporation is mediated by the Caf-1 complex and Asf-1 (Tagami et al., 2004). In agreement 
with this model, microinjection of tagged H3.1 into zygotes before pronuclear formation, only 
results in incorporation in S-phase, whereas microinjected tagged H3.3 mRNA can be 

Figure 2.6: Organisation of satellite 
repeats in maternal and paternal 
chromatin of mouse zygotes. DNA-
FISH for major (red) and minor 
(green) satellite repeats. DNA was 
visualized with DAPI (blue). pb: 
second polar body; PN: pronucleus; 
SN: sperm nucleus (PN0); arrows 
indicate the NPB. A mouse embryonic 
fibroblast (MEF) cell is shown for 
comparison. Scale bar: 10 µm. 
Adapted from Probst et al, 2007. 

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incorporated into the paternal PN already during its formation (Santenard and Torres-Padilla, 
2009).  
 Interestingly, mouse oocytes fertilized with human sperm show dots of H3.1/2 staining in 
the paternal PN before DNA synthesis, suggesting that retained histones in human sperm 
remain chromatin bound even after the global protamine-to-histone exchange in the zygote (van 
der Heijden et al., 2008). It is possible that these H3.1/2 histones are post-translationally 
modified and serve as templates for the propagation of a paternally inherited chromatin state. 
For mouse oocytes fertilized by mouse sperm, no such paternal H3.1/2 staining has been 
observed so far (van der Heijden et al., 2005). Recently, we stained mouse oocytes fertilized 
with mouse sperm immediately after fertilization and in later pronuclear stages, using an 
antibody specific for H3.1 and H3.2. We detect a dot-like staining from decondensing mouse 
sperm onwards (Figure 2.7.A), suggesting inheritance of paternal H3.1/2 histones, which remain 
bound to paternal chromatin. In later pronuclear stages, the dot-like staining throughout the 
nucleus is maintained, while patches of stainings on or within the paternal ring structure become 
apparent (Figure 2.7.B). The shape and localization of these patches strongly resemble DNA-
FISH signals from minor satellite repeats (Probst et al., 2007). Furthermore, in order to exclude 
that these H3.1/2 dots and patches are due to DNA lesions, the zygotes were incubated in 5-
ethynyl-2'-deoxyuridine (EdU), which is incorporated into newly synthesized DNA. No de novo 
DNA synthesis was observed in these regions (Figure 2.7.B). Additionally, incubation in EdU 
allowed us also to analyze the replication timing of putatively paternally inherited H3.1/2. While 
the small euchromatic dots are replicated early (Figure 2.7.C), the patches around or within the 
NPB are late-replicative, consistent with their being minor satellite repeats (Figure 2.7.D). 
Whether those retained histones serve any function in pre-implantation development remains to 
be investigated. A recent study, however, showed that histone H3.3, in particular residue K27 is 
crucial for early development (Santenard and Torres-Padilla, 2009). Micro-injection of H3.3K27R-
GFP into zygotes resulted in a developmental arrest at the 2-cell stage, aberrant transcription of 
pericentromeric transcripts and mislocalization of Hp1β in 2-cell embryos (Santenard et al., 
2010). Therefore, it is possible that the paternally inherited H3.1K27me3 and H3.2K27me3 
serve as a template for spreading K27 methylation paternally. Injection of excess H3.3K27R 
would disable this propagation, which might lead to the observed phenotype.  
 The asymmetry of the histones is finally resolved during the first DNA synthesis in the 
zygote, a few hours after fertilization, when the canonical cell cycle dependent H3.1/2 histones 
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are globally incorporated maternally and paternally (Santenard et al., 2010; van der Heijden et 
al., 2005).  
  

 
 
 
 
 
Figure 2.7: Immunofluorescence analysis of H3.1 
and H3.2 presence in paternal PN of in vitro 
fertilized zygotes. DNA was visualized by DAPI. 
H3.1 and H3.2 presence was visualized by an 
antibody raised against both canonical histones 
(antibody name: #34). DNA synthesis and repair 
was scored by incorporation of EdU, which is 
incorporated into DNA during active DNA 
synthesis and repair. Zygotes were incubated in 
10 µM EdU from fertilization onwards. A. Zygotes 
fixed after 1-3 hours post fertilization. The H3.1 
and H3.2 staining is only visible with enhanced 
detection. B. Zygotes fixed 3-5 hours post 
fertilization. Neither DNA synthesis nor DNA 
repair is observed in these zygotes, whereas the 
paternal H3.1 and H3.2 staining is evident. C. 
Zygotes fixed 5-7 hours post fertilization. DNA 
synthesis initiated. The H3.1 and H3.2 patches 
are late replicative. D. Zygotes fixed 7-9 hours 
post fertilization. DNA synthesis is nearly 
completed. The paternal H3.1 and H3.2 patches 
were replicated.   
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2.3.3.2. Asymmetry of Global Histone Marks 
  
 Not only core histones are arranged asymmetrically in the mouse zygote, but also post-
translational modifications of the histone tails vary between the maternal and the paternal PN. 
While maternal histone marks are mostly inherited from the oocyte, the major part of paternal 
marks are set up de novo, after or with the global de novo incorporation of the H3.3 histones. 
Many HMT are not present or active in the zygote. This leads to the differential epigenetic 
signatures of the maternal and the paternal PN. Upon paternal histone H3.3 incorporation, 
strong lysine acetylation is observed (Adenot et al., 1997; Santos et al., 2005; Sarmento et al., 
2004; van der Heijden et al., 2006). At this early stage, the paternal PN still lacks histone 
methylation marks, while the maternal PN exhibits the inherited H3K4, H3K9, H3K27 and 
H4K20 methylation. The first methylation mark to appear paternally is H4K20me1 (van der 
Heijden et al., 2005). This is followed by mono-methylation of H3K4, H3K9 and H3K27, later di- 
and eventually tri-methylation. Interestingly, Ezh2 and Eed are present during PN1 in the 
paternal PN, but nonetheless H3K27me3 appears only around PN3/4 concurrent with DNA 
replication (Erhardt et al., 2003; Santos et al., 2005). Paternal acquisition of H3K9me2/3 is even 
further delayed, with H3K9me2/3 appearing only around the 4-cell stage (Lepikhov and Walter, 
2004; Liu et al., 2004; Merico et al., 2007; Yeo et al., 2005). Interestingly, transferring a paternal 
PN into enucleated GV or MII stage oocytes resulted in its de novo H3K9 di-methylation, 
suggesting that the HMT is active before fertilization, but not afterwards (Liu et al., 2004). 
Surprisingly, the maintenance of asymmetric H3K9me2 is an active process that depends on 
protein synthesis and zygotic transcription, as de novo methylation in the male PN occurred 
when either protein synthesis or gene expression was inhibited by cycloheximide or α-amanitin 
(Liu et al., 2004). 
 
  
2.3.3.3. Asymmetry at PCH in the Mouse Zygote 
  
 In addition to this global asymmetry of histone marks, also PCH in the zygote displays 
asymmetric features. The maternal PCH is enriched for the histone marks of the canonical 
Su(var) pathway, H3K9me3 and H4K20me3 (Probst et al., 2007; Santos et al., 2005). 
Furthermore, Hp1β, but not Hp1α or Hp1γ localizes to PCH (Meglicki et al., 2008; Puschendorf 
PN

et al., 2008; Santos et al., 2005) (Figure 2.8). Since the paternal PCH does not contain these 
marks, it is possible that the Suv39h and Suv4-20 HMTs remain absent in the zygote, until they 
are transcribed and translated form the zygotic genome upon ZGA. It is also possible, though, 
that the maintenance of the PCH asymmetry is an active process, as was described for 
H3K9me2 (Liu et al., 2004). Thus, only the maternally inherited chromatin displays the features 
of heterochromatin as it is observed in most cell types. Recently, it was shown that paternal 
PCH within this developmental phase is marked by PcG proteins (Puschendorf et al., 2008) 
(Figure 2.8). This was the first study, which described wt constitutive heterochromatin as a 
target of PcG proteins. Earlier, it was shown that ESCs lacking both Suv39h HMTs possess 
constitutive heterochromatin with H3K27me3 enrichment (Peters et al., 2003). Interestingly, 
PRC1 is detected at paternal PCH already in decondensing sperm, prior to PRC2, where it 
remains throughout the zygotic stages, and diminishes only by the 4-8 cell stage from paternal 
PCH, when Su(var) marks also paternal PCH. PRC2 localizes to paternal PCH from PN4/5 
pronuclear stage onwards only (Puschendorf et al., 2008). Thus, PRC1 is targeted to paternal 
PCH before it is enriched for H3K27me3. Furthermore, it was shown that PRC1 at paternal PCH 
represses the transcription of the major satellite repeats, since Ring1bm-z+ show enhanced 
transcription of the paternal major satellite repeats. Thus, PRC1 possibly ensures sufficient 
silencing of the paternal repeats, backing up the Su(var) pathway paternally in this function, but, 
nevertheless, keeping the parental heterochromatin domains epigenetically distinct.  
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Figure 2.8: Asymmetry of the Suv39h pathway and PcG proteins observed at PCH of mouse zygotes. DNA is 
visualized by DAPI. The depicted zygote was stained with an antibody raised against Hp1β representing the 
Suv39h pathway. It strongly stains maternal PCH. Additionally, the zygote was stained with an antibody against 
the PRC1 member Rnf2, which stains paternal PCH.
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 Interestingly, in zygotes deficient for Suv39h-2, the maternal PCH lacks any marks 
established by the Su(var) pathway. Instead, PRC1 members are now detected not only at 
paternal PCH, but also at maternal PCH (Figure 2.9). This suggests that the Su(var) pathway 
prevents PRC1 from binding to maternal PCH in wt mouse zygotes (Puschendorf et al., 2008). 
Surprisingly, in Suv39h-2m-z+ zygotes, where PRC1 localizes to maternal PCH, the 
transcriptional level of maternal major satellite repeats is not enhanced, suggesting an 
additional level of transcriptional regulation maternally, which has not been detected so far. 
Suv39h2mz+/Ring1bmz+-dn zygotes have not been analyzed in this respect so far. Despite the 
upregulation of the major satellite transcripts in Ring1b deficient mice, they do not show a 
severe phenotype in preimplantation embryos and are lethal only after implantation (Voncken et 
al., 2003), suggesting that repression of major satellite repeats by PRC1 is not crucial for 
preimplantation development. Nevertheless, correct repression/expression of these major 
satellite repeats has been suggested to be involved in setting up the canonical heterochromatin 
configuration paternally. These non-coding transcripts of heterogenous length are transcribed 
from the 234bp long AT-rich major satellite subunits. They have been implicated in recruiting 
Hp1β to paternal PCH. Indeed, in PN5 zygotes, little paternal PCH enrichment of Hp1β, which is 
independent of the Su(var) pathway, is observed, coinciding with transcription of major satellites 
(Probst et al., 2010; Santos et al., 2005). This has been suggested to be crucial for the 
formation and maturation of paternal PCH (Probst and Almouzni, 2011). This hypothesis is 
strengthened by the observation that the hinge domain of Hp1α binds RNA (Maison et al., 2002; 
Muchardt et al., 2002). Additionally, in 2-cell embryos, co-localization of HP1β with forward and 
reverse major satellite transcripts from putative paternal origin is observed (Probst et al., 2010). 
Finally, this might lead to the targeting of the Suv39h HMT in the 4-cell embryo and the 
epigenetic equalization of maternal and paternal constitutive heterochromatin.  
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2.3.3.4. DNA ‘demethylation’ in the Mouse Zygote 
  
 Paternal chromatin differs in respect to DNA methylation from maternal chromatin. 
Within a few hours after fertilization (prior to the first zygotic S-phase), the paternal genome 
rapidly loses its global DNA methylation (Mayer et al., 2000a; Oswald et al., 2000; Santos et al., 
2002), implying an active mechanism of DNA demethylation. In contrast, the maternal genome 
is only passively DNA demethylated via DNA replication and synthesis. This is due to the 
absence of the maintenance DNA methyltransferase Dnmt1 at this stage (Reik, 2007). De novo 
methylation occurs then specifically only in the inner cell mass (ICM) of the blastocyst, whereas 
lower levels of methylation are detected in the trophectoderm (Santos et al., 2002). 
Nevertheless, the paternal DNA is not fully demethylated. Paternally imprinted genes (Olek and 
Walter, 1997), pericentromeric heterochromatin (Rougier et al., 1998; Santos et al., 2002; 
Santos et al., 2005) and the IAP retrotransposons (Lane et al., 2003) are excluded from active 
DNA demethylation. The maintenance of this DNA methylation is thought to involve both, an 
oocyte specific Dnmt1 isoform as well as the somatic Dnmt1 (Cirio et al., 2008; Gaudet et al., 

Figure 2.9: PRC1 enrichment at paternal and maternal PCH in Suv39h2m-z+ zygotes. DNA is visualized by DAPI. 
Hp1β staining represents the Suv39h pathway. It is not enriched at maternal PCH in Suv39h2m-z+ zygotes 
(arrow), whereas Rnf2 (Ring1b) as a member of PRC1 is enriched at maternal and paternal PCH in Suv39h2m-z+ 
zygotes (arrow).
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2004; Hirasawa et al., 2008; Kurihara et al., 2008). Since only paternal DNA is demethylated in 
the mouse zygote, it was suggested that maternal DNA is protected from this process. Indeed, a 
maternal factor essential for early development called PGC7/Stella was identified as being 
involved in the protection of the DNA methylation state of several imprinted loci and of the 
epigenetic asymmetry (Nakamura et al., 2007). Furthermore, a number of proteins have been 
implicated in DNA demethylation (Guibert, 2009). More recently, it was shown that 5mC can be 
hydroxylated to form 5hmC (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). 5hmC might 
reflect an intermediate DNA modification before it is fully demethylated or re-methylated. This 
hydroxylation can be performed by the dioxygenases Tet1, Tet2 and Tet3. IF stainings in wt 
zygotes indeed revealed the appearance of 5hmC paternally from PN3 onwards as 5mC 
disappears (Iqbal et al., 2011; Wossidlo et al., 2011). Furthermore, PGC7/Stella deficient 
zygotes, which lack maternal 5mC protective protein, show 5mC erasure and concomitant 
5hmC appearance in maternal and paternal PN (Wossidlo et al., 2011). The paternal 5hmC 
enrichment in the male PN of zygotes is further diluted in a replication-dependent manner during 
preimplantation development (Inoue and Zhang, 2011). Finally, Tet3 was also shown to be 
enriched in the paternal PN. In Tet3 deficient zygotes, the paternal genome conversion of 5mC 
to 5hmC fails to occur and the level of 5mC remains constant (Gu et al., 2011).  
 
 
2.3.3.5. Maternal-to-Zygotic Transition 
  
 Most reprogramming taking place in the zygote is due to the activity of maternally 
provided proteins. A first wave of zygotic transcription is observed at the late zygote stage, 
known as the minor ZGA. This is followed by the major ZGA in the 2-cell embryo. Genome 
activation is accompanied by a global degradation of maternally inherited transcripts at the 2-
cell stage, which restricts the period of time in which those maternal transcripts function. 
Furthermore, it allows the embryo to replace oocyte-specific transcripts with those required for 
embryonic development (Aoki et al., 1997; Knowles et al., 2003; Schultz, 2002; Stitzel and 
Seydoux, 2007).  
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2.4. Scope of the thesis 
  
 The recent discovery that implicates PcG proteins in constitutive heterochromatin 
localization and repression of major satellite transcripts raised the question, how these proteins 
are targeted to the major satellite repeats. Together with Mareike Albert (maiden name 
Puschendorf), we analyzed their targeting mechanism. We already had indications that this 
targeting is dependent on two modules of Cbx2: the CD and the AT-hook motif. It was then my 
part of the project to provide further and more detailed insight into this targeting mechanism by 
analyzing it in wt and transgenic zygotes, by microinjection of recombinant mRNA, performing 
life imaging and analyzing the targeting modules in an evolutionary context. 
 The larger scope of my project was to map the interdependency of the Suv39h and the 
PcG pathways. It is interesting to note the similarities between these two major epigenetic 
repressive pathways. Both contain proteins with SET domains (Suv39h1, Suv39h2, Suv4-20h1, 
Suv4-20h2 and Ezh1 and Ezh2). These proteins ‘write’ their signature onto chromatin by tri-
methylating specific aa residues of the histone tails (H3K9me3, H4K20me3 and H3K27me3, 
respectively). In a next step, proteins containing a CD specific for one of these marks, ‘read’ 
them and bind to them. Thus, HP1 family members bind to H3K9me3, while the PC orthologs 
bind either H3K27me3 or both H3K9me3 and H3K27me3. Furthermore, ‘readers’ from both 
families have been described to bind RNA (Bernstein et al., 2006; Maison et al., 2002; Muchardt 
et al., 2002). Finally, in a mechanism not fully understood for the moment, the presence of both 
of these pathways at chromatin results in transcriptional silencing.  
 Altogether, these two pathways share many similarities. Generally, this suggests that 
epigenetic silencing of chromatin is most efficiently achieved using this model of ‘writers’ and 
‘readers.’ Nevertheless, the two pathways were originally identified in very different 
experiments. While the members of the Su(var) pathway were identified by screens for mutants 
affecting PEV, the PcG pathway mutants were shown to result in homeotic transformations, 
suggesting already that their targets are different. Interestingly, they have not been shown to 
colocalize and may be mutually distinct. Only recently, a study suggested H3K9me3 (mediated 
by Eset though and not by Suv39h) at the Hox gene cluster, a classical PcG target (Bilodeau et 
al., 2009). Nevertheless, this colocalization of the H3K9me3 histone mark with a PcG target 
does not necessarily mean colocalization of the two pathways. It is quite possible, that the 
H3K9me3 histone mark is set in temporal window where no PcG proteins are present. Another 
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study that identified colocalization of the two pathways at a gene was performed in cancer cell 
lines, which by their nature may not display normal chromatin dynamics (Li et al., 2010). 
Besides these two studies, no report of colocalization of the two pathways has been published, 
despite the publication of hundreds of studies examining each of these pathways.  In the mouse 
zygote, however, Su(var) and PcG share constitutive heterochromatin as a target. Interestingly, 
zygotes that lack Suv39h2 and, therefore, any downstream signal from this pathway, show 
enrichment of PRC1 at maternal PCH. This suggests that there is a interdependency at 
heterochromatin of the two pathways, with the Su(var) pathway upstream of  PRC1, blocking 
PRC1 from binding to maternal PCH. Thus, it was the scope of my PhD to analyze, dissect and 
possibly overcome the interdependency of these two major epigenetic pathways.               
 In addition to the epigenetic asymmetries discussed so far, there is also a morphological 
asymmetry in respect to the size of the maternal and paternal PN. Although the maternal and 
the paternal genomes are equally large, the paternal PN is bigger. This suggests that DNA in 
the paternal PN is less compacted. Interestingly, this size difference is not only observed in PN5 
zygotes but throughout zygotic development, which suggests that it is maintained by proteins 
present in the zygote. Therefore, we wondered what impact epigenetic repressors have on the 
size of maternal and paternal PN. 
 Finally, it has been shown that the paternal genome loses its global 5mC DNA 
methylation within a few hours after fertilization (Mayer et al., 2000a; Oswald et al., 2000; 
Santos et al., 2002). The maternal genome remains DNA methylated in the zygote. Recently, it 
was shown that paternal 5mC is converted to 5hmC by the Tet3 proteins (Gu et al., 2011). 
Epigenetic repressors have been associated with DNA methylation as well as with 5mC to 
5hmC conversion in various cell types. Thus, it was the scope of my thesis to analyze the global 
impact of epigenetic repressors on the 5mC to 5hmC conversion of paternal DNA in the mouse 
zygote. 
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Abstract 
 In early pre-implantation mouse embryos, parental genomes are epigenetically distinct 
despite their genetic resemblance. While pericentromeric heterochromatic (PCH) regions of 
maternal chromosomes are marked by Suv39h-mediated H3K9 trimethylation (H3K9me3), 
paternal PCH structure and function are controlled by maternally provided proteins of the 
Polycomb repressive complex 1 (matPRC1). Suv39h-dependent H3K9me3 established during 
oogenesis constitutes a dominant intergenerational signal for PCH formation in the embryo. In 
absence of this signal, like at the paternal genome, matPRC1 functions as a repressive back-up 
mechanism. The molecular mechanisms underlying matPRC1 localization to paternal and 
exclusion from maternal PCH are unknown. Here, we show that Cbx2 directs matPRC1 to PCH 
in mouse zygotes and Suv39h double null embryonic stem cells. Cbx2 targeting depends on its 
chromo domain (CD), binding to Ezh2-mediated H3K27me3, and the neighboring AT-hook, 
binding to DNA, likely major satellites underlying paternal PCH. The CD of Cbx2 prevents DNA 
binding by the AT-hook when PCH is marked by H3K9me3/Hp1. However, the Cbx2A14V mutant 
with moderate H3K9me3 affinity localizes to PCH marked by H3K9me3/Hp1β. In Hp1β 
maternally deficient zygotes lacking HP1β protein, matPRC1 strongly localize to maternal PCH 
that is still marked by H3K9me3 and H4K20me3. Thus, Hp1β prevents matPRC1 from binding 
to maternal PCH. Together, our data indicate that the CD and AT-hook motifs of Cbx2 function 
together as one reader domain that modulates matPRC1 binding to chromatin by integrating 
local histone modification states. Our work elucidates the mechanism underlying the molecular 
hierarchy of Suv39h/Hp1 over PRC1, two major chromatin repressive pathways in flies and 
mammals.  
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INTRODUCTION 
 The Suv39h pathway has been associated with constitutive heterochromatin in 
pluripotent and in somatic cell types. It is conserved from S. pombe to humans. Within this 
pathway, the Suv39h histone methyltransferases (HMT) specifically tri-methylate histone tail 
H3K9 (Rea et al., 2000). Deficiency for the two mammalian Suv39h histone HMTs result in loss 
of H3K9me3 at constitutive heterochromatin (Peters et al., 2001). In the wild-type background, 
the H3K9me3 histone mark is bound by the chromodomains (CD) of heterochromatin protein 1 
(Hp1) family members (Jacobs and Khorasanizadeh, 2002; Lachner et al., 2001). Three murine 
Hp1 proteins have been described: Hp1α, Hp1β and Hp1γ, of which Hp1α and β localize to 
heterochromatin. Furthermore, Hp1 form homo- and/or heterodimers via their C-terminal 
chromoshadow domain (CSD), which is linked to the CD by an unstructured hinge domain, 
which itself has been described to bind RNA (Muchardt et al., 2002). Finally, the Hp1 proteins 
recruit the Suv4-20h methyltransferases, which tri-methylate H4K20 (Schotta et al., 2004). 
These three proteins reflect the canonical Suv39h pathway.  
 Facultative heterochromatin displays a more wide range of chromatin condensation 
states than constitutive heterochromatin. Most studied is the inactivated X chromosome. One of 
the X chromosomes in female cells is stably silenced before gastrulation and this state is 
maintained throughout life. This maintenance of silencing is assured by the Polycomb group 
(PcG) proteins. PcG proteins were first shown in Drosophila to repress the HOX gene cluster 
and localize to a various number of other repressed genes (Lewis, 1978; Schuettengruber and 
Cavalli, 2009). They are mainly detected in two complexes: Polycomb Repressive Complexes 
(PRC) 1 and PRC2. Vertebrate PRC1 comprises of four core subunits, which all have their 
founding member in Drosophila: PC homologs (Cbx2, Cbx4, Cbx6, Cbx7, Cbx8), dRING 
homologs (Ring1a, Rnf2), PSC homologs (Bmi1, Pcgf1-6, Mel18) and PH homologs (Phc1-3) 
(Sawarkar and Paro, 2010). PRC1 binding to target loci is thought to be crucial for the 
establishment of transcriptional silencing. The molecular mechanism that underlies the 
repression is widely studied. Interestingly, the Ring proteins were shown to ubiquitinate histone 
H2A, which compacts chromatin (Wang et al., 2004a). Furthermore, Cbx2 contains a charged 
region that compacts chromatin (Grau et al., 2011).  PRC2 comprises the core components 
Ezh2, Suz12 and Eed (Schuettengruber and Cavalli, 2009), while Suz12 and Eed are both 
required for complex stability and for the methyltranserferase activity of Ezh2 (Pasini et al., 
2004). In the canonical model, Ezh2 tri-methylates histone tail H3K27. This histone mark is 
recognized by the CD of a Cbx homolog, which in turn recruits PRC1. 
QM

 In the mouse zygote, an asymmetry, in respect to maternal and paternal chromatin, is 
observed for the Suv39h and the PcG proteins (Puschendorf et al., 2008). In mouse zygotes 
and early 2-cell embryos the pericentromeric heterochromatin from various chromosomes form 
a ring like structure, surrounding the rDNA, unlike in most other cell types where they would 
cluster to form so-called chromocenters. This ring like structure consists of the AT-rich major 
satellite repeats. Maternal PCH displays the canonical heterochromatin marks: H3K9me3, 
H4K20me3 and Hp1β (Santos et al., 2005). Paternal PCH within this developmental phase is 
marked by PcG proteins, where they repress transcription of the major satellite repeats 
(Puschendorf et al., 2008). In respect to heterochromatin targeting and localization, unlike in 
other cell types, PRC1 is detected already in decondensing sperm (PN0) prior to PRC2 at 
paternal PCH, which is detected only in late zygotes (PN4-5) (Puschendorf et al., 2008), 
suggesting a PRC1 function independent of PRC2. PRC1 and 2 remain at paternal PCH up to 
the 4-8 cell stage (Puschendorf et al., 2008), upon which the ring like arrangement of PCH is 
restructured to chromocenters and maternally as well as paternally inherited heterochromatin is 
marked by the Suv39h pathway.   
 Taken together, in the mouse zygote constitutive heterochromatin, the classical Suv39h 
target, was shown to be also a target of PcG. This observation raises the question how PcG 
proteins are targeted to PCH in the paternal PN. And even more, how and why they specifically 
localize to paternal PCH? Interestingly, in maternally deficient Suv39h2 mouse zygotes, PRC1 
is targeted to maternal as well as to paternal PCH (Puschendorf et al., 2008). This suggests that 
there is a negative interaction and a hierarchy between the Suv39h pathway and PRC1. Thus, 
PRC1 is prevented from binding to maternal PCH by a component of the Suv39h pathway.  
 In this study, we elucidate how PRC1 is targeted to paternal PCH and why it does not 
localize to maternal PCH. 
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RESULTS 
 
Cbx2 mediates matPRC1 targeting to constitutive heterochromatin in Suv39h dn ES cells 
 We have previously shown that the localization of the matPRC1 complex at constitutive 
heterochromatic regions of the paternal genome in early embryos can be recapitulated by over-
expression of matPRC1 proteins in embryonic stem cells that are deficient for the two Suv39h 
HMTs (Puschendorf et al., 2008). In order to investigate whether any of the four core matPRC1 
members would target the other matPRC1 components to heterochromatin, we overexpressed 
the individual components in Suv39h dn and wild-type control ESCs and measured by 
immunofluorescence microscopy their localization at chromocenters, which represent clusters of 
pericentromeric heterochromatic regions of different chromosomes (PCH) (Figure 3.1A). Among 
the four overexpressed matPRC1 proteins, only Cbx2 showed strong enrichment at PCH in 
Suv39h dn ESC (Figure 3.1A). In contrast, neither Cbx2 nor any other matPRC1 member 
localized to PCH in wild-type ESCs. This dependence of Cbx2 localization to PCH on Suv39h 
deficiency phenocopies the localization of the matPRC1 complex in zygotes (Puschendorf et al., 
2008), suggesting an important function for Cbx2 in targeting matPRC1 to PCH in 
preimplantation mouse embryos.  
The mouse genome encodes five Cbx orthologs of the Drosophila POLYCOMB (PC) 
protein which are part of functionally distinct PRC1 complexes (Beisel and Paro, 2011). To 
address whether Cbx4, Cbx6, Cbx7 and Cbx8 localize to PCH under similar conditions as the 
Cbx2, we over-expressed them individually in wild-type and Suv39h dn ESCs. None of the other 
PC orthologs, however, localized to chromocenters in any condition (Figure 3.1.B). To test the 
interdependencies for heterochromatic targeting of Cbx2 and other matPRC1 components, we 
co-transfected matPRC1 components with Cbx2 into Suv39h dn ESC cells. We observe that 
Cbx2 is required for PCH localization of endogenous Rnf2 and that Cbx2 and Rnf2 are both 
required for localization of Bmi1 or Phc2 to PCH (data not shown). These dependencies are 
consistent with known protein-protein interactions between PRC1 components (Bardos et al., 
2000; Garcia et al., 1999; Whitcomb et al., 2007). In summary, among the five Pc Cbx proteins, 
Cbx2 has the unique ability to target the matPRC1 complex to PCH in Suv39h dn ESCs.  
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Figure 3.1. Cbx2 is targeted to heterochromatin in Suv39h dn ESC. A. Immunofluorescence characterization 
of wt and Suv39h dn ESC overexpressing tagged PRC1 components. Overexpressed 3Flag-Bmi1 was detected 
using an antibody against flag. For EGFP tagged proteins, the EGFP was detected. B. Immunofluorescence 
characterization of Suv39h dn ESC overexpressing EGFP-tagged PC homologs: Cbx2, 4, 6, 7, 8. The EGFP 
signal was detected. C. Schematic representation of the 5 PC homologs in mammals. Chromodomains in purple, 
AT-hook motifs in green, AT-hook like motifs in light green, PcBox in blue. 

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Chromodomain and AT-hook of Cbx2: promising PCH targeting modules 
Sequence comparison of the five Cbx proteins shows a N-terminal CD and a C-terminal 
Polycomb Box (Pc-box) (Whitcomb et al., 2007) (Figure 3.1.C). Among Cbx proteins, the Pc-box 
is unique to homologues of the PC protein (Senthilkumar and Mishra, 2009). This domain 
mediates the interaction of Cbx2 and Cbx8 with Ring1 (Bardos et al., 2000; Schoorlemmer et 
al., 1997) and is in flies required for PC function (Breiling et al., 1999). 
CDs preferentially bind methylated histone residues via an aromatic cage, composed of 
three aromatic residues (Figure 3.2.A) (Fischle et al., 2003; Jacobs et al., 2001). While CDs of 
mammalian HP1 homologs strongly bind to H3K9me3, CDs of mouse and human CBX proteins 
have reduced binding affinities for H3K27me3 and/or H3K9me3 (Bernstein et al., 2006; Kaustov 
et al., 2011). The relative affinities of mammalian PC homologues for these modifications vary 
between the different Cbx proteins (Bernstein et al., 2006; Kaustov et al., 2011). For example, 
while CBX2 binds to H3K27me3, CBX4 and CBX7 have higher affinity for H3K9me3 relative to 
H3K27me3 peptides (Kaustov et al., 2011D. Given that PCH in Suv39h dn ESC is marked by 
H3K27me3, the CD of Cbx2 is the first candidate for targeting Cbx2 to PCH.  
Unique to Cbx2 is an AT-hook motif that is separated from the CD by a 15 amino acid 
linker with a predicted alpha-helix configuration (Figure 3.2.A) (Kaustov et al., 2011).  AT-hook 
motifs are known to bind to the minor groove of a variety of AT-rich DNA sequences (Reeves, 
2001). Despite the relaxed specificity, the AT-hook containing protein HMGA1 binds to DNA 
with nanomolar affinity (Reeves and Nissen, 1990) and methylation interference studies located 
its binding site to the minor groove of AT tracts (Thanos and Maniatis, 1992). The AT-hook motif 
of Cbx2 contains the core sequence GRP that is necessary for the recognition and binding of 
AT-rich DNA in the minor groove of the helix (Reeves and Nissen, 1990) (Figure 3.2.A, B). The 
other four Cbx proteins lack this consensus sequence. Instead, they contain only an AT-hook 
like motif that is unlikely to bind AT-rich DNA (Figure 3.2.B). Likewise, Cbx2 contains two AT-
hook like (ATL) motifs lacking the GRP core consensus sequence. Since major satellite repeats 
in mouse cells are AT-rich, the AT-hook of Cbx2 represents the second candidate for targeting 
Cbx2 to chromo centers in mouse Suv39h-dn ESCs.  
 
 
 
Cbx2 targeting to PCH in Suv39h dn ESC depends on its chromodomain and AT-hook 
 To test the function of the CD in PCH targeting, we mutated one of its three aromatic 
residues that is essential for H3K27me3 binding (F12A; Figure 3.2.C) (Bernstein et al., 2006). 
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We transiently transfected Suv39h dn ES cells with full length Cbx2-EGFP and Cbx2F12A-EGFP 
constructs and scored the enrichment of the EGFP fusion proteins at PCH relative to 
euchromatin (Figure Supp 3.1). While Cbx2-EGFP was strongly enriched at PCH in many cells, 
heterochromatic enrichment was significantly reduced for the Cbx2F12A-EGFP protein (Figure 
3.2.D, E), demonstrating that the CD of Cbx2 contributes to targeting to PCH. Nevertheless, 
heterochromatin localization was not impaired by the F12A mutation in all cells suggesting that 
binding of the CD to H3K27me3 is not solely responsible for Cbx2 localization at PCH.  
 We subsequently tested the importance of the AT-hook motif for heterochromatin 
targeting by introducing several different point mutations (Figure 3.2.C). Compared to Cbx2F12A-
EGFP, mutation of the AT-hook “GRP” consensus sequence into “AAA” or just of a single 
residue (G78R or G78L) reduced PCH enrichment in even more cells. None of these mutations, 
however, completely abrogated heterochromatic enrichment (Figure 3.2.D, E).  
A comparable point mutation in the first ATL motif of Cbx2 (G137R) did not impair 
heterochromatin enrichment. Likewise, mutations in both ATL motifs of Cbx2 (G137R, G165R) 
did not extravagate the reduction in PCH binding caused by mutations in the AT-hook alone 
(Figure 3.2.D, E). Thus, only the AT-hook of Cbx2 and not its two ATL motifs contributes to 
binding of Cbx2 to PCH in Suv39h dn ES cells.  
To test whether the CD and AT together confer Cbx2 full binding capacity to PCH, we 
transfected Suv39h dn ES cells with a Cbx2-EGFP construct containing point mutations in both 
domains and observed a complete loss of heterochromatin targeting (Figure 3.2.D, E). 
Furthermore, an EGFP fusion reporter protein harboring only the CD and AT-hook domains 
displayed PCH enrichment comparable to the full length Cbx2-EGFP protein while PCH binding 
of single domain fusion proteins was strongly diminished (Figure Supp 3.2). Therefore, these 
data evidently demonstrate that the CD and AT-hook of Cbx2 are sufficient for PCH targeting in 
Suv39h dn ES cells. Further, the data reveal an additive, potentially cooperative effect of the 
two modules in Cbx2 targeting to chromatin in ESCs.  
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Figure 3.2: Cbx2 targeting to heterochromatin in Suv39h dn ESC depends on its chromodomain and first 
AT-hook. A. Alignment of the first 90 amino acids of the five mouse Pc homologs. The blue line highlights the N-
terminal chromodomain. Blue arrows indicate the aromatic caging residues required for methyl-lysine binding. 
The Cbx2 AT-hook 1 is marked by a green line. Green arrows indicate the central RGR core. B. Alignment of 
AT-hook motifs detected in various proteins. C. Point mutations introduced into the Cbx2 chromodomain and 
AT-hooks. Blue arrow indicates the caging residues, green arrows highlight the central RGR core of the AT-
hooks 1, 2 and 3. D. Selection of overexpressed Cbx2 mutation constructs in Suv39h-dn ESC. DAPI and direct 
GFP signals are shown for a representative cell. E. Quantification of heterochromatin enrichment in Suv39h-dn 
ESC for each construct.
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Cbx2 targeting to eu- and heterochromatin in zygotes  
 In order to test the importance of the CD and AT-hook domains for Cbx2 targeting to 
heterochromatin in pre-implantation embryos, we micro-injected mRNA of various Cbx2-EGFP 
reporter constructs into early mouse zygotes shortly after fertilization. We subsequently cultured 
these zygotes until the stage just prior to the first cleavage division (pro-nuclear stage 5; PN5) 
and scored enrichment of the Cbx2-EGFP reporters at PCH sequences of the paternal genome. 
Full length Cbx2-EGFP was strongly enriched at paternal PCH, like the endogenous protein 
(Figure 3.3.A). Unlike in Suv39h dn ESCs, the F12A point mutation in the CD did not impair 
localization to PCH, suggesting a greater contribution of the AT-hook to PCH binding in zygotes. 
This finding is consistent with the reported Ezh2-independent targeting of matPRC1 to paternal 
PCH (Figure 3.3.A) (Puschendorf et al., 2008). Indeed, Cbx2-EGFP remains strongly enriched 
at paternal PCH in Ezh2 maternally deficient (Ezh2m-z+) zygotes in which H3K27me3 fails to be 
established on the paternal PN due to absence of the maternally provided enzyme (Figure 
3.3.B).  
On the other hand, the G78R mutation in the AT-hook reduces paternal PCH enrichment 
in wt zygotes (Figure 3.3.A), but to a lesser extent than observed in Suv39h dn ESC (Figure 
3.3.B). This possibly hints to a stronger compensatory back-up mechanism provided by the CD 
binding to H327me3 that is not revealed by the F12A mutant alone. To test this, we first 
analyzed the F12A-G78R double mutant in wild-type zygotes (Figure 3.3.A). Secondly, to 
circumvent potential negative effects of the two point mutations on protein stability, we tested 
the G78R construct in Ezh2m-z+ zygotes lacking H3K27me3 at paternal PCH (Figure 3.3.B). In 
both cases we observed a dramatic decrease in EGFP reporter localization at paternal 
heterochromatin compared to control conditions. We conclude that the CD and AT-hook of Cbx2 
are the major determinants of Cbx2 localization to PCH in mouse preimplantation embryos. 
Compared to Suv39h dn ESCs, either domain can compensate better for the deficiency of the 
other domain in mouse zygotes.   
 To assess the importance of the AT-hook in heterochromatin targeting without mutating 
its sequence, we aimed at interfering with its ability to interact with DNA. We therefore treated 
early zygotes and Suv39h dn ESCs with distamycin, a small compound that binds to the minor 
groove of DNA and that impairs binding of AT-hook containing proteins to AT-rich satellites in 
Drosophila (Susbielle et al., 2005). In decondensing sperm nuclei of just fertilized oocytes, 
heterochromatic localization of the endogenous matPRC1 components Cbx2 and Rnf2 was 
abrogated in a distamycin concentration depend manner (Figure 3.3.C). Likewise, exogenous 
Cbx2-EGFP was dislocalized from chromocenters of Suv39h dn ESCs while heterochromatic 
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localization of H3K9me3 and HP1β was unaffected in wild type ESCs (Figure Supp 3.4). These 
data underscore the importance of the Cbx2 AT-hook in heterochromatic targeting of the 
matPRC1 complex in vivo.  
 To further rule out a contribution of RNA transcripts to the targeting of PRC1 to 
heterchromatin, we micro-injected RNaseA directly into the paternal PN. RT-PCR analysis of 
transcripts of housekeeping genes demonstrated activity of the injected RNaseA (Figure Supp 
3.3). However, we did not observe loss of matPRC1 members from paternal PCH in RNase A 
injected zygotes (Figure Supp 3.3), excluding a major role for RNA in PCH targeting of 
matPRC1.    

 
 
 
 
 
Figure 3.3: Cbx2 targeting to 
heterochromatin in zygotes. A. 
Micro-injection of EGFP-tagged 
Cbx2 mutation constructs. Shown 
are representative maternal and 
paternal PN5 pronuclei for each 
construct. On the right, quantification 
of maternal and paternal PCH 
enrichment for each construct. On 
the far right, quanification of 
euchromatic EGFP-signal for each 
construct. B. Immunofluorescence 
analysis for Cbx2 and Rnf2 
enrichment at heterochromatin in 
untreated and distamycin (20mM 
and 50mM) treated PN0 zygotes. 
Shown are representative 
decondensing spermheads. Below, 
quantification of Cbx2 and Rnf2 
enrichment at heterochromatin. C. 
Micro-injection of EGFP tagged 
Cbx2 constructs into Ezh1 deficient 
and Ezh1/2 deficient zygotes. 
Shown are representative maternal 
and paternal PN5 pronuclei for both 
construct. Below left, quantification 
of paternal PCH enrichment; below 
right, quantificaiton of euchromatin 
signal. 

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 Finally, unlike in Suv39h dn ES cells, Cbx2-EGFP containing the F12A and G78R point 
mutations failed to enrich at euchromatin of paternal pronculei in wild-type zygotes (Figure 
3.3.A). Similarly, euchromatic staining was also lost for Cbx2-EGFP containing the G78R 
mutation in the AT-hook in Ezh2m-z+ zygotes lacking H3K27me3 (Figure 3.3.B). In Ezh2m-z+ 
zygotes the euchromatic localization pattern of Cbx2-EGFP appeared qualitatively less distinct 
than in wild- type control zygotes, arguing for a role of the CD - H3K27me3 interaction in 
specifying euchromatin binding (Figure 3.3.B).  
 Altogether, these data indicate that Cbx2 is targeted to pericentromeric heterochromatin 
of the paternal genome and to euchromatin in one-cell embryos by its AT-hook motif binding the 
minor groove of DNA and by its CD binding to H3K27me3, which is catalyzed de novo by the 
maternally provided Ezh2 protein.  
 
The CD of Cbx2 regulates DNA binding of the AT-hook by integrating histone 
modification states  
 In wild-type ESCs, transiently overexpressed Cbx2-EGFP does not accumulate at 
chromocenters (Figures 3.1.A, 4.A). Surprisingly, Cbx2-EGFP containing the F12A mutation in 
its CD is enriched at PCH in wild type ESCs to a similar extent as in Suv39h dn ESCs (Figure 
3.4.A). Combining the F12A and G78R mutations leads to a complete loss of PCH enrichment 
in wild-type ESCs indicating that the AT-hook mediates PCH enrichment of the Cbx2-CDF12A 
protein in wt cells (Figure 3.4.A). To test whether the gain in PCH binding in wild-type ESCs is 
specifically due to the inability of the CDF12A to bind methylated histones, we generated a CD-
AT-EGFP reporter protein in which we mutated another residue (W33) that is also required for 
the formation of the “aromatic cage”, the histone methylation binding site of the CD. Indeed, we 
observed for the CDCbx2-W33A-ATCbx2-EGFP reporter a similar gain in PCH enrichment that was 
dependent on a functional AT-hook as we observed for the CDCbx2-F12A-ATCbx2-EGFP reporter in 
wt ESCs (Figure 3.4.B). Furthermore, we obtained a similar result in zygotes, where the F12A 
mutation leads to Cbx2-EGFP enrichment at maternal PCH in the presence of H3K9me3, 
H4K20me3 and HP1β (Figure 3.3.A). Together, these data show that the CD of Cbx2 prevents 
binding of the AT-hook to PCH defined by the Suv39h dependent pathway.  
 Based on these results, we wondered what mechanism underlies the inhibition of DNA 
binding of the AT-hook by the CD of Cbx2. Phylogenetic studies indicate that the 15 amino acid 
linker sequence between the CD and AT in Cbx2 homologs is partly conserved from fish to 
human. Based on this notion we hypothesize that the CD and AT-hook function as one 
molecular unit in which DNA binding of the AT-hook is determined by the CD integrating the 
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status of chromatin at neighboring nucleosomes. While the Suv39h-dependent state 
characterized by the presence of H3K9me3, H4K20me3 and Hp1 proteins is inhibitory, 
nucleosomes carrying H3K27me3 or none of the three modifications are proficient states for 
DNA binding by the AT-hook of Cbx2. This model raises the questions whether the inhibitory 
capacity of CDCbx2 is specific towards the AT-hook of Cbx2, whether it depends on the length of 
the linker sequence and whether it is specific to the CD of Cbx2. Furthermore, it asks what 
molecular mechanism underlies this inhibition of DNA binding by the Suv39h dependent 
chromatin state? Is it histone methylation and/or HP1 proteins?  
  
Figure 3.4: The Cbx2 chromodomain blocks PCH accumulation in wt ESC. A. Schematic representation of 
the Cbx2 full length constructs. Quantification of heterochromatin enrichment in wt and Suv39h dn ESC. B. 
Schematic representation of the Cbx2 reporter constructs and quantification of heterochromatin enrichment in wt 
and Suv39h dn ESC. C. Schematic representation of the Cbx2-Hmga fusion constructs analyzed and 
quantification of heterochromatin enrichment in wt and Suv39h dn ESC. Asteriks indicate the location of the 
inserted mutation. 

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CDCbx2 and ATCbx2 function as one molecular unit 
 To investigate whether or not the CDCbx2 modulates DNA binding of more potent AT-
hook motifs, we linked it to the AT-hooks number 2 and 3 of HMGA1, which have been 
described to have high affinity to DNA (Reeves, 2001). While HMGA1-EGFP itself strongly 
localized to heterochromatin in wild-type conditions, as reported before (Amirand et al., 1998; 
Martelli et al., 1998), the CD of Cbx2 reduced heterochromatin localization of the CDCbx2-
AT2/3HMGA1-EGFP reporter in wild-type but not in Suv39h dn ESCs (Figure 3.4.C). As for the 
CDCbx2-F12A-ATCbx2 reporter (Figure 3.4.B), the F12A mutation restored localization of the CDCbx2-
F12A-AT2/3HMGA1-EGFP reporter to chromocenters in wild-type ESCs (Figure 3.4.C). These 
results indicate that the CD of Cbx2 effectively inhibits binding of neighboring AT-hooks to DNA 
in the context of a Suv39h dependent chromatin configuration.  
 To test whether this inhibitory effect is alleviated by spatial separation of the CD and AT-
hooks, we replaced the linker sequence by a 30 amino acid long flexible linker (ten ‘TGS’ 
repeats). We observed a similar gain in heterochromatin localization for the CDCbx2-flex-
AT2/3HMGA1-EGFP as for the CDCbx2-F12A-AT2/3HMGA1-EGFP reporter in wild type ESCs (Figure 
3.4.C). Together, these data support the model in which the CD and AT-hook in Cbx2 function 
as one molecular entity that integrates the chromatin state for DNA binding. 
 
The CDs of Cbx4 and Cbx7 lack chromatin sensing ability 
 Next we addressed whether the inhibitory effect of CDCbx2 is conserved among Cbx2 
orthologs. The CDs of these orthologs and of the Drosophila PC exhibit different binding 
affinities for H3K9me3 and H3K27me3 (Bernstein et al., 2006; Kaustov et al., 2011). While 
CDCbx2 and CDdPC bind to H3K27me3 only, the CDs of Cbx4 and Cbx7 bind with intermediate 
Kds to histone peptides tri-methylated at H3K9 and H3K27 (Kaustov et al., 2011). These 
H3K9me3 affinities are, however, at least one order of magnitude higher than those of the CDs 
of HP1 proteins (Bernstein et al., 2006; Kaustov et al., 2011). Consistently, we failed to detect 
Cbx4 and Cbx7 at PCH in wild-type ESCs while HP1α and HP1β were detectable (data not 
shown). Given these Kd values, we hypothesized that linking CDCbx4 or CDCbx7 to ATCbx2 would 
enable localization to chromocenters in wild-type ESC. In agreement, we observed strong PCH 
enrichment of CDCbx4- ATCbx2-EGFP and CDCbx7-ATCbx2-EGFP. Furthermore, the chimaeric CDdPC 
-ATCbx2-EGFP was significantly less frequently localized to PCH in wild-type ESCs (Figure 
3.5.A). Together, these data suggest that the DNA binding capacity of the Cbx2 AT hook motif 
depends on the relative affinity of the adjacent CD for H3K27me3 versus H3K9me3.  
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Alanine 14 defines the histone methylation binding and chromatin targeting specificity of 
Cbx2 
 To prove this hypothesis, we aimed at increasing the affinity of CDCbx2 for H3K9me3 by 
changing one or more of its amino acids and assessing the level of PCH enrichment in wt 
ESCs. Sequence comparison of CDs of mammalian Cbx and Suv39h proteins revealed several 
amino acid variations between classes of proteins with different histone methylation binding 
affinities (Figure 3.5.B). However, analysis of crystal structures of all CBX CDs (Kaustov et al., 
2011) indicate that most variant amino acids are not in contact with the H3 N-terminus and may 
therefore not be critical for direct recognition of methylated residues. A few residues though, 
which are located within the hydrophobic cavity that embraces the methylated H3 tail, differ 
between the CDs of Cbx2 and Cbx4/Cbx7 (Figure 3.5.B). Particularly residue 14 (Cbx2 
nomenclature), which is located C-terminally of the F12 “aromatic cage” residue in a highly 
conserved region, caught our interest. This residue is an alanine in the CDs of Cbx2, Cbx6, 
Cbx8 and dPC, while it is a valine in the CDs of Cbx4 and Cbx7, as well as in the CDs of the 
mammalians Hp1 isoforms, dHP1 and the Suv39h HMTs (Figure 3.5.B). In light of our PCH 
localization data (Figure 3.5.A), this residue may play a key role in specifying binding to 
H3K27me3 or H3K9me3.  
  
 In agreement, the A14V point mutation revealed strong enrichment of the CDCbx2_A14V-
ATCbx2-EGFP reporter at chromocenters in wild-type ESCs, supporting the notion that Cbx2A14 
confers binding specificity towards H3K27me3 (Figure 3.5.C). Interestingly, as for Cbx2, the 
A14V mutation within the CDdPC-ATCbx2-EGFP construct resulted in significant enrichment at 
chromocenters in wt ESCs, indicating functional conservation of that residue in fly PC (Figure 
3.5.C). Inversely, replacing the valine of CDCbx4 and CDCbx7 by an alanine (V13A) caused 
reduction in chromocenter enrichment of wild-type ESCs (Figure 3.5.C). Finally, to assess the in 
vivo relevance of A14 in modulating chromatin binding, mRNA encoding Cbx2 or Cbx2-CDA14V 
was micro-injected into mouse zygotes. As in ESCs, the Cbx2-CDA14V construct was significantly 
enriched at maternal PCH in comparison to the Cbx2 construct (Figure 3.5.D).  
 Based on these cellular results, we measured the Kds between methylated histone 
peptides and Cbx2, Cbx4 and Cbx7 CD constructs containing an alanine or valine at positions 
14 or 13 (Figure 3.5.E). For Cbx2, the A14V mutation decreased the Kd for H3K9me3 while 
leaving its Kd for H3K27me3 intact. In contrast, V13A in Cbx4 and Cbx7 results in a strong 
increase in Kd values for H3K9me3 and H3K27me3.  
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 In summary, alanine 14 in Cbx2 plays a crucial role in specifying binding of Cbx2 to 
H3K27me3, and to constitutive heterochromatin in mouse ESCs and early embryos. By 
enhancing the binding affinity of CDCbx2 for H3K9me3 using the A14V mutation, Cbx2 localizes 
to maternal PCH and to chromocenters in wt ESCs, marked by components of the Suv39h 
pathway like H3K9me3, H4K20me3 and HP1 proteins.  
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Figure 3.5: The Cbx2_A14V mutation enhances H3K9me3 binding affinity and gets targeted to wt 
ESC and maternal PCH. A. Schematic representation of fusion reporter construct. Right: quantification of 
heterochromatin enrichment for the indicated reporter constructs. B. Alignment of the CD of PC and its 
mouse homologues as well as HP1 and its mouse homologues, together with the CDs from the Suv39h 
methyltransferases. C. Representative IF staining for the Cbx2_CD_A14V_AT1 reporter construct in wt 
ESC. Right: quantification of heterochromatin enrichment for the indicated constructs. D. Repre-sentative 
IF staining for the Cbx2_CD_A14V_AT1 reporter construct in wt PN5 zygotes. Right: quantification of 
heterochromatin enrichment for this construct. E. Dissociation constant values (Kd) measured by 
fluorescence polarization for CD from Cbx proteins with methylated peptides and their mutants are shown. 
Interactions were designated as >500 uM when the values were too weak to accurately estimate a Kd 
value.
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Hp1β but not Suv4-20h HMTs prevents PRC1 binding to maternal PCH in zygotes  
 To investigate which component in the Suv39h pathway prevents PRC1 members from 
binding to PCH in wild-type ESCs and at maternal chromosomes in zygotes, ESC or zygotes 
deficient for the downstream members of the Suv39h pathway were analyzed. In mammals, the 
Suv4-20 HMTs mediate H4K20me2 and H4K20me3 at euchromatin and at PCH (Schotta et al., 
2004). In early pre-implantations embryos, changes in PCH associated H4K20me3 levels 
suggest that these enzymes are not active in early embryos. Nonetheless, maternal PCH in 
zygotes is marked by H4K20me3 that is presumably inherited from oocytes (Figure 3.6.B). 
Thus, this modification and/or downstream binding factors could, in principle, prevent PRC1 
binding to maternal PCH. To test this model, Suv4-20 dn ESCs, which lack H4K20me3 but still 
contain H3K9me3 and HP1 proteins at chromocenters, were transiently transfected with Cbx2-
EGFP. Like in wt ESCs, no enrichment of recombinant Cbx2 at chromocenters in Suv4-20 dn 
ESCs was observed (Figure Supp. 3.5). This indicates that neither the Suv4-20 HMTs nor 
H4K20me3 or any downstream acting factor prevent PRC1 binding to heterochromatin.  
 Next, the role of Hp1 proteins, acting upstream of the Suv4-20h HMTs and downstream 
of the Suv39h HMTs, were tested in respect to PRC1 heterochromatin binding. In mouse, three 
Hp1 orthologs are expressed in most cell types including ESCs. Chromocenters are 
predominantly marked by Hp1α (Cbx5) and Hp1β (Cbx1), but not by Hp1γ (Cbx3). In mouse 
zygotes, Hp1β enrichment at maternal PCH that is dependent on Suv39h2 expression in 
oocytes is observed. It correlates with H3K9me3 enrichment at maternal PCH (Figure Supp. 
3.5) (Puschendorf et al., 2008). Hp1β localization at euchromatin of both pronuclei is 
independent of Suv39h2 activity in oocytes. We failed to detect Hp1α by IF in zygotes while 
Hp1γ displayed weak euchromatic staining (Figure 3.6.B). Given that only Hp1β is localized to 
maternal PCH, mice that are conditionally deficient for Hp1β during oogenesis and lack the 
maternal protein during pre-implantation development were generated. In such Hp1β maternally 
deficient (Hp1βm-z+ or Cbx1m-z+) zygotes, neither Hp1α nor Hp1γ were significantly up-regulated 
(Figure 3.6.B). Furthermore, H3K9me3 was still enriched at maternal PCH like in wt zygotes 
while H4K20me3 levels were slightly reduced (Figure 3.6.B). Subsequently, Hp1βm-z+ zygotes 
were stained for Rnf2, Cbx2 and Bmi1, the core components of the matPRC1 complex 
(Puschendorf et al., 2008).  Strong enrichments for all three members on maternal and paternal 
PCH were observed in absence of Hp1β protein (Figure 3.6.C).  
RQ

 Together, these data demonstrate that matPRC1 binds to maternal PCH in the presence 
of H3K9me3 and H4K20me3. In wild-type mouse zygotes, Hp1β prevents matPRC1 from 
binding to maternal PCH, presumably by binding to H3K9me3 and inhibiting Cbx2 binding to 
major satellite DNA sequences. 
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Figure 3.6: PRC1 localizes to maternal PCH in Hp1β maternally deficent zygotes. A. 
Immunofluorescence analysis for the presence of maternal histone marks in wt and Hp1βm-z+ zygotes, in 
respect to PRC1 localization. B. Immuno-fluorescence analysis of wt and Hp1βm-z+ PN5 zygotes for the 
three mammalian Hp1 isoforms. C. Immunofluorescence analysis of wt and Hp1βm-z+ PN5 zygotes for 
Hp1 and PRC1 components.  

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DISCUSSION 
 
 In Drosophila, the core PRC1 complex consists of four subunits. In vertebrates, each of 
these proteins has multiple orthologs that are thought to serve different functions during 
development (Whitcomb et al., 2007). For example, the five mammalian orthologs of dPC are 
present in biochemically distinct PRC1-like complexes in human cell lines (Vandamme et al., 
2011), which originate likely from variations in primary sequences of the different Cbx proteins 
(Senthilkumar and Mishra, 2009). All five orthologs contain N-terminally localized 
chromodomains that display different in vitro binding affinities for histone H3 peptides marked by 
H3K9me3 or H3K27me3 (Bernstein et al., 2006; Kaustov et al., 2011). These affinities are, 
however, at least one order of magnitude lower than those of mammalian and fly Hp1 proteins 
or dPC (Bernstein et al., 2006; Fischle et al., 2003). Up to date, it is unknown whether the 
various Cbx proteins would target PRC1 complexes to distinct sets of targets genes in response 
to local histone methylation profiles.  
 
Targeting of matPRC1: additive functions of the CD and AT-hook of Cbx2 
 By using EGFP-tagged Cbx proteins in embryonic stem cells and mouse pre-
implantation embryos, we show here that Cbx2 mediates binding of the matPRC1 complex to 
constitutive heterochromatin in a parental specific manner. As proposed by Senthilkumar and 
Mishra (Senthilkumar and Mishra, 2009), we demonstrate that Cbx2 is a protein with two 
functional chromatin reader domains, the CD and the closely neighboring AT-hook, that are 
sufficient for targeting to paternal heterochromatin. By combining mutation analysis of the CD 
and AT-hook with Ezh2 maternal deficiency we are the first to demonstrate the importance of 
the specific interaction between the CD and H3K27me3 for chromatin binding and localization of 
Cbx2 at euchromatin and PCH in vivo. The observed H3K27me3 selectivity is consistent with in 
vitro binding specificity reported previously (Bernstein et al., 2006; Kaustov et al., 2011). 
Likewise, mutations analysis and competition experiments with distamycin indicate that the AT-
hook of Cbx2 mediates direct binding to the minor groove of AT-rich DNA.  
 Cbx2 is unique among Cbx proteins of the PcG family in having two reader domains. It 
allows the protein to bind to constitutive PCH regions that is composed of AT-rich major satellite 
sequences and marked by H3K27me3, as observed at paternal chromosomes in early embryos 
and in Suv39h dn ESCs (Peters et al., 2003; Puschendorf et al., 2008). In contrast, the CDs of 
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Cbx4 and Cbx7 proteins which display moderate binding affinities to H3K9me3 and H3K27me3 
(Bernstein et al., 2006; Kaustov et al., 2011) do not direct binding to PCH, neither in wild type 
nor Suv39h dn ESCs. Addition of the AT-hook of Cbx2, however, resulted in efficient targeting 
of the chimaeric reporter to PCH in wild-type cells, arguing that only the combination of these 
CDs and the AT-hook provides the protein sufficient affinity to compete with Hp1 proteins for 
binding to H3K9me3-labeled major satellites.  
 
Chromatin sensing by the CD/AT-hook module 
 It is increasingly recognized that chromatin proteins or complexes are bound to 
chromatin through multiple (weak) interactions with identical or different posttranslational 
modifications on histones and sometime directly with DNA (Ruthenburg et al., 2011; Yun et al., 
2011). The CD/AT-hook double reader module of Cbx2 is particularly interesting since it harbors 
an intrinsic ability to promote binding under H3K27me3 conditions while inhibiting binding under 
H3K9me3/Hp1 conditions. Our linker insertion experiments suggest that the short peptide linker 
between the two domains is critical for the inhibitory function (Figure 3.4). We propose that the 
two reader domains actually function as one molecular unit assessing the local histone 
methylation and Hp1 state for binding.  
 
Evolutionary conservation 
 In zygotes, the CD and AT-hook are together required for proper targeting of Cbx2 to 
euchromatin (Figure 3.3). These data suggest that both modules are important for proper PRC1 
mediated gene repression during pre-implantation development. Supporting a gene regulatory 
function is the notion that the CD and the AT-hook motif are conserved between Cbx2 homologs 
among vertebrates. Interestingly, all Cbx2 orthologs contain at least one AT-hook like motif that 
is moderately conserved among vertebrates (data not shown) supporting the idea that AT-hook 
sequence arose prior to gene duplication and speciation. Additionally, the exon-exon 
organization as well as the distance between the CD and the AT-hook in Cbx2 is conserved 
from zebrafish to men (data not shown). Finally, the A14 and V13 amino acids in mammalian 
Cbx2, respectively Cbx4 and Cbx7 proteins that are critical for histone methylation binding 
specificity are evolutionary conserved. Together, these data suggest that Cbx2 acquired early 
during evolution the ability to sense chromatin states, placing Cbx2/PRC1 complexes 
functionally subordinate to the Suv3h/Hp1 pathway.  
 Exceptions to this rule are bilateral animals such as Drosophila in which the AT-hook is 
absent (data not shown). The loss of the AT hook in dPC is likely compensated by the increased 
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affinity of the CD for H3K27me3 (Fischle et al., 2003). The absence of the AT-hook suggests 
that the molecular hierarchy as observed in mouse is non-functional in Drosophila. Furthermore, 
the multiple gene duplications of Cbx genes within vertebrates point to a more diverse mode of 
gene regulation by distinct PRC1 complexes in these organisms.  
 
Transcriptional regulatory functions 
 In mouse, Cbx2 is predominantly expressed in oocytes and in early pre-implantation 
embryos while Cbx7 and other Cbx proteins are more highly expressed later during 
development in a tissue specific manner (Wu et al., 2009; Zeng et al., 2004). Cbx2 is similarly 
expressed during early development of zebrafish (Kawamura et al., 2002). In mouse early 
embryos, matPRC1 is initially preferentially localized to the paternal genome. This asymmetric 
labeling correlates with the absence of H3K9me2 and H3K9me3. At later stages, however, the 
parental asymmetry in H3K9me2/3 states is resolved and the paternal matPRC1 specific 
labeling as well. Given the matPRC1 mediated repression of major satellite sequences 
specifically at the paternal genome (Puschendorf et al., 2008), the fluorescence labeling data 
may indicate an early role for H3K9 specific HMTs and PRC1 complexes in regulating parental 
specific gene repression.  
 Recently, it was shown that repressed somatic lineage regulators like Hox, Gata and 
Sox factors that carry bivalent chromatin modifications (like H3K4me2, H3K27me3 and Rnf2 
occupancy) in ESCs are also marked by H3K4me2 and H3K27me3 in trophectodermal stem 
cells (TSCs). Nonetheless, Rnf2 was not enriched at these genes in TSCs. Instead, they were 
marked by Suv39h1-mediated H3K9me3 and DNA methylation (Alder et al., 2010). These data 
support a model in which cross talk between H3K9me3/Hp1 and PRC1 pathways may regulate 
gene specific repression in a lineage specific manner. Our current molecular understanding of 
this cross talk will direct future experiments addressing the role of both pathways in 
transcriptional regulation.  
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EXPERIMENTAL PROCEDURES 
Constructs 
 Constructs for N-terminal enhanced GFP (EGFP) fusion proteins of Rnf2 and Phc2 in 
the EGFP-C2 backbone (BD Biosciences) were obtained from K. Isono, the 3Flag Bmi1 
construct in the pCAGIPuro vector was obtained from M. Endoh. The C-terminally enhanced 
GFP fusion proteins of Cbx2, Cbx4, Cbx6, Cbx7, Cbx8 in the EGFP-N1 backbone (BD 
Biosciences) were obtained from E. Bernstein (Bernstein et al., 2006). Point mutation of the 
Cbx2 CD and AT-hooks were generated by site-directed mutagenesis. Approximately 25bp long 
primers containing the mutation in the centre were used for amplification with Phusion Taq 
(Finnzymes). The PCR reaction was digested with the methylation sensitive restriction enzyme 
Dpn1 (New England BioLabs) to remove the original construct and subsequently used for 
transformation. Successful mutagenesis was performed by sequencing. The Cbx2 truncation 
constructs were generated by PCR from the Cbx2-EGFP construct. For the Cbx4, Cbx7 CD 
fusion constructs with the Cbx2 AT-hook, a Pst1 site was introduced between the CD of Cbx2 
and the Cbx2 AT-hook for cloning. The CDs of Cbx4 and Cbx7 were amplified by PCR. Hmga1 
was cloned by PCR from NIH3T3 cDNA. For microinjection, the constructs were cloned into a 
pcDNA3.1-poly(A) vector kindly provided by K. Yamagata (Yamagata et al., 2005).  
 
Antibodies 
 For immunofluorescence analysis the following antibodies were used: anti-GFP (Roche, 
1:200), anti-flag-M2 (Sigma, 1:500), anti-M33 (Cbx2; Otte, 1:500), anti-Rnf2 (Koseki, 1:500), 
anti-Bmi1 (Upstate, 1:100), anti-Hp1α (Euromedex, 1:500), anti-Hp1β (Serotec, 1:500), Hp1γ 
(Euromedex, 1:500), anti-H3K9me3, anti-H3K27me3, and anti-H4K20me3 (Jenuwein, 1:500). 
The primary antibodies were used in combination with cross-absorbed Alexa 488-, 568-, or 633-
coupled secondary antibodies (Molecular Probes). 
 
Mice and Cell Lines 
 Zygotes used for microinjection experiments were obtained from CD1 mice, if not cited 
otherwise. Mice maternally deficient for Ezh2 have been reported previously (Puschendorf). 
Mice conditionally ablated for Cbx1 were obtained by blastocyst aggregation using ESC 
generated by Eucomm. To produce maternally deficient Hp1β mice, Cbx1F/F mice that carried 
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the Zp3-cre recombinase transgene were generated. Housing and handling of mice conformed 
to the Swiss Animal Protection Ordinance, chapter 1. 
 Wild-type, Suv39h-dn (Lehnertz et al., 2003; Peters et al., 2001) and Suv4-20h-dn 
(Schotta et al., 2004) ES cells were cultured in DMEM medium with 4.5g/l glucose (Gibco) 
containing 15% FCS (fetal calf serum, Chemicon), penicillin, streptomycin, 2mM L-glutamine, 
0.1mM 2β-mercaptoethanol, non-essential amino acids and 1mM sodium pyruvate (Gibco). ES 
cells were transfected with fusion constructs using Lipofectamine 2000 (Invitrogen) and after 
approximately 16h were seeded on poly-L-lysine coated coverslips, fixed with PFA and mounted 
in Vectashield containing DAPI (Vector). 
 
Collection, in vitro fertilization (IVF) and culture of mouse embryos 
 Mouse oocytes and embryos were derived from superovulated 5-10 week old females 
according to standard procedures (Hogan 1994). For IVF, females were injected with PMSG 
(5U, Intervet) and 48h later with hCG (5U each, Intervet). M-II oocytes were then collected 14h 
after hCG injection. Sperm was obtained from 10-16 week old control males. Capacitation was 
carried out in human tubular fluid (HTF) containing 7.5 mg/ml BSA for 2h. IVF was performed in 
HTF containing 7.5 mg/ml BSA for 2h. If not in vitro fertilized, CD1 mice were mated and 
zygotes were isolated from the ampullae. Thereafter, the embryos were cultured in KSOM 
medium plus amino acids (Chemicon) in a humidified atmosphere of 5% CO2 until required. 
Zygotes were substaged according to morphology of pronuclei using criteria as defined 
previously (adenot 1997, santos 1997). In brief, PN0 refers to oocytes immediately after 
fertilization and PN5 refers to large central pronuclei. For distamycin treated PN0 zygotes, 
fertilization was performed in HTF containing 7.5 mg/ml BSA supplemented with 20µM 
Distamycin (Sigma, #D6135) for 2h.   
 
Microinjection 
 For in vitro transcription the plasmids were linearized and the mMessage mMachine T7 
kit (Ambion, AM1344) was used. The synthesized mRNA was diluted to the optimal 
concentration using nuclease-free water (Ambion, AM9937). 2-4 pl mRNA (100ng/µl) was 
microinjected into the cytoplasm of in vitro fertilized CD1 zygotes using the Eppendorf FemtoJet 
injector system. Zygotes were then cultured in KSOM medium plus amino acids (Chemicon) 
under a 5% CO2 atmosphere at 37ºC and fixed at late zygotic stages (PN5). For micro-injection 
of RNaseA, zygotes were isolated 20h after hCG injection from CD1 mice and further cultured in 
M2 medium until the late pronuclear stage (PN4/5, 26h after hCG). RNase A (Roche, #109169) 
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was dissolved in TE buffer (pH 8.0) at 2 mg/ml. Approximately 5 pl of RNaseA were micro-
injected into the paternal pronucleus. Control zygotes were injected with TE buffer into the 
paternal pronucleus. Following micro-injection, zygotes were cultured for further 15 min.  
 
Immunofluorescence Staining 
 Before fixation of embryos, the zona pellucida was removed by incubation in acidic 
tyrode for 30 seconds. Embryos were washed twice in FHM, fixed for 15 min in 4% 
paraformaldehyde in PBS (pH 7.4) and permeabilized with 0.2% Triton-X 100 in PBS for 15 min 
at room temperature (RT). Fixed embryos were blocked at least 4 hours at RT in 0.1% Tween-
20 in PBS containing 2% BSA and 5% normal goat serum, and were then incubated with 
primary antibodies in blocking solution overnight at 4ºC. Embryos were washed three times for 
30 min in 0.1% Tween-20 in PBS containing 2% BSA before application of secondary antibodies 
for 1 h at RT followed by three washing steps for 30 min in 0.1% Tween-20 in PBS containing 
2% BSA in the dark. Embryos were mounted in Vectashield containing DAPI (Vector).  
 ES cells were trypsinized and placed on poly-L-lysine coated coverslips for 10 min to 
attach. Cells were fixed with 2% paraformaldehyde in PBS (pH 7.4), permeabilized in 0.1% 
Triton-X100 in 0.1% sodium citrate and blocked for 30 min in 0.1% Tween-20 in PBS containing 
2% BSA and 5% normal donkey serum at RT. Incubation with primary and secondary antibodies 
as well as mounting was performed as described above. 
 
Microscopy and Image Analysis 
 Immunofluorescence stainings of embryos were analyzed using the laser scanning 
confocal microscopes LSM510 META (Zeiss; software: LSM Image Browser) and LSM700 
(Zeiss; software: ZEN, 2009). One confocal slice through the maximal radius of each (pro-) 
nucleus was scanned. The images were projected using ImageJ. For numerical evaluation, all 
images of embryos and cells were analyzed individually and scored as follows: (-) no staining; 
(=) equal staining at heterochromatin and euchromatin; (+) weakly enriched; (++) clearly 
enriched; (+++) strongly enriched staining at heterochromatin versus euchromatin.  
 
RNA isolation and RT-PCR 
 RNA was isolated from 15 embryos. The embryos were transferred into Trizol and 100ng 
of E.coli RNA was added to each sample as carrier. RNA was isolated according to the 
manufacturer’s instructions. Briefly, reverse transcription was performed using random primers 
(200ng) and SuperScript II RNase H Reverse Transcriptase (Invitrogen). For PCR reactions, 
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cDNA corresponding to 0.2 embryos was used as a template. 30 amplification cycles were 
performed using Taq DNA polymerase (Qiagen), PCR products were resolved on a 2% agarose 
gel and subsequently detected via SYBR green I staining (Molecular Probes; 1:10’000). 
Fluorescence was detected on a Typhoon 9400 scanner (Amersham Biosciences). The 
following primers and cycle numbers were used: 
Actb:  F: 5’-TGGGAATGGGTCAGAAGGACT,  R: 5’-GGGTCATCTTTTCACGGTTGGC 
Gapdh: F: 5’-AACAACCCCTTCATTGACCTC,  R: 5’-TTCTGAGTGGCAGTGATGGC 
Dap:  F: 5’-GATCTATACGCAACCGGAACC,  R: 5’-ACAAGAATTTCCGCAGTACCC 
 
 
Fluorescence Polarization 
 Chromodomains of Cbx2 (9-66), Cbx4 (8-65) and Cbx7 (8-62) were amplified by PCR 
from the Mammalian Gene Collection clones and were subcloned into a modified pET28a-LIC 
vector. The recombinant proteins and their corresponding mutants were overexpressed as N-
terminal His6-tagged proteins at RT using E. coli BL21 (DE3) Codon plus RIL (Stratagene) as a 
host organism. These expressed proteins were purified by Talon (BD) affinity chromatography 
under native conditions and eluted with buffer containing 500mM Imidazole followed by size 
exclusion chromatography using a HiLoad 26/60 Superdex-75 column (GE Healthcare). The 
proteins were monomeric in solution as determined by size exclusion chromatography. The final 
samples were prepared in buffer containing 20 mM Tris (pH 8), 250 mM NaCl, 1mM DTT, 1mM 
TCEP, 1 mM Benzamidine, 0.5 mM PMSF.  
 H3K9Me3 (ARTKQTARK(me3)STGGKA) and H3K27Me3 (QLATKAARK(me3)SAPATG) 
were synthesized, N-terminally labeled with fluorescein and purified by Tufts University Core 
Services (Boston, MA, USA). Binding assays were performed in 10 µl volume at a constant 
labeled peptide concentration of 40 nM, and Cbx protein concentrations at saturation ranging 
from 800 to 1300 µM in buffer containing 20 mM Tris pH 8.0, 250 mM NaCl, 1 mM DTT, 5mM 
BME (B-Mercaptoethanol), 1mM Benzamidine, 1 mM PMSF, 0.01% Tween-20. Fluorescence 
polarization assays were performed in 384 well plates using Synergy 2 microplate reader 
(BioTek, Vermont, USA). The excitation wavelength of 485nm and the emission wavelength of 
528 nm were used. The data was corrected for background of the free labeled peptides. To 
determine Kd values, the data were fit to a hyperbolic function using Sigma Plot software (Systat 
Software, Inc., CA, USA). The Kd values represent averages ± standard errors for at least three 
independent experiments. 
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SUPPLEMENTAL INFORMATION 
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Figure Supp 3.1: Scoring of 
heterochromatin enrichment in 
chromocenters and in PCH. A. Scoring 
of heterochromatin enrichment in wt and 
Suv39h-dn ESC. ++: strong enrichment; 
+: weak; =: equally enriched as 
euchromatin; -: less enriched than 
euchromatin. B. Scoring of 
heterochromatin and euchromatin 
enrichment in zygotes. Shown are 
paternal PN5 pronuclei. Heterochromatin: 
+++: very strong, ++: strong; +: weak; =: 
equal to euchromatin; -: weaker than 
euchromatin (not observed). 
Euchromatin: ++: strong; +: weak; -: no 
signal.
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Figure Supp 3.2: The Cbx2 CD and AT-hook1 are sufficient for heterochromatin targeting. A. Schematic 
representation of the truncated Cbx2 constructs analysed. B. Representative IF pictures of transiently 
transfected Suv39h dn ESC with truncated constructs as indicated. C. Analysis of transiently transfected 
Suv39h dn ESC with truncated constructs as indicated. D. Analysis of transiently transfected Suv39h dn ESC 
for the Cbx2_CD_AT1 reporter construct. 

Figure Supp 3.3: PRC1 localization to paternal PCH is RNA-independent in zygotes. A. Immuno-
fluorescence staining for PRC1 members in RNaseA microinjected zygotes. RNase A was injected into 
the paternal pronucleus. B. RT-PCR of control, TE- and RNaseA microinjected paternal pronuclei. Actb 
and Gapdh are strongly decreased following RNase treatment, whereas a spike control (Dap) remains 
unchanged. 

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Figure Supp 3.4: Cbx2 enrichment in Suv39h dn ESC at chromocenters is sensitive to distamycin 
treatment. Top: Distamycin treatment of wt ESC does not affect chromocenter localization of H3K9me3 
and Hp1β. Bottom: Distamycin treatment results in loss of Cbx2 enrichment at chromocenters in Suv39h 
dn ESC. Right: Data analysis of distamycin treated wt and Suv39h dn ESC. 

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Figure Supp 3.5: Suv4-20h methyltransferases do not block 
Cbx2 from binding to heterochromatin in ES cells.Top left: 
immunofluorescent analysis of wt ESC. Bottom left: 
immunofluorescent analysis of Suv4-20h dn ESC. Right: Scoring 
of Cbx2 heterochromatin enrichment in wt and Suv4-20h dn ESC. 

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Figure Supp. 3.6: PRC1 localizes to maternal PCH in Suv39h2 maternally deficent zygotes. Left: Immuno-
fluorescence analysis of wt and Suv39h2m-z+ PN5 zygotes for the PRC1 members, Rnf2, Cbx2 and Bmi1 together 
with Hp1β. Right: analysis of wt and Suv39h2m-z+ PN5 zygotes of Hp1 and PRC1 components. 

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3.2. Additional Results  
 
3.2.1. Additional Results: PRC1 targeting to constitutive heterochromatin and its 
dependency with the Suv39h/Hp1β pathway in mouse zygotes 
 
3.2.1.1. FRAP of Cbx2 at Heterochromatin in Suv39h-dn ESC. 
 
Rico Kunzmann and Laurent Gelman 
Introduction 
 Dynamics of the Suv39h pathway proteins at heterochromatin have been analyzed in 
various cell types by FRAP experiments, as introduced in 2.2.2.2. One can conclude from these 
experiments, that the SET domains of the HMTs ensure stable binding. The Hp1 paralogs on 
the other hand are highly mobile, with only a small fraction of them exhibiting lower dynamics. 
Generally, these experiments show that the epigenetic heterochromatin state is dynamic. Based 
on these results, we wondered how dynamic PRC1, especially Cbx2, at heterochromatin is. 
Furthermore, we wanted to test to what extend the two targeting modules of Cbx2, the CD and 
the AT-hook motif, influence its dynamics at heterochromatin. To measure the targeting 
dynamics, we performed FRAP experiments in Suv39h-dn ESC overexpressing various Cbx2 
constructs.  
 
Results 
 The Suv39h-dn ESCs were transiently transfected with Cbx2-EGFP, Cbx2-CDF12A-EGFP 
or Cbx2-ATG78R-EGFP. After an incubation time of 24 hours, the EGFP enriched 
heterochromatin foci were bleached and the recovery time was measured (Figure 3.7.A.). The 
average half recovery time for full length EGFP tagged Cbx2 was measured to be 7 seconds 
(Figure 3.7.B). In comparison, half recovery time for Hp1 is measured between 2.5 – 4 seconds 
(Cheutin et al., 2003; Prasanth et al., 2010). Thus, the turnover of Cbx2 proteins at 
heterchromatic foci is slower than the turnover of Hp1 proteins. Nevertheless, in comparison to 
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the dynamics of HMTs (half recovery time greater than 19 seconds (Krouwels et al., 2005; 
Souza et al., 2009)), Cbx2 can be considered to be dynamic at heterochromatin.  
 Furthermore, our results suggest the existence of three populations of Cbx2 proteins at 
heterochromatic foci. The first population consists of highly mobile Cbx2 proteins with half 
recovery times between 4 – 6 seconds (Figure 3.7.C.). The second population consists of a 
more stably bound fraction of Cbx2 proteins with half recovery times ranging from 13 to 20 
seconds (Figure 3.7.C.). A third population of Cbx2 proteins is immobile. This is visualized by 
the plateau, which is reached 60 seconds after bleaching, just below 70 % of the initial intensity 
(Figure 3.7.B.). It suggests that up to 30 % of Cbx2-EGFP proteins remain bound to the 
bleached heterchromatic foci within this time frame.  
 Interestingly, FRAP analysis in Suv39h-dn ESC for constructs containing either a non-
functional CD or a non-functional AT-hook revealed higher dynamics as well as overall higher 
recovery rate than full length Cbx2. Surprisingly, point mutations in both targeting modules of 
Cbx2 resulted in a similar reduction of half recovery times to 2 seconds in average and a 
recovery over 80 % after 60 seconds (Figure 3.7.B.). This suggests that both modules are 
similarly important for targeting dynamics of Cbx2. The individual half recovery times for these 
two constructs revealed one major population around 3 seconds (Figure 3.7.C.).  
  
 
Discussion 
 Taken together, Cbx2 dynamics at heterochromatic foci of Suv39h-dn ESC is of high 
velocity. Interestingly, it is not as high as for the major population measured for the Hp1 
isoforms. It suggests that Cbx2 is bound more stably to heterochromatic foci than Hp1. This is 
surprising, especially in light of the Kd measured for the CDs of Hp1 and Cbx2. Whereas the CD 
of Hp1 binds to H3K9me3 in the µM range, the CD of Cbx2 binds to H3K27me3 at least ten fold 
weaker. Therefore, the AT-hook motif of Cbx2 accounts for this lower dynamic. Upon insertion 
of a point mutation into the AT-hook motif of Cbx2, the velocity increases to a level comparable 
to Hp1 dynamics. Nevertheless, it does not fully reflect the Kd measurements, suggesting that 
there are additional factors that influence the dynamics of CD containing proteins at 
heterochromatin. Furthermore, the insertion of a point mutation into the CD also enhances the 
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dynamics. Therefore, the two protein 
modules together account for the 
Cbx2 dynamics. This is in agreement 
with our analysis of Cbx2 constructs 
in fixed Suv39h-dn ESC.    
 A substantial amount of 
Cbx2-EGFP proteins at 
heterochromatic foci is less dynamic 
or even immobile. The detection of 
this immobile fraction is not simply 
due to technical issues, because the 
recovery rate Cbx2-CDF12A-EGFP or 
Cbx2-ATG78R-EGFP proteins from 
bleached foci is above 80 % after 60 
seconds, whereas Cbx2-EGFP 
recovers only up to 70 %. Thus, this 
immobile fraction, as well as the 
heterochromatic foci displaying slow 
half recovery times, is Cbx2-EGFP 
specific. It depends on the two 
functional targeting modules. This 
immobile fraction might facilitate the 
targeting of other PRC1 members, 
whereas the more mobile fraction 
might not be PRC1 complex bound. 
Indeed, we never measured the 
ability of Cbx2-CDF12A-EGFP or 
Cbx2-ATG78R-EGFP to target other PRC1 members in fixed cells. It might be that targeting of 
other PRC1 members is more severely affected in cells transfected with Cbx2-CDF12A-EGFP or 
Cbx2-ATG78R-EGFP than in cells transfected with Cbx2-EGFP. This could be determined by 
measuring the dynamics of Cbx2 and other PRC1 members at heterochromatin simultaneously. 
Furthermore, the immobile fraction could also function as a template for other Cbx2 proteins, 
creating a positive feed-back loop.  
Figure 3.7: FRAP analysis of various Cbx2-EGFP constructs in 
Suv39h-dn ESC. A. Example of the experimental procedure. 
Distinct foci with high EGFP intensity were photobleached and 
recovery time was measured. B. Quantitative FRAP analysis for 
Cbx2-EGFP, Cbx2-CDF12A-EGFP and Cbx2-ATG78R-EGFP at 
heterochromatin in Suv39h-dn ESC over a period of 60 seconds. 
C. Representation of the half recovery time values for the 
individual measurments of Cbx2-EGFP, Cbx2-CDF12A-EGFP and 
Cbx2-ATG78R-EGFP at the photobleached foci.
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Material and Methods 
 The Suv39h-dn ESC were transiently transfected using Lipofectamin as described 
before. For imaging, cells were plated on Ibidi plates (Ibidi, Germany), grown 24 hours in ESC 
medium and imaged on a spinning disc confocal setup comprising an Olympus IX81 (Olympus, 
Japan) microscope equipped with a Yokogawa CSU-X1 scan head, a 491nm laser line, a 
PlanApo 100x/1.45 TIRFM oil immersion objective, an ASI MS-2000 with Z-piezo stage, a 
Semrock Di01-T488/568-13x15x0.5 dichroic, a Semrock FF01-525/40-25 emission filter and a 
Cascade II EM-CCD camera (Photometrics). The setup was enclosed in a heating box and 
temperature was set at 37°C and controled with a “Box” element (Life Cell imaging, Basel). The 
sample was covered with a plate dispensing humidified air containing 5% CO2 at a flux rate of 6 
l/hour controlled with a “Brick” element (Life Cell imaging, Basel). Final pixel size was 94nm. 
FRAP was performed using a Rapp-Optoelectronic module equipped with a 473 laser. The 
results were analyzed using ImageJ. 
 
 
3.2.1.2. Polycomb from an evolutionary point of view 
 
Rico Kunzmann and Hans-Rudolf Hotz 
 
 Five PC orthologs have been described in mouse: Cbx2, Cbx4, Cbx6, Cbx7 and Cbx8 
(Cbx1, Cbx3 and Cbx5 are orthologs of Hp1). With the increase of genomic size and organism 
complexity gene duplication and subsequent functional divergence is a commonly observed 
phenomenon. This is also true for the different PC mouse paralogs. As described in 2.2.2.2., 
they display different functions, and they are expressed in a temporally and spatially controlled 
manner. 
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Chromosomal arrangement 
 Interestingly, mouse Cbx2, Cbx4 and Cbx8 are all three located within 80 kb on 
chromosome 11. In addition, also Cbx6 and Cbx7 are within 200 kb on chromosome 15 (Figure 
3.2.). Together, this implies at least three gene duplications. In order to investigate whether this 
gene order is evolutionary conserved, we compared the chromosomal arrangement of the PC 
orthologs in various vertebrate species, from fish to humans. The sequential arrangement as 
well as the orientation of Cbx2, Cbx4 and Cbx8 on one chromosome and Cbx6 and Cbx7 on 
another chromosome is conserved among human, chicken (bird) and the anole lizard (reptile) 
(Figure 3.8). Unfortunately, the genome of Xenopus tropicalis (amphibian) is not fully sequenced 
yet. Thus, sequenced scaffolds have not been assigned to chromosomes. Nevertheless, Cbx6 
and Cbx7 are in proximity on one aligned scaffold in the same orientation as in mouse. Also, 
Cbx4 and Cbx8 are close to each other on another aligned scaffold, whereas Cbx2 was 
sequenced on different scaffold. Nevertheless, once the genome is sequenced, it is possible, 
that Cbx2 turns out to be on the same chromosome as Cbx4 and Cbx8, just in greater distance 
to them than in other tetrapods. In zebrafish, finally, this chromosomal arrangement is not fully 
conserved. Zebrafish contains at least eight Cbx genes. The existence of several isoforms of 
one paralog in fish is possibly due to genome duplications. For six of the paralogs, a protein has 
been described (Figure 3.8). The eight Cbx genes show a chromosomal arrangement slightly 
different to the one observed in tetrapods. Although the gene order of Cbx2, Cbx8a and Cbx4 
on chromosome 3 is conserved, Cbx2 is in great distance to Cbx8a and Cbx4, and it is also 
differentially orientated compared to tetrapods. Interestingly, Cbx6b and Cbx7a are also located 
on chromosome 3 within 300 kb of each other and 6 Mb apart from Cbx8a and Cbx4 (Figure 
3.8). This means that the five Cbx genes once were all on the same chromosome and only in 
tetrapods, Cbx7 and Cbx6 were separated to another chromosome via chromosomal 
translocation. In zebrafish, the additional Cbx paralogs are on chromosome 6 (Cbx8b), 
chromosome 12 (Cbx7b) and chromosome 22 (Cbx6a). Taken together, the chromosomal 
arrangement detected in mouse is conserved among tetrapods (the exact Cbx2 location in 
Xenopus still has to be determined), and partly also within vertebrates (Figure 3.8).    
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Polycomb evolution 
 Alignment of the five mouse paralogs showed that solely Cbx2 contains an AT-hook 
motif, whereas Cbx4, Cbx6, Cbx7 and Cbx8 contain AT-hook-like motifs only. Furthermore, 
Cbx2, Cbx6 and Cbx8 contain an alanine at position 14, ensuring H3K27me3 specificity (at least 
for Cbx2), while Cbx4 and Cbx7 contain a valine, displaying binding preference for H3K9me3, 
as described before. Also, the exon exon boundaries of the first four exons, which encode for 
the CD, are highly conserved between all five paralogs (Figure 3.9.A.). These exon exon 
boundaries are conserved among vertebrates from fish to mammals (Figure 3.9.B. and C.). 
Furthermore, all zebrafish paralogs show great similarity to its mouse ortholog. Additionally, 

Figure 3.8: Chromosomal arrangement of the five Cbx paralogs of mouse, chicken, the anole lizard and 
zebrafish.
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Cbx2 in fish is the only paralog that contains an AT-hook motif and position 14 is like in mouse 
an alanine in Cbx2, Cbx6 and Cbx8 and a valine in Cbx4 and 7 (Figure 3.9.B.). Comparison of a 
number of fish species with mouse Cbx2 again showed conservation of A14, the AT-hook motif 
and the exon exon boundaries. Surprisingly, A13, which is highly conserved among the mouse 
Cbx paralogs, is mutated to an aspartate in fish Cbx2, suggesting lower evolutionary constraint 
on aa A13 than on aa A14 (Figure 3.9.C.).  
 Cbx2 orthologs have also been described in early deuterstomia. The sea urchin 
(Echinodermata) shows perfect conservation of the CD with A14 and the exon exon boundaries 
of the first four exons. Furthermore, of the two Cbx2 paralogs described in Sea urchins, one of 
them already contains an AT-hook like motif, suggesting that the Cbx2 AT-hook evolved 
convergent to other AT-hook motifs containing proteins from an imperfect sequence. It also 
suggests that the AT-hook is evolutionary younger than the CD with the A14 and the exon exon 
boundaries (Figure 3.9.E.).  
 Alignment of mouse Cbx2 with different Drosophila species and other arthropods (all 
protostomia) displayed a different exon exon structure. Nevertheless, the primary amino acid 
structure remained conserved, encoding for a CD with A14. Furthermore, neither an AT-hook 
motif nor an AT-hook like motif (Figure 3.9.D.) was detected in the protostomia species 
investigated. The Water flea (a mandibulata like Drosophila, but from the crustacean family; it 
must be noted that the A14 of the Water flea is shifted N-terminally by three aa), and the Deer 
tick (also an arthropod, but a chelicerata) showed conservation of the first three exon junctions. 
The Honey bee on the other hand shows conservation of only the first two exon boundaries. 
Finally, only the first exon exon boundary is conserved in Drosophila (Figure 3.9.D.).  
 Importantly two Cbx2 transcripts were also detected in the Sea anemone, a cnidaria. 
This animal is placed in the tree of life before the separation into the two major bilateria groups 
of protostomia and deuterostomia. Thus, it is the oldest organism that contains a Cbx paralog 
described so far. Surprisingly, the CD with A14 as well as the exon exon boundaries is fully 
conserved for one of the two isoforms with mouse Cbx2, while the other isoform shows at least 
partial exon exon boundary conservation. Both isoforms do not contain an AT-hook like motif 
(Figure 3.9.E). Finally, this protein sequence in Sea anemones strongly suggests that the exon 
exon boundaries are conserved beyond bilateria, and that the protostomia species lost these 
boundaries.  
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Figure 3.9: Alignments of the the mouse Cbx paralogs and orthologs displaying the first four exons. A. Mouse 
Paralogs, exon 1 to exon 4 (CBX2: ENSMUSP00000026662; CBX4: ENSMUSP00000026665; CBX6: 
ENSMUSP00000105255; CBX7: ENSMUSP00000105245; CBX8: ENSMUSP00000026663); B. Zebrafish 
Paralogs, exon 1 to exon 4 (Cbx2: ENSDARP 00000066052; Cbx4: ENSDARP00000095047; Cbx6: 
ENSDARP00000117129; Cbx7: ENSDARP00000055427; Cbx8a: ENSDARP00000095045; Cbx8b: ENSDARP 
00000093874); C. Mouse Cbx2 and Fish orthologs, exon 1 to exon 4 (mouse: ENSMUSP 00000026662; 
Tetraodon: ENSTNIP00000014215; Fugu-1: ENSTRUP 00000004914; Fugu-2: ENSTRUP 00000008095; 
Sticklebacks: ENSGACP00000019004; Medacka: ENSORLP 00000001129; Zebrafish: ENSDARP00000066052); 
D. Mouse Cbx2 and selected Protostomia (arthropods) orthologs, exon 1 to exon 4 according to mouse (mouse: 
ENSMUSP00000026662; Water flea (Daphnia pulex): P191862; Deer tick (Ixodes scapularis): ISCW012843; 
European honey bee (Apis mellifera): GB12523; Yellow fever mosquito (Aedes aegypti): AAEL014098;   
D.melanogaster: FBpp0078059); E. Mouse Cbx2 (a late deuterostomia), a Cnidaria (before protostomia and 
deuterostomia division), an early deuterostomia (Sea urchin) and Zebrafish (a deuterstomia) (mouse: 
ENSMUSP00000026662; Zebrafish: ENSDARP00000066052; Sea urchin  (Strongylocentrotus purpuratus): 
020586, 020946; Sea anemone (Nematostella vectensis): v1g238789, v1g243415); arrow: amino acid residue 14 
according to mouse Cbx2; long bar: chromodomain; short bar: AT-hook motif. Colors of aa residues: black and 
blue letters distinguish exons; red letters display exon exon junctions within a codon.
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Furthermore, for the Sea anemone as well as for the Sea urchin two Cbx2 homologs have been 
described. Firstly, this suggests that a Cbx2-like protein was the founding member of the Cbx 
protein family. Secondly, it also suggests that the protostomia lineage lost one of the Cbx2 gene 
copies during evolution (Figure 3.10.A.). Interestingly, we did not detect any Cbx homolog in C. 
elegans (Nematodes), Schistosoma mansoni (Platyhelminthes) and Oikopleura dioica 
(Urochrodata), as described previously (Schuettengruber et al., 2007) (Figure 3.10.B). This 
implies that those species lost several Cbx gene copies. Therefore, the loss of Cbx genes 
during evolution occurred several times. And thirdly, the founding member of the Cbx proteins 
might be even older than the Cnidarians, and upon Cnidarian evolution an early, first gene 
duplication must have taken place, resulting in the two Cbx2 Cnidarian homologs (Figure 
3.10.A).  
  
Discussion 
 Taken together, the chromosomal arrangement of the Cbx paralogs is conserved among 
the tetrapod model organisms (the correct localization of Cbx2 in Xenopus still needs to be 
determined). Furthermore, the first 3 exon junctions of the Cbx paralogs, coding for the CD, are 
highly conserved from cnidarians to humans, but diverged in the protostomia lineage. The CD 
with aa residue A14 remains preserved in the deuterostomia and the protostomia lineage, 
though. Finally, the AT-hook motif, putatively evolved from an AT-hook like motif, originates in 
early deuterostomia. It is unique for the Cbx2 orthologs, suggesting importance of the AT-hook 
motif from fish to humans, in respect to Cbx2 function (Figure 3.10.A).  
 Cbx2 has been described to function within the PRC1 complex. The presence of two 
Cbx homologs in Cnidarians raises the question, whether or not other PRC1 members are 
present in Cnidarians. Interestingly, for the Cnidarian Sea anemone a Ring homolog as well as 
a Ph homolog has been described, whereas it is not known presently if it contains also a Bmi1 
homolog (Schuettengruber et al., 2007). Nevertheless, the presence of three of the four core 
PRC1 members in the Sea anemone strongly suggests the presence of PRC1 itself. 
Furthermore, the Sea anemone also contains a partial Hox gene cluster, the well described 
target of PRC1 in other species. It is possible that the maintenance of silencing of this Hox gene 
cluster in the Sea anemone is dependent on PRC1. 
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Figure 3.10: A. Phylo-genetic 
tree of selected organism 
displaying Pc evolution within 
metazoa. Black nodes indicate 
common ancestor. The branch 
lengths do not represent 
evolutionary distance between 
orga-nisms. Red letters indicate 
evolutionary events. B. 
Phylogenetic distribution of the 
PRC1, PRC2 and Hox gene 
clusters. Adapted from 
Schuettengruber et al., 2007.  

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3.2.1.3. Exogenously provided Hp1β restores PCH asymmetry in Hp1βm-z+ zygotes  
 
Introduction 
 In wt zygotes, Hp1β, putatively bound to H3K9me3, is strongly enriched at maternal 
PCH, while PRC1 localizes to paternal PCH. In zygotes maternally deficient for Hp1β, though, 
PRC1 members localize to paternal and also to maternal PCH. Therefore, Hp1β prevents PRC1 
binding to maternal PCH. To test whether this blocking effect takes place directly by Hp1β in the 
zygote, or whether it appears to be indirect or relies on an Hp1β function during oocyte 
development, recombinant N-terminal myc tagged Hp1β was micro-injected into zygotes right 
after fertilization. These zygotes were then analyzed for PRC1 localization and possible restored 
asymmetry. 
  
Results 
 In zygotes, which were microinjected with recombinant Hp1β, endogenous Cbx2 at 
maternal PCH was reduced in comparison to Hp1βm-z+ zygotes microinjected with water (Figure 
3.11.A and 3.11.B). This suggests that the epigenetic asymmetry can be directly rescued and 
restored in the zygote by Hp1β. It must be stated though, that recombinant Hp1β never reached 
the same level of maternal PCH enrichment as endogenous Hp1β in wt zygotes (Figure 3.11.A 
and 3.12.A). This reduced targeting might be due to the lack of post-translational, cell cycle 
dependent modifications of recombinant Hp1β, such as phosphorylation. In contrast, in 2-cell 
embryos the enrichment of recombinant Hp1β at heterochromatin is equally strong as 
endogenous Hp1β (data not shown). 
  Next, we asked whether Hp1β dimerization and potential higher order organization of 
chromatin is required to prevent Cbx2 from binding to maternal heterochromatin. To address 
this question, we microinjection of Hp1βI161E, an Hp1β construct that lacks the ability to form 
homo- and heterodimers, did not result in the reduction of Cbx2 at maternal PCH (Figure 
3.11.B). Localization of Hp1βI161E to maternal PCH, though, was even lower than the localization 
of full length recombinant Hp1β (Figure 3.11.A and 3.12.A). Thus, we cannot conclude whether 
the inability to rescue the asymmetry is due to the inability to form homo- and heterodimers or 
due to inefficient targeting of Hp1βI161E to PCH.  
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 Interestingly, microinjection of Hp1α, an Hp1 isoform, which is not present in wt zygotes, 
into Hp1βm-z zygotes did not restore the epigenetic asymmetry (Figure 3.11.B), suggesting that 
the blocking effect of Hp1β toward PRC1 is Hp1β specific. However, enrichment of recombinant 
Hp1α in Hp1m-z+ zygotes at PCH was low, as observed for Hp1βI161E (Figure 3.11.A and 3.12.A). 
Therefore, we cannot formally conclude whether restoring the asymmetry by Hp1α in Hp1βm-z+ 

 
 
Figure 3.11: Microinjection of 
recombinant myc tagged Hp1 
constructs into wt and Hp1βm-z+ 
zygotes. A. Representative confocal 
images of wt and Hp1βm-z+ zygotes 
microinjected with myc tagged Hp1β, 
Hp1βI161E and Hp1α mRNA or H2O. 
DNA was visualized by DAPI. PRC1 
localization by an antibody against 
Cbx2 and the recombinant construct 
by a myc9E10 antibody. B. Graph 
displaying the Cbx2 enrichment at 
maternal and paternal PCH of Hp1βm-
z+ zygotes.

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zygotes fails due to insufficient PCH targeting or because Hp1α cannot prevent Cbx2 from 
binding to maternal PCH. Interestingly though, enrichment of recombinant Hp1α at maternal 
PCH was high in wt zygotes. This suggests that Hp1α targeting to maternal PCH in wt zygotes 
is Hp1β dependent. 
  
Discussion 
 Taken together, the epigenetic asymmetry in Hp1βm-z+ zygotes is restored upon 
microinjection of recombinant Hp1β, whereas it is not restored by a construct that lacks the 
ability to form homo- and heterodimers (Hp1βI161E) or by Hp1α. Therefore, Hp1β directly 
prevents PRC1 from binding to maternal PCH in the mouse zygote. This asymmetry is set up de 
novo in the zygote. Surprisingly, the exogenously provided Hp1α was recruited to maternal PCH 
only in the presence of Hp1β in wt zygotes. Therefore, targeting of exogenously provided Hp1α 
to maternal PCH depends on Hp1β in the mouse zygote (Figure 3.12.A). The endogenously 
present Hp1β might be post-translationally modified. This might enhance the targeting efficiency 
of exogenously provided, putatively unmodified, Hp1α. Nevertheless, there is no such 
dependency of exogenously provided Hp1β observed in respect to PCH targeting (Figure 
3.12.A). In wt as well as in Hp1βm-z+ zygotes, recombinant Hp1β is enriched at maternal PCH to 
a similar degree. Therefore, this specificity in zygotes must be due to sequence differences 
between the two paralogs (Figure 3.12.B). Mutational analysis of recombinant Hp1α might 
identify the aa residues responsible for this specificity.  
 
Material and Methods 
 Recombinant myc tagged Hp1β, Hp1βI161E and Hp1α mRNA or H2O was microinjected 
into cytoplasm of IVF zygotes right after fertilization at a concentration of 7.5 ng/µl as previously 
described.   
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Figure 3.12: A. Graph displaying the enrichment of Hp1 constructs at PCH in wt and Hp1βm-z+ 
zygotes. The enrichment was scored based on the myc9E10 antibody staining. B. Alignment of the 
mouse and human Hp1α and Hp1β homologs. 

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3.2.1.4. The Effect of SUV39H Activity in Mouse Zygotes on the PCH Asymmetry  
 
Introduction  
 In the paternal PN of wt zygotes there is no H3K9me3 detected in IF stainings. This lack 
of paternal H3K9me3 propagation suggests absence of the Suv39h and other H3K9me3 HMTs. 
One can also envision that the maintenance of asymmetric H3K9me3 is an active process that 
depends on zygotic transcription and protein synthesis, as it has been described for the 
asymmetric H3K9me2 (Liu et al., 2004). This would be in agreement with the detection of 
mRNA of Suv39h2 in zygotes (Puschendorf et al., 2008). To test whether asymmetric H3K9me3 
is due to the absence of the HMTs and its enzygmatic activity, we microinjected myc-tagged 
human SUV39H1 and mouse Suv39h2 mRNA into wt zygotes.  
 
Results 
 Whereas microinjection of water did not affect the PCH asymmetry with conventional 
maternal Hp1β and H3K9me3 and paternal Cbx2 enrichment (Figure 3.13.A, Figure 3.14.A), 
microinjection of 100ng/µl SUV39H1 mRNA resulted in the loss of PCH asymmetry. 
Interestingly, recombinant human SUV39H1 was not only targeted to paternal PCH, but also tri-
methylated H3K9 at paternal PCH (Figure 3.14.B). Furthermore, paternal PCH got highly 
enriched for Hp1β (Figure 3.13.B). Surprisingly, this de novo paternal localization of the Su(var) 
pathway did not result in the loss of paternal Cbx2 enrichment. On the contrary, Cbx2 
enrichment was now also observed at PCH of maternal PN (Figure 3.13.B). Microinjection of a 
hyperactive SUV39H1 construct (SUV39H1H320R) revealed an even stronger abolishment of the 
PCH asymmetry, displaying high enrichment of the Suv39h pathway and PRC1 equally strong 
at maternal and paternal PCH (Figure 3.13.C, Figure 3.8.C). Microinjection of an inactive 
SUV39H1 (SUV39H1H324L), however, did not result in paternal H3K9me3 (Figure 3.14.D) and 
did not affect the PCH asymmetry (Figure 3.13.D). Thus, the loss of PCH asymmetry is 
dependent on the activity of SUV39H1.  
 Furthermore, microinjection of 100ng/µl Suv39h2 mRNA resulted in the enrichment of 
the Su(var) pathway paternally and colocalization with Cbx2 (Figure 3.13.E, Figure 3.14.E). 
Interestingly and in contrast to microinjection of SUV39H1, Cbx2 was still prevented from 
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binding to maternal PCH (Figure 3.13.E). Thus, the asymmetry remained at least maternally 
intact upon Suv39h2 microinjection. 
  
Figure 3.13: Microinjection of recombinant 
myc-tagged SUV39H1 and Suv39h2 
constructs into wt zygotes. Zygotes were 
stained Hp1β and Cbx2 (determination of 
PCH asymmetry). A. Microinjection of H2O. 
B. Microinjection of myc-tagged SUV39H1. 
C. Microinjection of myc-tagged 
SUV39H1H320R, which displays enhanced 
H3K9me3 activity. D. Microinjection of myc-
tagged SUV39H1H324L, which lacks 
H3K9me3 activity. E. Microinjection Suv39h2.  

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Figure 3.14: Microinjection of 
recombinant myc-tagged 
SUV39H1 and Suv39h2 
constructs into wt zygotes. 
Zygotes were stained with 
antibodies raised against 
myc9E10 in order to detect the 
recombinant protein and 
H3K9me3 (detection of the HMT 
activity). A. Microinjection of H2O. 
B. Microinjection of myc-tagged 
SUV39H1. C. Microinjection of 
myc-tagged SUV39H1H320R, which 
displays enhanced H3K9me3 
activity. D. Microinjection of myc-
tagged SUV39H1H324L, which 
lacks H3K9me3 activity. E. 
Microinjection Suv39h2.

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Discussion 
 Upon Suv39h HMT activity in the mouse zygote, the asymmetry for the Su(var) pathway 
and PcG proteins at PCH is resolved. The two pathways colocalize at the PCH of maternal and 
paternal PN. This result is highly surprising and unexpected, and it raises more questions than it 
answers.  
 It has been shown for the Hp1 isoforms that they are highly dynamic at heterochromatin 
with half recovery times around 2.5 seconds and that their dynamics rely on the Suv39h HMT. 
In 4-cell embryos, the dynamic of Hp1β at heterochromatin is reduced. Half recovery times of 9 
seconds were measured. This decrease of mobility in early preimplantation embryos might be 
due to the absence of Suv39h HMT activity. This implies that Hp1β is bound stronger to 
heterochromatin in the absence of Suv39h HMT activity. Therefore, in addition to the high 
affinity for H3K9me3 of Hp1β, this low mobility might lead to a more fixed chromatin 
configuration at maternal PCH in early embryos, which putatively results in the maternal and 
paternal asymmetry at PCH. Upon Suv39h HMT activity, though, Hp1β at PCH might become 
more dynamic. The enhanced dynamic of the Suv39h pathway together with the high content of 
PRC1 proteins in zygotes compared to other cell types might result in this colocalization at PCH.  
 This does not explain the result for microinjected Suv39h2 where Hp1β, putatively bound 
to H3K9me3, and Cbx2 colocalize paternally, but not maternally. Thus, the abundant presence 
of Suv39h2 keeps Cbx2 from maternal PCH, by an unknown Suv39h2 specific mechanism, 
while SUV39H1, the major embryonic HMT does not distinguish maternal and paternal PCH in 
this respect. Interestingly, sequence alignments of the human and mouse Suv39h HMT display 
a basic stretch of aa, which is specific to the C-terminus of Suv39h2. Human SUV39H2 does 
not contain this basic stretch (Figure 3.15). Therefore, it would be interesting to microinject 
human SUV39H2, in order to test whether or not this specificity is due to this basic C-terminus. 
Interestingly, overrepresentation of basic aa have been shown to correlate with the compaction 
capability for members of the PRC1 complex (Grau et al., 2011). Thus, the basic aa stretch of 
mouse Suv39h2 might also result in a higher level of compaction maternally compared to 
SUV39H1. This, together with the inherited maternal heterochromatic state might prevent 
colocalization with PRC1 proteins.  
 Further investigation and comparison of the two Suv39h HMT, the importance of the 
Suv39h pathway and PcG proteins in chromocenter formation and heterochromatin maturation 
in late 2-cell, analysis of targeting mechanisms of the Suv39h pathway to paternal PCH might 
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give more insight into these unexpected observations. Altogether, though, they show that the 
Suv39h pathway and PcG proteins under these circumstances colocalize.  
 
Materials and Methods  
 Plasmids containing the myc-tagged SUV39H1 and Suv39h2 ORFs were obtained from 
T. Jenuwein. mRNA was generated as described before and 100ng/µl were individually 
microinjected into the cytoplasm of wt C57BL/6 zygotes. They were fixed at the PN5 zygotic 
stage. Zygotes were stained with antibodies against myc-9E10, H3K9m3, Hp1β and Cbx2. 
Confocal images were taken with a LSM 700 microscope (Zeiss, Germany). Enrichment at 
maternal and paternal PCH was scored using ImageJ.  
 
 
  

Figure 3.15: Sequence alignment of the human and mouse Suv39h proteins. Domains are indicated above the 
sequence.  
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3.2.2. Size Difference of Maternal and Paternal Pronuclei 
 
 In addition to the epigenetic asymmetries discussed so far, there is also a morphological 
asymmetry in respect to the size of the maternal and paternal PN. The distinction of the 
maternal and the paternal PN is usually determined in a first step by their relative size 
difference, with the paternal PN being bigger than the maternal PN. This size difference is 
visualized by DAPI, which intercalates with DNA. DAPI dense regions are thought to consist of 
DNA within more condensed chromatin than weakly stained DAPI regions.  
 Although the maternal and the paternal genomes are equally large, the paternal PN is 
bigger. This suggests that DNA in the paternal PN is less compacted. Indeed, DAPI stainings of 
paternal PN display more dispersed weak staining patterns than maternal PN DAPI stainings. 
Interestingly, this size difference is not only observed in PN5 zygotes but throughout zygotic 
development, which suggests that it is maintained by proteins present in the zygote. 
Furthermore, paternal DAPI dense regions are usually limited to PCH. To emphasize whether it 
is indeed the paternal PN that is bigger than the maternal PN in a mouse model, further analysis 
is needed (e.g. DNA methylation status, H3K9me2/3 or PRC1 stainings). To date, no KO or 
cKO mouse model, neither maternally nor zygotically deficient for a gene, has been described 
that results in the increase of maternal and/or paternal PN size or the decrease of maternal 
and/or paternal PN.  
 
Histone variants 
 The compaction of DNA into higher order chromatin involves epigenetic regulators 
(Trojer and Reinberg, 2007). After the protamine to histone exchange in the paternal PN, 
maternally provided H3.3 histones are incorporated paternally, whereas maternal DNA remains 
wrapped around the canonical H3.1/2 histone variants. Thus, it is possible that global H3.3 
incorporation does not compact chromatin to the same level as H3.1/2. Nevertheless, after the 
first round of DNA synthesis in the zygote, where H3.1/2 variants are incorporated also 
paternally, the size difference of maternal and paternal PN persists. Finally, it is possible that 
the global paternal histone content is lower than the maternal histone content, which might 
result in the relative size difference.  
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Transcriptional activity 
 The major ZGA takes place in the 2-cell embryo. Nevertheless, minor transcription has 
been observed from S-phase zygotes onwards. Interestingly, the transcriptional levels of the 
paternal PN are 4 to 5 times higher than in the maternal PN (Aoki et al., 1997). This enhanced 
paternal transcription might be in relationship to the putatively less compacted chromatin of the 
bigger paternal PN. Therefore, the transcriptional machinery might have better access to 
paternal transcription start sites than to maternal transcription start sites. Additionally, it is 
known that the paternal PN is enriched for histone H4 acetylation in comparison to the maternal 
PN (Adenot et al., 1997). The elevation of global acetylation in the zygote led also to enhanced 
maternal transcription (Wiekowski et al., 1993). This suggests that the transcriptional asymmetry 
is due to acetylation, resulting in a more transcription favorable chromatin state of the paternal 
PN. Nevertheless, this hyperacetylation in zygotes has not been reported to have any effect on 
the PN size.   
 
DNA methylation 
 It is also possible that the active, global, paternal DNA demethylation is responsible for 
this pronuclear size difference. But neither PGC7/Stella mutants, which lack protection of the 
maternal DNA from demethylation, nor TET3 mutants, which do not show 5mC to 5hmC 
conversion paternally, an effect on the relative size difference between the maternal and the 
paternal PN have been described (Gu et al., 2011; Nakamura et al., 2007). Furthermore, late 
PN5 stage zygotes show less relative size difference of the maternal and the paternal PN in 
comparison to earlier PN stages, whereas active paternal DNA demethylation is completed by 
then and the two PN are highly asymmetric in respect to DNA methylation. Therefore, it is 
unlikely that the global paternal hydroxymethylation of 5mC residues is responsible for the size 
difference of the two maternal and the paternal PN. 
 
Suv39h pathway 
 It is possible that the size difference between the maternal and the paternal PN is due to 
the absence of repressors paternally, such as the Su(var) pathway. Therefore, we analyzed the 
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size of maternal and paternal PN of Hp1βm-z+ zygotes and compared them to the PN sizes of wt 
zygotes. The maternal PN was determined by H3K9me3 and euchromatic PRC1 staining. 
Interestingly, the analysis of Hp1βm-z+ zygotes displayed a significantly bigger maternal PN. In 
Hp1βm-z+ zygotes the size of maternal and the paternal PN are identical. They are similar to the 
size of the paternal PN in wt zygotes (Figure 3.16.A, B and C).  
 
 
 
 
Figure 3.16: The effect of Suv39h2 
and Hp1β maternal deficiency on the 
PN size. A. Representative images of 
the DNA from wt, Suv39h2m-z+ and 
Hp1βm-z+ PN5 zygotes. DNA was 
visualized by DAPI. Bar = 10µm. B. 
Graph displaying sizes of wt, 
Suv39h2m-z+ and Hp1βm-z+ PN5 
zygotes, including t-test values for the 
three mouse lines. C. Relative size 
differences between maternal and 
paternal PN (matPN/patPN) of the 
three mouse lines, including p-values. 

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 Based on this result, we wondered whether the phenotype observed for Hp1βm-z+ 
zygotes is within the Suv39h pathway. Therefore, PN sizes of Suv39h2m-z+ zygotes were 
analyzed. Based on weak maternal euchromatic H3K9me3 and euchromatic PRC1 staining, the 
maternal PN was determined. Strangely, both PN of Suv39h2m-z+ zygotes were smaller than wt 
zygotes (Figure 3.16.B). Generally, one would expect that maternal loss of the heterchromatic 
H3K9me3 HMT would result rather in the size increase of a PN than in its decrease. For the 
moment, we do not have an explanation for this observation. Also, the distance between the 
maternal and the paternal PN is not changed in Suv39h2m-z+ compared to wt zygotes. This 
suggests that there is no developmental delay in the Suv39h2m-z+ zygotes, which could explain 
this size difference. Despite the reduction in size of both PN, the relative size difference 
between the maternal and the paternal PN was less obvious in Suv39h2m-z+ zygotes compared 
to wt zygotes, although not significantly (Figure 3.16.C). The examination of additional 
Suv39h2m-z+ zygotes will resolve whether or not the loss of the size difference between maternal 
and paternal PN in Hp1βm-z+ zygotes is within the Suv39h pathway.    
 Altogether, the equal size of maternal and paternal PN in Hp1βm-z+ zygotes suggests that 
the chromatin of the maternal PN is more compacted by Hp1β than the paternal PN. This 
coincides with the enrichment of H3K9me3 maternally, which is the prominent chromatin binding 
site of the Hp1β CD. Neither euchromatic paternal Hp1β nor the little Hp1β PCH enrichment in 
late PN5 zygotes is involved in global paternal chromatin compaction. Therefore, Hp1β, 
putatively bound to maternal H3K9me3, globally compacts maternal chromatin, which results in 
the relative size difference of the maternal and the paternal PN. 
 Furthermore, the function of the two other well described H3K9 HMT, G9a and Eset, 
should be analyzed in respect to PN size. Preliminary analysis revealed that the maternal PN is 
even bigger than the paternal PN in G9am-z+ deficient zygotes, whereas maternally deficiency for 
Eset did not affect the PN size difference.   
 The loss of the size difference between maternal and paternal PN in Hp1βm-z+ zygotes 
raised the question whether or not this is a zygotic phenotype. To investigate this, the PN sizes 
of late wt and Hp1βm-z+ zygotes microinjected with either H2O or with 7.5 ng/µl recombinant 
Hp1β were analyzed in respect to their PN sizes. The microinjection of 7.5 ng/µl recombinant 
Hp1β, Hp1βI161E and Hp1α into wt zygotes did not affect the PN size in comparison to H2O 
microinjected zygotes (Figure 3.17.A). The maternal PN size compared to the paternal PN size 
remained (Figure 3.17.B). Microinjection of recombinant Hp1β into Hp1βm-z+ zygotes, though, 
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affected the size of the maternal PN in Hp1βm-z+ zygotes. Whereas the size difference of 
maternal and paternal PN in H2O, Hp1βI161E and Hp1α injected Hp1βm-z+ zygotes did not differ 
significantly, the microinjection of Hp1β resulted in the reestablishment of the significant size 
difference of the two PN (Figure 3.17.A). It is surprising that only exogenously provided Hp1β 
and not Hp1α reestablished the mat/pat PN size difference. This might be due to inefficient 
targeting of the recombinant Hp1α.  
Unexpectedly, the actual PN sizes of Hp1βm-z+ zygotes microinjected with different Hp1 
constructs varied (Figure 3.17.A). For the moment, there is no explanation for this. 
Nevertheless, the differences between the maternal and the paternal PN remained the same, 
despite the size increase, suggesting that this is a technical issue. Comparison of the 
matPN/patPN ratio of microinjected Hp1βm-z+ zygotes revealed a low p-value for H2O - Hp1β 
compared to the other p-values of this group. Nevertheless, it is not significant (Figure 3.17.B). 
Furthermore, the comparison of the matPN/patPN ratio of wt and Hp1βm-z+ zygotes shows that it 

 
 
 
 
 
 
Figure 3.17: Re-
establishing the 
maternal/paternal PN size 
difference in Hp1βm-z+ 
zygotes by exogenously 
provided Hp1β. A. Box 
plot displaying the effect 
of microinjected H2O, 
Hp1β, Hp1βI161E and Hp1α 
on the PN size in wt and 
Hp1βm-z+ zygotes. Below: 
p-values. B. Relative size 
differences between 
maternal and paternal PN 
(matPN/patPN) of 
microinjected wt and 
Hp1βm-z+ zygotes, 
including p-values. 

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is significant for microinjected H2O, Hp1βI161E and Hp1α, but not for microinjected Hp1β (Figure 
3.17.B). This strongly suggests that exogenously provided Hp1β is able to reduce the maternal 
PN size of Hp1βm-z+ zygotes and to establish the significant size difference of maternal and 
paternal PN as observed in wt zygotes, putatively by binding to maternally provided H3K9me3.  
 Another set of experiments, performed in wt zygotes, suggests that the activity of the 
SUV39H1 together with Hp1β influences the PN size. Upon microinjection of SUV39H1 mRNA 
into wt PN0 zygotes, a significant size reduction of the maternal PN was detected at the PN5 
zygotic stage. The overexpression of a hyperactive SUV39H1 HMT (SUV39H1H320R) then 
resulted in a significant decrease in PN size of both PN. Interestingly, microinjection of an 
inactive form of the SUV39H1 HMT (SUV39H1H324L) also affected the PN sizes. It led to a 
significant size decrease of the maternal PN. This might be explained by the maternally 
inherited H3K9me3, which is the binding site of the SUV39H1 CD, possibly compacting 
chromatin (Figure 3.18). Surprisingly, the presence and activity of Suv39h2 in zygotes did not 
significantly reduce the size of neither maternal nor paternal PN (Figure 3.18). Mutational 
analysis or domain swaps of the two Suv39h HMTs might give insight into this specificity. 
Finally, the co-microinjection of SUV39H1 together with Hp1β led to a highly significant size 
decrease of the maternal and the paternal PN (Figure 3.18). Nevertheless, in all these 
measures, the relative size difference of the two PN was less affected than the actual size. This 
is in not full agreement with our previous results where maternal Hp1β deficiency led to a PN 
size increase only maternally. It might be explained by the accumulation of H3K9me3 
maternally. Possibly, the exogenously provided HMTs are maternally and paternally equally 
active, leading to similar de novo H3K9me3 on both PN, and, therefore, resulting in more 
maternal H3K9me3 putatively bound by Hp1β and, therefore, compacting chromatin.   
 Taken together, our results suggest that the maternal PN is smaller than the paternal PN 
because of Hp1β, putatively bound to maternal H3K9me3, and therefore compacting maternal 
chromatin to a higher extend than paternal chromatin. In Hp1βm-z+ zygotes, this size difference is 
lost. Microinjection of recombinant Hp1β into Hp1βm-z+ zygotes, though, reestablishes the size 
decrease of maternal PN, suggesting that it is a zygotic phenotype. Furthermore, the maternal 
and paternal PN sizes of wt zygotes can be decreased by the presence and the enzymatic 
activity of abundant exogenously provided members of the Suv39h pathway.  
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Figure 3.18: The effect of exogenously provided Suv39h and Hp1β on the size of C57BL/6 wt zygotes. The 
zygotes were microinjected with the constructs indicated right after fertilization. The Suv39h and the Hp1β 
mRNA were injected at a concentration of 100ng/µl. They were fixed at the PN5 zygotic stage. Below: p-
values.   


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Discussion 
 The chromatin marks of maternal PN resemble the chromatin signature of ESC and 
other cell types, whereas the chromatin marks of the paternal PN in the mouse zygote display a 
more immature chromatin state, hyperacetylated and hypomethylated and therefore less 
condensed than maternal chromatin. This is visualized by the size difference of the maternal 
and the paternal PN. Therefore, the mouse zygote is a good model to study determinants of the 
nuclear size and chromatin compaction. Zygotes maternally deficient for chromatin associated 
factors can be analyzed for either size increase of maternal PN or size decrease of the paternal 
PN. Interestingly, we show here experimentally that Hp1β is a determinant factor for the 
compaction of maternal chromatin. Hp1β IF analysis in wt zygotes displays maternal and 
paternal euchromatic staining. Despite the euchromatic presence of Hp1β in both PN, the 
maternal PN is smaller. A major difference between maternal and paternal chromatin is the lack 
of global paternal H3K9me3, which is the histone mark that is bound by CD of Hp1β with the 
highest affinity. This suggests that it is Hp1β bound to H3K9me3 that determines the PN size 
reduction. According to that, the reduction, but not complete loss of H3K9me3 in Suv39h2m-z+ 
zygotes results in an intermediate increase of the maternal PN size, compared to wt and Hp1βm-
z+ zygotes. Furthermore, exogenously provided SUV39H1 tri-methylates paternal H3K9, which 
results in the decrease of the paternal PN size.  
 The results of these experiments show that Hp1β within the Suv39h pathway compacts 
chromatin globally in vivo. 
 Finally, it would be interesting to analyze the effect of the PN size increase or decrease 
in respect to global zygotic transcription. Possibly, it also affects the ZGA in 2-cell embryos. 
Thus, also the developmental potential of these zygotes should be analyzed. Furthermore, the 
precocious enzymatic activity of the Suv39h HMT in zygotes might lead to early formation of 
heterochromatin.   
 
Material and Methods  
 Wild-type and mutant zygotes were obtained, cultured and fixed at the PN5 zygotic 
stage as described before. Plasmids containing the myc-tagged SUV39H1, Suv39h2 and Hp1β 
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ORFs were obtained from T. Jenuwein. mRNA was generated as described before. In the 
rescue experiment, 7.5 ng/µl mRNA was microinjected into the cytoplasm of in vitro fertilized wt 
and Hp1βm-z+ C57BL/6 zygotes as described before. In the Suv39h activity experiment, 100 
ng/µl mRNA was microinjected into the cytoplasm of in vitro fertilized wt C57BL/6 zygotes. 
Zygotes were fixed at the PN5 zygotic stage. Maternal and paternal PN were determined based 
on DAPI, H3K9me3, Hp1β and Rnf2 IF stainings. Confocal images of the zygotes at their 
biggest radius were taken with a LSM700. Images were analyzed with ImageJ.  


3.2.3. Impact of Epigenetic Repressors on Zygotic 5mC to 5hmC conversion  
 
Introduction  
 Within a few hours after fertilization, the paternal genome rapidly loses its global 5mC 
DNA methylation (Mayer et al., 2000a; Oswald et al., 2000; Santos et al., 2002). The maternal 
genome remains DNA methylated in the zygote and is only passively DNA demethylated via 
DNA synthesis. A maternal factor essential for early development called PGC7/Stella was 
identified to protect the maternal DNA methylation state of several imprinted loci and of the 
epigenetic asymmetry (Nakamura et al., 2007).  
 Recently, it was shown that 5mC is converted to 5hmC by the TET proteins (Williams et 
al., 2011; Wu and Zhang, 2010). Interestingly, 5hmC was detected to appear in the paternal PN, 
while 5mC diminishes (Iqbal et al., 2011), suggesting that paternal 5mC is not removed, but 
hydroxymethylated to 5hmC in the zygote. This process has been shown to be dependent on 
TET3 (Gu et al., 2011). After hydroxymethylation of the paternal 5mC in the zygote, the 5hmC 
modification is diluted passively via DNA synthesis up to blastocyst embryos, like 5mC 
maternally (Inoue and Zhang, 2011).  
 In ESC, Tet1 was shown to convert 5mC to 5hmC (Williams et al., 2011; Wu and Zhang, 
2010). Tet1 preferentially binds CpG-rich sequences at promoters of transcriptionally active and 
also Polycomb-repressed genes (Williams et al., 2011; Wu and Zhang, 2010). In respect to 
repression, Tet1 contributes to silencing by facilitating recruitment of PRC2 to CpG-rich gene 
promoters (Wu and Zhang, 2010). Therefore, DNA hydroxymethylation has been linked to 
PRC2. DNA methylation on the other hand has been associated with the Suv39h pathway. In 
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cells, members of the Suv39h pathway as well as other H3K9 HMTs interact with DNA 
methyltransferases, linking H3K9 methylation and Hp1β with DNA methylation (Fuks et al., 
2003; Smallwood et al., 2007). These results implicate a role of epigenetic modifiers in DNA 
methylation and DNA hydroxymethylation.  
 Therefore, we wondered whether or not epigenetic modifiers globally affect DNA 
methylation or DNA hydroxymethylation. Zygotes, which were maternally deficient for either 
PcG proteins or members of three H3K9 HMT pathways, were 
analyzed for their maternal and paternal 5mC and 5hmC 
content.  
 
Results  
 In order to determine the 5mC/5hmC content of a 
zygote, the sum of the signal intensity for either 5mC or 5hmC 
of a confocal stack was plotted against the maximum area of 
each zygote (Figure 3.20). The 5mC intensity, 5hmC intensity 
and the area of the all zygotes from one group were displayed 
in a box plot (Figure 3.21.A.B.C). The signal intensity of 
zygotes of one group was then either multiplied by their areas 
(Figure 3.22.A) or divided by their areas (Figure 3.22.B), 
determining the signal intensity of 5mC or 5hmC per µm2. 
Furthermore, the relative maternal/paternal value for the 
intensity of the whole area for 5mC and 5hmC was determined 
(Figure 3.22.C).  
  
  
Figure 3.19: Representative confocal images of PN5 zygotes of 
the seven mouse lines analyzed. Zygotes were stained with 
antibodies against 5mC and 5hmC.   

LLT

 
Wild-type 
 First, we confirmed that wt PN5 zygotes display an asymmetry for 5mC DNA methylation 
(Figure 3.19). Maternal PN showed in average 1.7 times more 5mC signal than paternal PN 
(Figure 3.22.C). This indicates that paternal PN DNA is less methylated than maternal DNA. 
Nevertheless, paternal DNA is not completely devoid of 5mC. The asymmetry for 5hmC in wt 
zygotes is more evident with a maternal/paternal ratio of 0.3 (Figure 3.22.C). This difference 
between 5mC and 5hmC is probably caused by the different antibody properties. The intensity 
per µm2 as well as the intensity of the whole area is significantly different for 5mC and 5hmC 
between maternal and paternal PN in wt zygotes (Figure 3.22.A.B). 
 
PRC2 maternal deficiency 
 In PRC2 mutants (Ezh1m-z+; Ezh2m-z+), the maternal and paternal signal intensity for 5mC 
is similar to wt zygotes (Figure 3.19 and 3.20.A). The 5hmC signal in maternal PN is surprisingly 
high compared to wt zygotes (Figure 3.20.A). Nevertheless, 5hmC is more enriched paternally 
(Figure 3.20.A) and also the 5hmC value for the area×intensity between maternal and paternal 
PN is significantly different (Figure 3.22.A). Furthermore, the maternal/paternal ratio for 5mC is 
greater than one and for 5hmC it is smaller than 0.5 (Figure 3.22.C). 
 We conclude from these analyses that maternal deficiency of Ezh1m-z+; Ezh2m-z+ does 
not affect the protection of maternal 5mC or the paternal 5mC to 5hmC conversion.  
  
PRC1 maternal deficiency  
 Ring1am-z+; Ring1bm-z+ PN are small in size compared to wt zygotes. Furthermore, they 
often contain only one big NPB, unlike wt PN. It must be stated that in our analysis the area of 
NPBs were not subtracted from the PN area, which might affect the analysis of Ring1am-z+; 
Ring1bm-z+ PN (Figure 3.19). Nevertheless, paternal 5mC and maternal 5hmC are low, as in wt 
zygotes (Figure 3.20.A). Surprisingly, the enrichment of maternal 5mC and paternal 5hmC as it 
is observed in wt zygotes is not detected in Ring1am-z+; Ring1bm-z+ PN (Figure 3.20.A). This 
logically reduces the asymmetry of 5mC and 5hmC. Therefore, the comparison of the maternal 
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area×intensity value with the paternal area×intensity value is not significant (Figure 3.22.A). The 
intensity per µm2 for maternal and paternal 5mC is significant, though. Furthermore, the 
maternal/paternal ratio of the intensity of the whole area shows similar relative 5mC signal as wt 
zygotes, whereas the ratio of the 5hmC signal above 0.5 is higher than in wt PN (Figure 3.22.C).  
 Ring1am-z+; Ring1bm-z+ zygotes are defective in many aspects (Posfai et al, unpublished). 
Therefore, it is not known for the moment, whether or not the reduced 5mC/5hmC asymmetry 
compared to wt zygotes is due to the Ring1am-z+; Ring1bm-z+ deficiency directly or indirectly. 
Rescue experiments would answer this question.  
 
Suv39h2m-z+ zygotes 
 Among all mutant lines analyzed, Suv39h2m-z+ zygotes were most similar to wt zygotes in 
respect to DNA methylation and DNA hydroxymethylation. Analyses of the 5mC asymmetry in 
Suv39h2m-z+ PN show a similar asymmetry as in wt PN. The same is observed for 5hmC (Figure 
3.19, 3.20.B). Furthermore, the intensity per µm2 between maternal and paternal PN is 
significant for 5mC and 5hmC (Figure 3.22.B). Additionally, it is also significantly different 
between maternal and paternal PN for the intensity of the whole area for 5hmC (Figure 3.22.A).  
 These results suggest no effect of the Suv39h pathway on either paternal 5mC to 5hmC 
conversion or maternal protection of DNA methylation.  
 
Esetm-z+ zygotes 
 Zygotes maternally deficient for Eset display enhanced paternal 5mC signal (Figure 
3.20). This results in a maternal/paternal ratio for the intensity of the whole area for 5mC close 
to 1 (Figure 3.22). Nevertheless, the intensity per µm2 between maternal and paternal PN is 
significant for 5mC. The asymmetry for 5hmC on the other hand is more evident than the 
asymmetry for 5mC (Figure 3.20.B).  
 The enhanced maternal/paternal ratio of around 0.5 for 5hmC, and also the very low 
ratio of 5mC just above 1 (Figure 3.22), suggests a function of Eset in DNA demethylation.  
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G9am-z+ zygotes 
 Similar to Esetm-z+ zygotes, but more drastic, a low maternal/paternal ratio of the intensity 
of the whole area for 5mC together with a high maternal/paternal ratio clearly above 0.5 for 
5hmC was detected in G9a deficient zygotes (Figure 3.22.C). Most evident is the high intensity 
of the whole area value for maternal 5hmC (Figure 3.22.A), suggesting that G9a protects 
maternal 5mC from conversion to 5hmC. A scatter plot displaying the individual PN shows 
enhanced 5hmC maternally, but also more 5mC paternally (Figure 3.20.B).  
 The 5mC to 5hmC conversion in G9am-z+ zygotes is reduced paternally, whereas 
maternal DNA is enriched for 5hmC compared to wt zygotes.   
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Figure 3.20: Scatter plots displaying the area (X-axis) and the intensity (y-axis) of each PN. A. Scatter 
plots of wt, Ring1a/Ring1bm-z+ and Ezh1/Ezh2m-z+ PN. Left: maternal PN; right: paternal PN; top: 5mC 
signal; bottom: 5hmC signal. B. Scatter plots of wt, Suv39hm-z+, Esetm-z+, G9am-z+ and Hp1βm-z+ PN. Left: 
maternal PN; right: paternal PN; top: 5mC signal; bottom: 5hmC signal. 

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Hp1βm-z+ zygotes 
 Finally, Hp1βm-z+ zygotes display a similar phenotype as G9am-z+ zygotes. Whereas 
paternal 5mC is like in wt zygotes, maternal 5mC is reduced (Figure 3.20.B). Inversely, 5hmC is 
enriched maternally, suggesting that Hp1β protects 5mC from conversion to 5hmC. The 
intensity per µm2 is not significant for 5mC or for 5hmC (Figure 3.22.B). Interestingly, it is 
significant for the intensity of the whole area, though (Figure 3.16.A). The maternal/paternal 
ratio of the intensity of the whole area for Hp1βm-z+ zygotes for 5mC and for 5hmC is similar to 
G9am-z+ zygotes (Figure 3.22).  
 These results suggest that there is more 5mC to 5hmC conversion in the maternal PN of 
Hp1βm-z+ zygotes.  
 
Discussion 
 Our initial hypothesis that epigenetic repressors affect maternal 5mC content and 
paternal 5mC to 5hmC conversion was right. Among the six mutant mouse lines analyzed, we 
detected abnormalities in at least three lines. The results are all based on IF stainings, which is 
not the ideal method to quantitatively measure 5mC or 5hmC content. Nevertheless, the limited 
tissue available (one cell!) urged us to measure 5mC and 5hmC via IF stainings for pre-
screening of a possible effect of an epigenetic repressor towards 5mC or 5hmC. 
 In cell lines, PRC2 has been implicated with the TET proteins and 5hmC. In mouse 
zygotes maternally deficiency for Ezh1m-z+; Ezh2m-z+ did not result in the global change of 5hmC. 
The 5mC to 5hmC conversion occurs in these mutants like in wt zygotes. PRC1 mutants, on the 
other hand, affect the asymmetry. But not only 5hmC is affected, also 5mC is reduced. 
Interestingly, it is the maternal 5mC and the paternal 5hmC enrichment that is affected. The 
development of Ring1am-z+; Ring1bm-z+ zygotes is delayed (Posfai et al, unpublished). Therefore, 
it is possible that the Ring1am-z+; Ring1bm-z+ zygotes are not PN5 stage zygotes, but only PN3 
stage zygotes. In another step of analysis it needs to be determined whether or not this would 
influence the analysis. Furthermore, it should be analyzed whether or not this putative 
phenotype is directly due to the Ring1am-z+; Ring1bm-z+ genotype or not. It has been shown that 
Ring1am-z+; Ring1bm-z+ oocytes display the misregulation of thousands of genes (Posfai et al, 
unpublished). Therefore, it is very well possible that the effect of Ring1am-z+; Ring1bm-z+ on 5mC 
and 5hmC is only an indirect effect. This should be tested by rescue experiments. 
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 Interestingly, maternal deficiency for Suv39h2 did not result in the loss of 5mC/5hmC 
asymmetry. The Suv39h HMTs have been shown to interact with Dnmts. During zygotic 
development, they do not protect maternal 5mC or interact with proteins like PGC7/Stella that 
protect maternal 5mC. Maternal 5mC is not affected in Suv39h2m-z+ zygotes. Alike, maternal 
deficiency for the H3K9 HMT Eset does not result in the loss of maternal 5mC. Rather, paternal 
5mC is higher than in wt zygotes. This implicates a function of Eset in the 5mC to 5hmC 
conversion. Interestingly, paternal 5hmC is reduced, which is in agreement with a function of 
Eset in the 5mC to 5hmC conversion. Therefore, Eset should be tested for interactions with 
Tet3. The lack of paternal 5mC to 5hmC conversion observed in Esetm-z+ zygotes is less evident 
than in Tet3 mutants (Gu et al., 2011).  
 The most evident effect on the 5mC to 5hmC conversion in zygotes was observed in 
maternally deficient G9a and Hp1β zygotes. In both lines, enhanced conversion of maternal 
5mC is observed. This suggests that G9a and even more so Hp1β protect maternal DNA 
methylation. G9a and Hp1β have been shown to interact (Chin et al., 2007). Thus, their putative 
function in the protection of maternal DNA might be in the same pathway. The analysis of G9a 
and Hp1β double mutants would answer that question. Furthermore, it would be interesting to 
test, whether or not this protection of DNA methylation by G9a and Hp1β is PGC7/Stella 
dependent or independent. Altogether, these results suggest that G9a and Hp1β not only 
interact with the DNA methyltransferases (Esteve et al., 2006; Smallwood et al., 2007), but also 
protect DNA methylation from its conversion to 5hmC. It remains to be determined though, 
whether this occurs in a histone methylation dependent or independent manner.  
 
Material and Methods 
 Zygotes of the different mouse lines were in vitro fertilized at once and fixed at the PN5 
stage. The fixed zygotes were stained as previously described (Iqbal et al., 2011). 5mC was 
detected using a monoclonal antibody from eurogentec (1:500). 5hmC was detected using a 
polyclonal antibody from Active Motif (1:500). Images were analyzed by ImageJ. 
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Figure 3.21: Box plots of the 5mC intensity (A.), the 5hmC intensity (B.) and 
the area (C.) of the zygotes from the seven mouse lines analyzed. 

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Figure 3.22: A. Box plot displaying the values for area×intensity of 
maternal and paternal PN of the seven mouse lines. B. Box plot 
displaying the values for intensity/area (µm2) for the seven mouse 
lines. C. Relative value of the area×intensity between 
maternal/paternal PN. Red: maternal PN. Blue: paternal PN. Black: 
5mC. White: 5hmC. 

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 Figure 3.23: p-values determined by t-test for the graphs of Figure3.16.A and B. Significant 
values are written in bold. 

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4. Discussion 
 
Targeting of PRC1 by Cbx2 
 Recently, it was shown for BPTF, which is a subunit of the NURF chromatin remodeling 
complex regulator, that it recognizes H3K4me3 and H4K16 acetylation simultaneously at the 
mononucleosomal level (Ruthenburg et al., 2011). The C-terminal plant homeodomain (PHD) 
finger has been described to bind H3K4me3 (Wysocka et al., 2006). This PHD finger is linked 
by a 15 aa long α-helix with a bromodomain (Li et al., 2006), which exhibits binding selectivity 
for H4K16 acetylation in combination with H3K4me3 (Ruthenburg et al., 2011). Thus, the 
authors show that binding of BPTF is dependent on two protein modules that covalently bind 
modified histone tails. We propose in this study also a bi-modular targeting mechanism of Cbx2 
whith one module, the CD, binding the H3K27me3 modified histone tail and with the other 
module binding AT-rich DNA sequences. These two modules are, similar as in BPTF, linked by 
15 aa long linker. In the crystal structure of the human CBX2 CD, the N-terminus of the linker 
forms an α-helix (Kaustov et al., 2011), like the linker in BPTF. This suggests that the CD and 
the AT-hook motif together function in a given conformation, whereas the AT-hook motif confers 
rather unspecific binding to AT-rich DNA sequences, the CD ensures higher specificity. At PCH 
both modules are sufficient to target Cbx2. Only abrogation of both modules together results in 
loss of enrichment at heterochromatin. This suggests that the CD and the AT-hook motif display 
a positive, additive effect on Cbx2 targeting to heterochromatin. This is emphasized by the 
protein dynamics measured for Cbx2 containing point mutations in either the CD or the AT-
hook, which result in a similar increase of Cbx2 mobility at heterochromatin.  
 It is interesting to note that mitotic chromosomes in the first three cell divisions of the 
mouse embryo display also an asymmetry for Ring1b and H3K9me3 on chromosomal arms, 
thus at euchromatic sites, and not only at pericentromeric sites (Puschendorf et al., 2008). It is 
possible that the banding pattern observed for Ring1b coincide with the AT-rich G-bands 
observed by Giemsa staining. AT-richness of these bands would implicate a PRC1 targeting 
mechanism to euchromatin similar as observed in PCH, which would be dependent on the CD 
and the AT-hook of Cbx2.  
 Among the Cbx orthologs, Cbx2 is the only one to contain an AT-hook motif. Its 
expression peaks in oocytes and in preimplantation embryos. This suggests that the targeting 
LMT

mechanism for PRC1 we propose is occurring in a defined developmental time window. 
Interestingly, the CD and the AT-hook of Cbx2 are conserved in zebrafish. Furthermore, 
zebrafish Cbx2 has been shown to be maternally provided with putative function during early 
embryonic development (Kawamura et al., 2002). This suggests conservation of Cbx2 function 
in respect to its targeting mechanism within a developmental window among vertebrates.      
 It is evident that PRC1 complexes containing different Cbx orthologs exhibit different 
chromatin targets. A PRC1 complex containing Cbx2 is enriched at paternal PCH and also in a 
certain pattern at euchromatic bands in mitotic chromosomes. These chromatin targets are 
probably specific to Cbx2 due to its AT-hook. In ESCs or in differentiated cells, though, other 
Cbx orthologs are predominant. They do not only lack the AT-hook, but also display different 
binding affinities for methylated H3 histone tails. Thus, PRC1 containing different Cbx orthologs 
will localize to certain chromatin regions due to specific targeting properties. Therefore, it would 
be interesting to investigate the localization of the Cbx orthologs in a genome wide approach in 
different cell types. This would not only display the AT-hook dependent Cbx2 targets, but also 
unravel the target properties of the other Cbx orthologs.  
 
Interdependency of the Suv39h pathway and PRC1  
 One might ask naively: why have the two major epigenetic repressive pathways besides 
DNA methylation, not been described to colocalize? Why are they kept separate? What 
disadvantage would result from such a colocalization to an organism?   
 I hypothesize that the answer to these questions lies in their targeting mechanism. 
Different targets display different chromatin features, which facilitate RNA or DNA targeting 
mechanisms and further silencing. Therefore, the silencing machineries have evolved 
simultaneously to their targets. The silencing of one chromatin stretch might be efficiently 
silenced by one pathway, but not by the other pathway, due to a long established linkage of the 
silencer and its target.  
 The Suv39h pathway is older than the PcG proteins. It appears already in S. pombe and 
is highly conserved up to humans (Krauss, 2008). In these organisms it is associated with the 
silencing of PCH. During time, PCH and the Suv39h pathway evolved together. Thus, its 
targeting mechanism evolved concomitantly. Whereas targeting in S. pombe implicates non-
coding centromeric transcripts in targeting (Grewal, 2010), non-coding transcripts of the 
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pericentromeric major satellite repeats have been proposed to target Hp1β also to paternal PCH 
in mouse zygotes (Probst et al., 2010). This is thought to be crucial for heterochromatin 
maturation and finally recruitment of the Suv39h pathway to paternal chromatin. Thus, in mouse 
Hp1 is thought to target the Suv39h pathway to PCH via interaction with ncRNA. Based on this 
model, though, it was surprising that recombinant SUV39H1 microinjected into wt zygotes 
resulted in paternal establishment of H3K9me3 within a few hours. This raises the question, 
whether the SUV39H1 targeting to paternal PCH is actually dependent on the interaction of 
Hp1β with major satellite transcripts, or whether it is not just zygotic Suv39h, which is targeted 
to paternal PCH by satellite transcripts from the 4-cell stage onwards in mouse. To test, whether 
Hp1β, as it has been proposed, or the Suv39h HMTs directly are targeted to PCH for de novo 
establishment of heterochromatin, it would be interesting to microinject recombinant SUV39H1 
into Hp1βm-z+ zygotes and analyze the ability of SUV39H1 in setting H3K9me3 paternally 
independent of Hp1β. Taken together, unlike the targeting mechanism of Cbx2 to PCH, 
targeting of the canonical Suv39h pathway is not fully understood yet.  
 We describe in our evolutionary study Cbx2 paralogs appearing in cnidarians 
(metazoan). Nevertheless, so far only early bilateral animals have been described to form PRC1 
and PRC2 (Whitcomb et al., 2007). Thus, the PcG are young in comparison to the Suv39h 
pathway. Unlike Suv39h targets, PcG proteins have evolved to maintain the repressed state of 
facultative heterochromatin or silenced genes. This demands higher specificity than the 
silencing of repeats, which might has led to the appearance of this pathway, ensuring this 
specificity. Nevertheless, the maintenance of transcriptional silencing is achieved using similar 
protein domains, such as SET domains and CDs. I hypothesize that the maintenance of 
silencing via such domains is simply most efficient. That would explain, why they evolved in this 
similar way, originally probably by gene or protein domain duplication and further functional 
separation. Simultaneously, again, a targeting mechanism of PcG must have evolved. This 
targeting mechanism might, like for the Suv39h pathway, involve ncRNA, as described for 
HOTAIR and ANRIL (Rinn et al., 2007; Yap et al., 2010). Nevertheless, this ncRNA must display 
a different feature compared to transcripts of major satellites. Perhaps, secondary RNA 
structures confer this specificity.  
 Taken into account that classical PcG targets were described to be genes, it was 
surprising to detect PRC1 at paternal PCH, a classical Suv39h target, and to unravel a targeting 
mechanism that is independent on ncRNA. It should be mentioned again that unlike the other 
Cbx orthologs, Cbx2 has not been described to bind RNA at all. In other words, the ncRNA 
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independent targeting mechanism of Cbx2 to the classical Suv39h target probably evolved in 
such a way that it does not interfere with the putative targeting mechanism of the Suv39h 
pathway to paternal PCH. Nevertheless, the similarities of the two pathways do interfere to a 
certain extent. The binding affinity of the CDs of Hp1β and Cbx2 putatively evolved in a way that 
inhibits colocalization. The question remains though, why this separation of the two pathways is 
at all necessary. Why is PRC1 blocked from binding to maternal PCH? And what consequence 
would colocalization of the two pathways have for preimplantation embryos? This might be due 
to a quality control for the zygote. Actually, the whole asymmetry of maternal and paternal 
chromatin might be a quality control for the newly formed organism. After all, entry of the sperm 
head into an oocyte, that will eventually form an embryo, nurtured by the mother, is a critical 
moment. Foreign DNA entering a cell is of potential danger. Therefore, it makes sense to mark 
the ‘intruders’ chromatin differentially than one’s own chromatin, initially. This gives the newly 
formed embryo a time window to abort development, in case the paternal DNA turns out to be 
unfavorable for embryonic development. This parent of origin specific epigenetic marking of 
chromatin enables discrimination of the two genomes even after intermingling of maternal and 
paternal DNA after the first cell division, beyond the ZGA in late 2-cell embryos and up to the 4-
8 cell stage embryos, where the parental chromatin states assimilate. Thus, from my point of 
view, blocking of PRC1 by Hp1β maintains the parent of origin specific marking of 
heterochromatin, keeping the highly repetitious paternal major satellite repeats, distinct from the 
maternal repeats. Finally, it would be interesting to test whether or not this parent of origin 
specific epigenetic marking is conserved in preimplanation embryos of other species. 
 
Size Difference of Maternal and Paternal Pronuclei 
 The chromatin marks of maternal PN resemble the chromatin signature of ESC and 
other cell types, whereas the chromatin marks of the paternal PN in the mouse zygote display a 
more immature chromatin state, hyperacetylated and hypomethylated and therefore less 
condensed than maternal chromatin. This is visualized by the size difference of the maternal 
and the paternal PN. Therefore, the mouse zygote is a good model to study determinants of the 
nuclear size and chromatin compaction. Zygotes maternally deficient for chromatin associated 
factors can be analyzed for either size increase of maternal PN or size decrease of the paternal 
PN. Interestingly, we show here experimentally that Hp1β is a determinant factor for the 
compaction of maternal chromatin. Hp1β IF analysis in wt zygotes displays maternal and 
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paternal euchromatic staining. Despite the euchromatic presence of Hp1β in both PN, the 
maternal PN is smaller. A major difference between maternal and paternal chromatin is the lack 
of global paternal H3K9me3, which is the histone mark that is bound by CD of Hp1β with the 
highest affinity. This suggests that it is Hp1β bound to H3K9me3 that determines the PN size 
reduction. According to that, the reduction, but not complete loss of H3K9me3 in Suv39h2m-z+ 
zygotes results in an intermediate increase of the maternal PN size, compared to wt and Hp1βm-
z+ zygotes. Furthermore, exogenously provided SUV39H1 tri-methylates paternal H3K9, which 
results in the decrease of the paternal PN size.  
 The results of these experiments show that Hp1β within the Suv39h pathway compacts 
chromatin globally in vivo. 
 
Impact of Epigenetic Repressors on Zygotic 5mC to 5hmC conversion  
 We hypothesized that epigenetic repressors affect maternal 5mC content and paternal 
5mC to 5hmC conversion. Among the six mutant mouse lines analyzed, we detected 
abnormalities in at least three lines. Our results are based on IF stainings, which is not the ideal 
method to quantitatively measure 5mC or 5hmC content. Nevertheless, the limited tissue 
available (one cell!) urged us to measure 5mC and 5hmC via IF stainings for pre-screening of a 
possible effect of an epigenetic repressor towards 5mC or 5hmC. 
 In mouse zygotes maternally deficiency for Ezh1m-z+; Ezh2m-z+ did not result in the global 
change of 5hmC. The 5mC to 5hmC conversion occurs in these mutants like in wt zygotes. In 
PRC1 mutants the maternal 5mC enrichment and the paternal 5hmC enrichment are affected. 
The development of Ring1am-z+; Ring1bm-z+ zygotes is delayed (Posfai et al, unpublished). 
Therefore, it is possible that the Ring1am-z+; Ring1bm-z+ zygotes are not PN5 stage zygotes, but 
only PN3 stage zygotes. In another step of analysis it needs to be determined whether or not 
this would influence the analysis. Furthermore, it should be analyzed whether or not this 
putative phenotype is directly due to the Ring1am-z+; Ring1bm-z+ genotype or not. It has been 
shown that Ring1am-z+; Ring1bm-z+ oocytes display misregulation of thousands of genes (Posfai 
et al, unpublished). Therefore, it is very well possible that the effect of Ring1am-z+; Ring1bm-z+ on 
5mC and 5hmC is only an indirect effect. This should be tested by rescue experiments. 
 Interestingly, maternal deficiency for Suv39h2 did not result in the loss of 5mC/5hmC 
asymmetry. Therefore, it does not protect maternal 5mC or interact with proteins like 
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PGC7/Stella that protect maternal 5mC. Alike, maternal deficiency for the H3K9 HMT Eset does 
not result in the loss of maternal 5mC. Rather, paternal 5mC is higher than in wt zygotes. This 
implicates a function of Eset in the 5mC to 5hmC conversion. Interestingly, paternal 5hmC is 
reduced, which would be in agreement with a function of Eset in the 5mC to 5hmC conversion. 
Therefore, Eset should be tested for interactions with Tet3. The lack of paternal 5mC to 5hmC 
conversion observed in Esetm-z+ zygotes is less evident than in Tet3 mutants (Gu et al., 2011).  
 The most evident effect on the 5mC to 5hmC conversion in zygotes was observed in 
maternally deficient G9a and Hp1β zygotes. In both lines, enhanced conversion of maternal 
5mC is observed. This suggests that G9a and even more so Hp1β protect maternal DNA 
methylation. Interestingly, G9a and Hp1β have been shown to interact (Chin et al., 2007). Thus, 
their putative function in the protection of maternal DNA might be within the same pathway. The 
analysis of G9a and Hp1β double mutants would answer that question. Furthermore, it would be 
interesting to test, whether or not this protection of DNA methylation by G9a and Hp1β is 
PGC7/Stella dependent or independent. Altogether, these results suggest that G9a and Hp1β 
not only interact with the DNA methyltransferases (Esteve et al., 2006; Smallwood et al., 2007), 
but also protect DNA methylation from its conversion to 5hmC. It remains to be determined 
though, whether this occurs in a histone methylation dependent or independent manner.  
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Sequence pcDNA3.1-polyA: 1-5677 
1gacggatcgggagatctcccgatcccctatggtcgactctcagtacaatctgctctgatgccgcatagttaagccagtatctgctccct
gcttgtgtgttggaggtcgctgagtagtgcgcgagcaaaatttaagctacaacaaggcaaggcttgaccgacaattgcatgaagaatc
tgcttagggttaggcgttttgcgctgcttcgcgatgtacgggccagatatacgcgttgacattgattattgactagttattaatagtaatcaatt
acggggtcattagttcatagcccatatatggagttccgcgttacataacttacggtaaatggcccgcctggctgaccgcccaacgaccc
ccgcccattgacgtcaataatgacgtatgttcccatagtaacgccaatagggactttccattgacgtcaatgggtggactatttacggtaa
actgcccacttggcagtacatcaagtgtatcatatgccaagtacgccccctattgacgtcaatgacggtaaatggcccgcctggcattat
gcccagtacatgaccttatgggactttcctacttggcagtacatctacgtattagtcatcgctattaccatggtgatgcggttttggcagtac
atcaatgggcgtggatagcggtttgactcacggggatttccaagtctccaccccattgacgtcaatgggagtttgttttggcaccaaaatc
aacgggactttccaaaatgtcgtaacaactccgccccattgacgcaaatgggcggtaggcgtgtacggtgggaggtctatataagca
gagctctctggctaactagagaacccactgcttactggcttatcgaaattaatacgactcactatagggagacccaagctggctagtta
agcttggtaccgagctcggatccactagtccagtgtggtggaattctgcagatatccagcacagtggcggccgctcgactatgggcac
pcDNA3.1 polyA
5677 bp
Neomycin
Ampicillin
SV40 poly(A)
CMV promoter
SV40 early promoter
T7 promoter
f1 origin
TRF2 3' UTR and poly(A)
BamHI (921)
Eco RI (944)
HindIII (903)
KpnI (913)
NotI (971)
Xho I (1160)
LPR

caaagaacctgtaaacgttatctttttaaattgaatgtgcacaaataaaagtttggaaaagaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaatacgcatcatacgctgtggcgt
acctcgagtctagagggcccttcgaacaaaaactcatctcagaagaggatctgaatatgcataccggtcatcatcaccatcaccattg
agtttaaacccgctgatcagcctcgactgtgccttctagttgccagccatctgttgtttgcccctcccccgtgccttccttgaccctggaagg
tgccactcccactgtcctttcctaataaaatgaggaaattgcatcgcattgtctgagtaggtgtcattctattctggggggtggggtggggc
aggacagcaagggggaggattgggaagacaatagcaggcatgctggggatgcggtgggctctatggcttctgaggcggaaagaa
ccagctggggctctagggggtatccccacgcgccctgtagcggcgcattaagcgcggcgggtgtggtggttacgcgcagcgtgacc
gctacacttgccagcgccctagcgcccgctcctttcgctttcttcccttcctttctcgccacgttcgccggctttccccgtcaagctctaaatc
ggggcatccctttagggttccgatttagtgctttacggcacctcgaccccaaaaaacttgattagggtgatggttcacgtagtgggccatc
gccctgatagacggtttttcgccctttgacgttggagtccacgttctttaatagtggactcttgttccaaactggaacaacactcaaccctat
ctcggtctattcttttgatttataagggattttggggatttcggcctattggttaaaaaatgagctgatttaacaaaaatttaacgcgaattaatt
ctgtggaatgtgtgtcagttagggtgtggaaagtccccaggctccccaggcaggcagaagtatgcaaagcatgcatctcaattagtca
gcaaccaggtgtggaaagtccccaggctccccagcaggcagaagtatgcaaagcatgcatctcaattagtcagcaaccatagtccc
gcccctaactccgcccatcccgcccctaactccgcccagttccgcccattctccgccccatggctgactaattttttttatttatgcagagg
ccgaggccgcctctgcctctgagctattccagaagtagtgaggaggcttttttggaggcctaggcttttgcaaaaagctcccgggagctt
gtatatccattttcggatctgatcaagagacaggatgaggatcgtttcgcatgattgaacaagatggattgcacgcaggttctccggccg
cttgggtggagaggctattcggctatgactgggcacaacagacaatcggctgctctgatgccgccgtgttccggctgtcagcgcaggg
gcgcccggttctttttgtcaagaccgacctgtccggtgccctgaatgaactgcaggacgaggcagcgcggctatcgtggctggccacg
acgggcgttccttgcgcagctgtgctcgacgttgtcactgaagcgggaagggactggctgctattgggcgaagtgccggggcaggat
ctcctgtcatctcaccttgctcctgccgagaaagtatccatcatggctgatgcaatgcggcggctgcatacgcttgatccggctacctgcc
cattcgaccaccaagcgaaacatcgcatcgagcgagcacgtactcggatggaagccggtcttgtcgatcaggatgatctggacgaa
gagcatcaggggctcgcgccagccgaactgttcgccaggctcaaggcgcgcatgcccgacggcgaggatctcgtcgtgacccatg
gcgatgcctgcttgccgaatatcatggtggaaaatggccgcttttctggattcatcgactgtggccggctgggtgtggcggaccgctatc
aggacatagcgttggctacccgtgatattgctgaagagcttggcggcgaatgggctgaccgcttcctcgtgctttacggtatcgccgctc
ccgattcgcagcgcatcgccttctatcgccttcttgacgagttcttctgagcgggactctggggttcgcgaaatgaccgaccaagcgac
gcccaacctgccatcacgagatttcgattccaccgccgccttctatgaaaggttgggcttcggaatcgttttccgggacgccggctggat
gatcctccagcgcggggatctcatgctggagttcttcgcccaccccaacttgtttattgcagcttataatggttacaaataaagcaatagc
atcacaaatttcacaaataaagcatttttttcactgcattctagttgtggtttgtccaaactcatcaatgtatcttatcatgtctgtataccgtcga
cctctagctagagcttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctcacaattccacacaacatacgagccgg
aagcataaagtgtaaagcctggggtgcctaatgagtgagctaactcacattaattgcgttgcgctcactgcccgctttccagtcgggaa
acctgtcgtgccagctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgctcttccgcttcctcgctcactg
actcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggata
acgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggc
tccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtt
LPS

tccccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcg
ctttctcaatgctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccg
accgctgcgccttatccggtaactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacag
gattagcagagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggt
atctgcgctctgctgaagccagttaccttcggaaaaagagttggtagctcttgatccggcaaacaaaccaccgctggtagcggtggtttt
tttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcctttgatcttttctacggggtctgacgctcagtggaac
gaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttttaaattaaaaatgaagttttaaatcaat
ctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgatctgtctatttcgttcatccata
gttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccgcgagacccac
gctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctcc
atccagtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgt
ggtgtcacgctcgtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaa
gcggttagctccttcggtcctccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctctt
actgtcatgccatccgtaagatgcttttctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctc
ttgcccggcgtcaatacgggataataccgcgccacatagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaa
ctctcaaggatcttaccgctgttgagatccagttcgatgtaacccactcgtgcacccaactgatcttcagcatcttttactttcaccagcgttt
ctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcgacacggaaatgttgaatactcatactcttcct
ttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtatttagaaaaataaacaaataggggttccg
cgcacatttccccgaaaagtgccacctgacgtc-5677 
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Sequence EGFP-N1: 1-4714 
1tagttattaatagtaatcaattacggggtcattagttcatagcccatatatggagttccgcgttacataacttacggtaaatggcccgcct
ggctgaccgcccaacgacccccgcccattgacgtcaataatgacgtatgttcccatagtaacgccaatagggactttccattgacgtc
aatgggtggagtatttacggtaaactgcccacttggcagtacatcaagtgtatcatatgccaagtacgccccctattgacgtcaatgacg
gtaaatggcccgcctggcattatgcccagtacatgaccttatgggactttcctacttggcagtacatctacgtattagtcatcgctattacca
tggtgatgcggttttggcagtacatcaatgggcgtggatagcggtttgactcacggggatttccaagtctccaccccattgacgtcaatgg
gagtttgttttggcaccaaaatcaacgggactttccaaaatgtcgtaacaactccgccccattgacgcaaatgggcggtaggcgtgtac
ggtgggaggtctatataagcagagctggtttagtgaaccgtcagatccgctagcgctaccggactcagatctacccagtcgacggtac
cgcgggcccgggatccaccggtcgccaccatggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagct
ggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagtt
catctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccc
EGFP-N1
4714 bp
EGFP
SV40 ORI
pUC Ori
SV40 polyA
HSV polyA
pEGFP-N1 R
EGFP seq R
CMV
Bac prom
SV40 early prom
Kanamycin
ApaLI (4343)
AvaI (638)
BamHI (642)
ClaI (2579)
SmaI (640)
XmaI (638)
SalI (621)
BglII (610)
NotI (1383)
BsgI (789)
BsgI (886)
BsgI (1210)
NcoI (361)
NcoI (659)
NcoI (2468)
NcoI (3171)
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cgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacg
gcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaagg
aggacggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaagaac
ggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacaccccc
atcggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgc
gatcacatggtcctgctggagttcgtgaccgccgccgggatcactctcggcatggacgagctgtacaagtaaagcggccgcgactct
agatcataatcagccataccacatttgtagaggttttacttgctttaaaaaacctcccacacctccccctgaacctgaaacataaaatga
atgcaattgttgttgttaacttgtttattgcagcttataatggttacaaataaagcaatagcatcacaaatttcacaaataaagcatttttttca
ctgcattctagttgtggtttgtccaaactcatcaatgtatcttaaggcgtaaattgtaagcgttaatattttgttaaaattcgcgttaaatttttgtt
aaatcagctcattttttaaccaataggccgaaatcggcaaaatcccttataaatcaaaagaatagaccgagatagggttgagtgttgttc
cagtttggaacaagagtccactattaaagaacgtggactccaacgtcaaagggcgaaaaaccgtctatcagggcgatggcccacta
cgtgaaccatcaccctaatcaagttttttggggtcgaggtgccgtaaagcactaaatcggaaccctaaagggagcccccgatttagag
cttgacggggaaagccggcgaacgtggcgagaaaggaagggaagaaagcgaaaggagcgggcgctagggcgctggcaagt
gtagcggtcacgctgcgcgtaaccaccacacccgccgcgcttaatgcgccgctacagggcgcgtcaggtggcacttttcggggaaa
tgtgcgcggaacccctatttgtttatttttctaaatacattcaaatatgtatccgctcatgagacaataaccctgataaatgcttcaataatatt
gaaaaaggaagagtcctgaggcggaaagaaccagctgtggaatgtgtgtcagttagggtgtggaaagtccccaggctccccagca
ggcagaagtatgcaaagcatgcatctcaattagtcagcaaccaggtgtggaaagtccccaggctccccagcaggcagaagtatgc
aaagcatgcatctcaattagtcagcaaccatagtcccgcccctaactccgcccatcccgcccctaactccgcccagttccgcccattct
ccgccccatggctgactaattttttttatttatgcagaggccgaggccgcctcggcctctgagctattccagaagtagtgaggaggctttttt
ggaggcctaggcttttgcaaagatcgatcaagagacaggatgaggatcgtttcgcatgattgaacaagatggattgcacgcaggttct
ccggccgcttgggtggagaggctattcggctatgactgggcacaacagacaatcggctgctctgatgccgccgtgttccggctgtcag
cgcaggggcgcccggttctttttgtcaagaccgacctgtccggtgccctgaatgaactgcaagacgaggcagcgcggctatcgtggct
ggccacgacgggcgttccttgcgcagctgtgctcgacgttgtcactgaagcgggaagggactggctgctattgggcgaagtgccggg
gcaggatctcctgtcatctcaccttgctcctgccgagaaagtatccatcatggctgatgcaatgcggcggctgcatacgcttgatccggc
tacctgcccattcgaccaccaagcgaaacatcgcatcgagcgagcacgtactcggatggaagccggtcttgtcgatcaggatgatct
ggacgaagagcatcaggggctcgcgccagccgaactgttcgccaggctcaaggcgagcatgcccgacggcgaggatctcgtcgt
gacccatggcgatgcctgcttgccgaatatcatggtggaaaatggccgcttttctggattcatcgactgtggccggctgggtgtggcgga
ccgctatcaggacatagcgttggctacccgtgatattgctgaagagcttggcggcgaatgggctgaccgcttcctcgtgctttacggtat
cgccgctcccgattcgcagcgcatcgccttctatcgccttcttgacgagttcttctgagcgggactctggggttcgaaatgaccgaccaa
gcgacgcccaacctgccatcacgagatttcgattccaccgccgccttctatgaaaggttgggcttcggaatcgttttccgggacgccgg
ctggatgatcctccagcgcggggatctcatgctggagttcttcgcccaccctagggggaggctaactgaaacacggaaggagacaa
taccggaaggaacccgcgctatgacggcaataaaaagacagaataaaacgcacggtgttgggtcgtttgttcataaacgcggggtt
cggtcccagggctggcactctgtcgataccccaccgagaccccattggggccaatacgcccgcgtttcttccttttccccaccccaccc
cccaagttcgggtgaaggcccagggctcgcagccaacgtcggggcggcaggccctgccatagcctcaggttactcatatatacttta
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gattgatttaaaacttcatttttaatttaaaaggatctaggtgaagatcctttttgataatctcatgaccaaaatcccttaacgtgagttttcgttc
cactgagcgtcagaccccgtagaaaagatcaaaggatcttcttgagatcctttttttctgcgcgtaatctgctgcttgcaaacaaaaaaa
ccaccgctaccagcggtggtttgtttgccggatcaagagctaccaactctttttccgaaggtaactggcttcagcagagcgcagatacc
aaatactgtccttctagtgtagccgtagttaggccaccacttcaagaactctgtagcaccgcctacatacctcgctctgctaatcctgttac
cagtggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaagacgatagttaccggataaggcgcagcggtcgggctg
aacggggggttcgtgcacacagcccagcttggagcgaacgacctacaccgaactgagatacctacagcgtgagctatgagaaag
cgccacgcttcccgaagggagaaaggcggacaggtatccggtaagcggcagggtcggaacaggagagcgcacgagggagctt
ccagggggaaacgcctggtatctttatagtcctgtcgggtttcgccacctctgacttgagcgtcgatttttgtgatgctcgtcaggggggcg
gagcctatggaaaaacgccagcaacgcggcctttttacggttcctggccttttgctggccttttgctcacatgttctttcctgcgttatcccct
gattctgtggataaccgtattaccgccatgcat4714 
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